
<html lang="en"     class="pb-page"  data-request-id="373dc986-23ed-4c68-bebb-bf4dcab0355e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01588;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239" /></meta><meta name="dc.Creator" content="Sylvia  Richard-Bildstein" /></meta><meta name="dc.Creator" content="Hamed  Aissaoui" /></meta><meta name="dc.Creator" content="Julien  Pothier" /></meta><meta name="dc.Creator" content="Gabriel  Schäfer" /></meta><meta name="dc.Creator" content="Carmela  Gnerre" /></meta><meta name="dc.Creator" content="Eleanor  Lindenberg" /></meta><meta name="dc.Creator" content="François  Lehembre" /></meta><meta name="dc.Creator" content="Laetitia  Pouzol" /></meta><meta name="dc.Creator" content="Philippe  Guerry" /></meta><meta name="dc.Description" content="The chemokine receptor CXCR7, also known as ACKR3, is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies such as neurological diseases, autoimmune diseases, and..." /></meta><meta name="Description" content="The chemokine receptor CXCR7, also known as ACKR3, is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies such as neurological diseases, autoimmune diseases, and..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 14, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01588" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01588" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01588" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01588" /></link>
        
    
    

<title>Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01588" /></meta><meta property="og:title" content="Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0025.jpeg" /></meta><meta property="og:description" content="The chemokine receptor CXCR7, also known as ACKR3, is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies such as neurological diseases, autoimmune diseases, and cancers. By binding and scavenging the chemokines CXCL11 and CXCL12, CXCR7 regulates their extracellular levels. From an original high-throughput screening campaign emerged hit 3 among others. The hit-to-lead optimization led to the discovery of a novel chemotype series exemplified by the trans racemic compound 11i. This series provided CXCR7 antagonists that block CXCL11- and CXCL12-induced ß-arrestin recruitment. Further structural modifications on the trisubstituted piperidine scaffold of 11i yielded compounds with high CXCR7 antagonistic activities and balanced ADMET properties. The effort described herein culminated in the discovery of ACT-1004-1239 (28f). Biological characterization of ACT-1004-1239 demonstrated that it is a potent, insurmountable antagonist. Oral administration of ACT-1004-1239 in mice up to 100 mg/kg led to a dose-dependent increase of plasma CXCL12 concentration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01588"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01588">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01588&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01588&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01588&amp;href=/doi/10.1021/acs.jmedchem.0c01588" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15864-15882</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01573" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01609" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sylvia Richard-Bildstein</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylvia Richard-Bildstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#ff8c869389969ed18d969c979e8d9bbf969b908d8c969ed19c9092"><span class="__cf_email__" data-cfemail="4a3933263c232b64382329222b382e0a232e253839232b64292527">[email protected]</span></a>. Phone: +41-58-844-06-87.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylvia++Richard-Bildstein">Sylvia Richard-Bildstein</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6588-1599" title="Orcid link">http://orcid.org/0000-0001-6588-1599</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hamed Aissaoui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hamed Aissaoui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hamed++Aissaoui">Hamed Aissaoui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julien Pothier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julien Pothier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julien++Pothier">Julien Pothier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gabriel Schäfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gabriel Schäfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gabriel++Sch%C3%A4fer">Gabriel Schäfer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7792-9542" title="Orcid link">http://orcid.org/0000-0002-7792-9542</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carmela Gnerre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carmela Gnerre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carmela++Gnerre">Carmela Gnerre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eleanor Lindenberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eleanor Lindenberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eleanor++Lindenberg">Eleanor Lindenberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">François Lehembre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">François Lehembre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fran%C3%A7ois++Lehembre">François Lehembre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laetitia Pouzol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laetitia Pouzol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laetitia++Pouzol">Laetitia Pouzol</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Philippe Guerry</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philippe Guerry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c3b3abaaafaab3b3a6eda4b6a6b1b1ba83aaa7acb1b0aaa2eda0acae"><span class="__cf_email__" data-cfemail="89f9e1e0e5e0f9f9eca7eefcecfbfbf0c9e0ede6fbfae0e8a7eae6e4">[email protected]</span></a>. Phone: +41-58-844-02-88.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Guerry">Philippe Guerry</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5631-1279" title="Orcid link">http://orcid.org/0000-0001-5631-1279</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01588&amp;href=/doi/10.1021%2Facs.jmedchem.0c01588" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15864–15882</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 14, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 September 2020</li><li><span class="item_label"><b>Published</b> online</span>14 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01588" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01588</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15864%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSylvia%2BRichard-Bildstein%252C%2BHamed%2BAissaoui%252C%2BJulien%2BPothier%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01588%26title%3DDiscovery%2Bof%2Bthe%2BPotent%252C%2BSelective%252C%2BOrally%2BAvailable%2BCXCR7%2BAntagonist%2BACT-1004-1239%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15882%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01588"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2017</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01588" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sylvia&quot;,&quot;last_name&quot;:&quot;Richard-Bildstein&quot;},{&quot;first_name&quot;:&quot;Hamed&quot;,&quot;last_name&quot;:&quot;Aissaoui&quot;},{&quot;first_name&quot;:&quot;Julien&quot;,&quot;last_name&quot;:&quot;Pothier&quot;},{&quot;first_name&quot;:&quot;Gabriel&quot;,&quot;last_name&quot;:&quot;Schäfer&quot;},{&quot;first_name&quot;:&quot;Carmela&quot;,&quot;last_name&quot;:&quot;Gnerre&quot;},{&quot;first_name&quot;:&quot;Eleanor&quot;,&quot;last_name&quot;:&quot;Lindenberg&quot;},{&quot;first_name&quot;:&quot;François&quot;,&quot;last_name&quot;:&quot;Lehembre&quot;},{&quot;first_name&quot;:&quot;Laetitia&quot;,&quot;last_name&quot;:&quot;Pouzol&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Guerry&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15864-15882&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01588&quot;},&quot;abstract&quot;:&quot;The chemokine receptor CXCR7, also known as ACKR3, is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies such as neurological diseases, autoimmune diseases, and cancers. By binding and scavenging the chemokines CXCL11 and CXCL12, CXCR7 regulates their extracellular levels. From an original high-throughput screening campaign emerged hit 3 among others. The hit-to-lead optimization led to the discovery of a novel chemotype series exemplified by the trans racemic compound 11i. This series provided CXCR7 antagonists that block CXCL11- and CXCL12-induced ß-arrestin recruitment. Further structural modifications on the trisubstituted piperidine scaffold of 11i yielded compounds with high CXCR7 antagonistic activities and balanced ADMET properties. The effort described herein culminated in the discovery of ACT-1004-1239 (28f). Biological characterization of ACT-1004-1239 demonstrated that it is a potent, insurmountable antagonist. Oral administration of ACT-1004-1239 in mice up to&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01588" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01588&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01588" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01588&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01588" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01588&amp;href=/doi/10.1021/acs.jmedchem.0c01588" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01588" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01588" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01588%26sid%3Dliteratum%253Aachs%26pmid%3D33314938%26genre%3Darticle%26aulast%3DRichard-Bildstein%26date%3D2020%26atitle%3DDiscovery%2Bof%2Bthe%2BPotent%252C%2BSelective%252C%2BOrally%2BAvailable%2BCXCR7%2BAntagonist%2BACT-1004-1239%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15864%26epage%3D15882%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The chemokine receptor CXCR7, also known as ACKR3, is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies such as neurological diseases, autoimmune diseases, and cancers. By binding and scavenging the chemokines CXCL11 and CXCL12, CXCR7 regulates their extracellular levels. From an original high-throughput screening campaign emerged hit <b>3</b> among others. The hit-to-lead optimization led to the discovery of a novel chemotype series exemplified by the trans racemic compound <b>11i</b>. This series provided CXCR7 antagonists that block CXCL11- and CXCL12-induced ß-arrestin recruitment. Further structural modifications on the trisubstituted piperidine scaffold of <b>11i</b> yielded compounds with high CXCR7 antagonistic activities and balanced ADMET properties. The effort described herein culminated in the discovery of ACT-1004-1239 (<b>28f</b>). Biological characterization of ACT-1004-1239 demonstrated that it is a potent, insurmountable antagonist. Oral administration of ACT-1004-1239 in mice up to 100 mg/kg led to a dose-dependent increase of plasma CXCL12 concentration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">C-X-C chemokine receptor type 7 (CXCR7) is a seven-transmembrane G-protein-coupled receptor (GPCR), also known as ACKR3 (atypical chemokine receptor 3), expressed mainly by endothelial cells and other nonlymphoid cells, including mesenchymal cells, cardiomyocytes, neurons, astrocytes, and oligodendrocyte precursor cells (OPCs).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> CXCR7 binds, internalizes, and degrades the chemokines CXCL11 (C-X-C chemokine ligand 11) and CXCL12 (C-X-C chemokine ligand 12). Importantly, CXCL11 and CXCL12 also bind to the chemokine receptors CXCR3 and CXCR4, respectively. Unlike classical GPCRs, CXCR7 does not couple with G proteins and consequently does not mediate signaling cascades but rather functions primarily as a scavenger receptor. Binding of its ligands leads to the recruitment of β-arrestin, internalization of the CXCR7-ligand complex,<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1,3)</a> and degradation of the ligand in lysosomes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Through its scavenging function, CXCR7 regulates the extracellular levels of CXCL11 and CXCL12 and, therefore, modulates CXCR3 and CXCR4 activities.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> CXCL11-CXCR3 signaling regulates migration, differentiation, and activation of immune cells including T helper type 1 cells and macrophages.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Activation of CXCR4 by CXCL12 mediates a wealth of cellular functions such as migration, adhesion, proliferation, differentiation, and cell survival.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Dysregulation of the CXCR7 axis has been associated with various disease states such as, neurological disorders,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> autoimmune diseases,<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14−17)</a> inflammation,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> cancers,<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26">(21−26)</a> and cardiac disorders.<a onclick="showRef(event, 'ref21 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref27 ref28">(21,27,28)</a></div><div class="NLM_p last">Antibodies and/or small interfering RNA (siRNA) have demonstrated the utility of targeting CXCR7 in some of these diseases.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29−33)</a> Although a number of small molecules were reported as CXCR7 antagonists,<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> they were later on described as bona fide agonists, recruiting β-arrestin to CXCR7 upon binding to the receptor (“functional antagonists”).<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> Very recently, a moderately potent CXCR7 antagonist inhibiting the recruitment of ß-arrestin to CXCR7 following CXCL12 stimulation was reported (“true antagonist”).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> We describe here the hit-to-lead process followed by the lead optimization of a novel chemotype series providing potent, selective, insurmountable, and orally available “true” CXCR7 antagonists.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Biological Assays</h3><div class="NLM_p">Binding of agonists to CXCR7 has been reported to mediate β-arrestin recruitment to the receptor. This recruitment can be monitored using the PathHunter CHO-K1 CXCR7 β-arrestin assay from DiscoverX (“CXCR7-agonist <b>1</b> assay” thereafter). The system is based on the enzyme fragment complementation technology. Two complementing fragments of the β-galactosidase (β-gal) enzyme are expressed within stably transfected cells. The larger portion of β-gal, termed EA for enzyme acceptor, is fused to the C-terminus of β-arrestin 2. The smaller fragment, termed ProLink tag, is fused to CXCR7 at the C-terminus. Upon activation, β-arrestin 2 is recruited to CXCR7, which forces the interaction of ProLink and EA, allowing complementation of the two fragments of β-gal, and the formation of a functional enzyme, which is able to hydrolyze the substrate and generating a chemiluminescent signal.</div><div class="NLM_p">This assay was used to screen the Idorsia, formerly Actelion, screening compound collection. For practical and cost reasons, we decided to screen our library against the low-molecular-weight agonist <b>1</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) instead of the natural ligands CXCL11 and CXCL12. It was also postulated that this innovative approach could lead to the identification of weak antagonists that we might not have identified by screening against the natural ligands. The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>. Compounds from our screening compound collection were screened at 10 μM. Compounds displaying more than 30% effect (inhibition) in the primary screen were selected, and their IC<sub>50</sub> values were determined.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the CXCR7 agonist <b>1</b> and primary screening hits <b>2–6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Following our screening cascade, another β-arrestin recruitment assay (CXCR7 Tango assay from Invitrogen, “CXCR7-CXCL12 assay” thereafter) was selected to further profile the active compounds using CXCL12 as a ligand. This assay was used as a biological <i>in vitro</i> assay to establish the SAR of the compounds identified in the primary screen. The CXCR7-β-lactamase U2OS cell line contains human CXCR7 fused at its intracellular C-terminus to the Gal4-VP16 transcription factor (CXCR7-Gal4-VP16). Interposed between CXCR7 and Gal4-VP16 is the tobacco etch virus (TEV) protease site that can be recognized and cleaved by the TEV protease. The parental cell line stably expresses a β-arrestin/TEV protease fusion protein and the β-lactamase reporter gene under the control of a UAS response element. Upon ligand binding and receptor activation, the protease-tagged β-arrestin molecule is recruited to CXCR7-Gal4-VP16. The protease cleaves the transcription factor Gal4-VP16 from CXCR7, which translocates to the nucleus and activates the expression of β-lactamase. A FRET-enabled substrate allows detecting β-lactamase activity. The results of this assay are reported as IC<sub>50</sub> values.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure–Activity and Structure–Property Relationships</h3><div class="NLM_p">The 300,000 compounds of the HTS deck of Idorsia were composed of vendor screening compounds and proprietary compounds. The high-throughput screening of this compound collection against CXCR7 activated with the agonist <b>1</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (CXCR7-agonist <b>1</b> assay) identified a small cluster of five basic molecules <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b>, all of them devoid of antagonistic activity against the natural ligand in the CXCR7-CXCL12 assay. Herein, we describe the conversion of this unique cluster of antagonists active exclusively against the agonist <b>1</b> to potent CXCR7 antagonists active against the natural ligands CXCL11 and CXCL12.</div><div class="NLM_p">Having no crystal structure of the target protein available to guide chemistry and in view of the structural features of the hits, a classical high-throughput chemistry approach was followed to explore the chemical space around these compounds using the CXCR7-agonist <b>1</b> assay. In the hit-to-lead phase of the project, several libraries were produced in an iterative manner starting mainly from commercially available building blocks. The five compounds depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> shared some common features. To confirm the emerging SAR, two amide libraries have been prepared (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The truncation of the thiophene moiety in hits <b>2</b> and <b>3</b> (compounds <b>7a</b> and <b>7b</b>) led to similar or improved ligand efficiency (LE) showing that this moiety was not a key part of the pharmacophore. Combination of amine and carboxylic acid parts of the hits was either inactive (<b>7c</b>, <b>7d</b>) or equipotent (<b>7e</b>) to the original hits. As shown by the inactive compound <b>7f</b>, the basic amine seemed to be important for potency. Bridging of the tertiary amine to a pyrrolidine (<b>7g</b>) decreased the LE. The extension of the amide linker from two to three carbons led to similar (<b>7h</b>, <b>7j</b>) or improved LE (<b>7k</b>). Introduction of additional ring constraints in the linker was investigated. The 4-amino-piperidine cores of compounds <b>7i</b> and <b>7l</b> gave only a moderate LE, but the substitution of the piperidine N-atom with larger alkyl groups as analogs of <b>7l</b> provided a significant increase in potency with improved or at least similar LE as shown by compounds <b>7m</b> to <b>7p</b>, <b>7o</b> exhibiting an IC<sub>50</sub> value of 78 nM. Considering the chemical structure of the compounds, a cardiac potassium channel hERG liability was anticipated and confirmed by the activity of <b>7o</b> in the hKV11.1 assay (IC<sub>50</sub> = 4.7 μM). To minimize the risk of inhibition of this ion channel, the compounds were designed by ideally keeping the cLog <i>D</i><sub>7.4</sub> in the range of 0.5–1.5.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. First SAR Iteration on Amides A and B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0009.gif" alt="" id="gr8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0010.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>, used as surrogate of endogenous CXCR7 ligands; data are the geometric mean (+/–2-fold) of at least three independent experiments. For synthesis and assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">For the second synthetic iteration, 1-cyclohexylpiperidin-4-amine was kept constant and coupled with a series of carboxylic acids to map the right-hand side amide part (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). An unsubstituted phenyl triazole <b>8a</b> and unsubstituted phenyl-4-oxobutanamide <b>8c</b> surprisingly led to a complete loss in activity, highlighting the importance of the substituents of the phenyl ring. It appeared that fluorine atoms had a synergistic effect and important role for reaching low nanomolar potency as shown by the <i>p</i>-fluorophenyl compound <b>8d</b> (IC<sub>50</sub> = 374 nM, 5-fold less potent than <b>7o)</b>. A <i>p</i>-bromo halogen atom was substantially less active (<b>8b</b>) and compound <b>8f</b> bearing a <i>p</i>-chloro substituent led to a 4-fold reduction in potency. A pyridine moiety as a bioisostere<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> of the 2,4-difluorophenyl group led to the inactive compound <b>8j</b>. The combination of an isoxazole and the key fluorine substituents as illustrated by compounds <b>8g</b>, <b>8h</b>, and <b>8i</b> gave an activity cliff to IC<sub>50</sub> = 5 nM for <b>8g</b> and confirmed the important role of the two fluorine atoms. Based on the low nanomolar potency reached, compound <b>8g</b> was further characterized. Tested in the CXCR7-CXCL12 assay with CXCL12 as a ligand, <b>8g</b> showed an IC<sub>50</sub> of 463 nM (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Despite an acceptable measured log <i>D</i><sub>7.4</sub> of 2.8, <b>8g</b> showed an hERG inhibition of 1.5 μM in the hKV11.1 assay. But the compound exhibited encouraging solubilities in fasted (FaSSIF) and fed state simulated intestinal fluid (FeSSIF) with 144 and 196 mg/L, respectively, and an aqueous solubility of 15 mg/mL at pH 7.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modulation of the Carboxamide Part</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0011.gif" alt="" id="gr10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>, used as surrogate of endogenous CXCR7 ligands; data are the geometric mean (+/–2-fold) of at least three independent experiments. For synthesis and assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exploration of the Tertiary Amine Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0013.gif" alt="" id="gr12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0014.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>, used as surrogate of endogenous CXCR7 ligands.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">nd: not determined. Data are the geometric mean (+/–2-fold) of at least three independent experiments. For synthesis and assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">For the next generation of compounds, the most potent ones were screened in the CXCR7-CXCL12 assay in addition to the CXCR7-agonist <b>1</b> assay. The left-hand part N-R<sup>1</sup> amine substituent was modified with the double aim of further improving the activity and tackling the identified hERG channel liability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Diverse alkyl chains were tolerated and led to nanomolar activities in the CXCR7-agonist <b>1</b> assay. Unfortunately, the shift in IC<sub>50</sub> between the CXCR7-agonist <b>1</b> assay and CXCR7-CXCL12 assay was still significant and the potency slightly decreased when the ring size was reduced (<b>9c</b> and <b>9d</b>). The amide analog <b>9a</b> confirmed that an amine group was mandatory for potency. In addition, attempts to reduce the basicity of the tertiary amine led also to a decrease in activity as depicted by the fluorinated example <b>9e</b> and ether analogue <b>9f</b>. A benzyl substituent <b>9g</b> led to the low IC<sub>50</sub> shift of 12 between the assays but with the price of an increased lipophilicity and potentially an added metabolic hotspot. The shift observed with the secondary amine <b>9b</b> was the lowest (5.8), but the potency was too low for further investigation.</div><div class="NLM_p">The replacement of the isoxazole ring with other 5-membered or 6-membered heterocycles was then explored. The modification had a marked impact on the lipophilicity of the compounds as shown by the clog <i>D</i><sub>7.4</sub> values. <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> depicts a selection of active molecules prepared. A decrease in affinity was observed for the pyrazole and triazole derivatives (<b>10a</b>, <b>10b</b>) in the CXCR7-agonist <b>1</b> assay. The inverted 3-(2,4-difluorophenyl)isoxazole analogue <b>10c</b> of <b>8g</b> was 5 times less potent in the CXCR7-agonist <b>1</b> assay but only 2 times less potent in the CXCR7-CXCL12 assay. Six-membered rings as exemplified by the pyrimidine <b>10f</b> led to a decrease in potency. Interestingly, the IC<sub>50</sub> shift between the assays was in the same range for all these analogues and lower than observed previously. The oxadiazoles <b>10d</b> and <b>10e</b> showed potencies in the same range than <b>8g</b>, with IC<sub>50</sub> values of 554 and 203 nM in the CXCR7-CXCL12 assay, respectively. Despite a measured log <i>D</i><sub>7.4</sub> of 1.6, the latest compound did not exhibit an improvement on the hERG inhibitory activity with an IC<sub>50</sub> of 2.7 μM.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Exploration of the Core Heteroaromatic Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0015.gif" alt="" id="gr14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0016.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>, used as surrogate of endogenous CXCR7 ligands.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand. Data are the geometric mean (+/–2-fold) of at least three independent experiments. For synthesis and assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">As the SAR observed so far remained steep in the CXCR7-CXCL12 assay, it was decided to investigate the potential of a new exit vector on the 4-amino-piperidine core with the aim of further increasing activity in this assay and improving the selectivity over the hERG channel. All the compounds described in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> are racemates unless otherwise stated, and their synthesis is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a> part.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Exploration of Exit Vectors and Substituents on the 4-Amino-piperidine Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0017.gif" alt="" id="gr16" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0018.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The CHO-K1 CXCR7 β-arrestin cell line was preincubated with the compounds to be screened for 15 min before the addition of 5 nM of the small molecule agonist <b>1</b>, used as surrogate of endogenous CXCR7 ligands.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">nd: not determined. Data are the geometric mean (+/–2-fold) of at least three independent experiments. For synthesis and assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">Alkylation of the secondary amide function was rapidly abandoned due to a dramatic decrease in potency of the examples produced. Among them, only the benzyl analogue <b>11a</b> is shown. The focus was then set on the introduction of substituents in position 3 of the piperidine core. The decrease of the basicity of the tertiary amine by the addition of two fluorine atoms (<b>11b</b>) led to an important decrease in potency as observed previously (compound <b>9e)</b>. The introduction of a methoxy group provided a significant improvement in potency as shown by compound <b>11c</b> with IC<sub>50</sub> values of 2 nM in the CXCR7-agonist <b>1</b> assay and 61 nM in the CXCR7-CXCL12 assay. Larger alkoxy groups like ethoxy (<b>11d</b>) caused a loss in potency by 2-fold in both assays. The same exercise with a hydroxy group (<b>11e</b>) gave potencies in a similar low nanomolar range in the CXCR7-agonist <b>1</b> assay but a 2-fold potency decrease in the CXCR7-CXCL12 assay as compared with the methoxy analogue. Extending the alcohol function by one carbon (<b>11f</b>) did not improve the potency in the CXCR7-CXCL12 assay. The introduction of a methyl ester in position 3 of the piperidine core (<b>11g</b>) delivered a very potent compound in the CXCR7-agonist <b>1</b> assay that unfortunately exhibited a 100-fold IC<sub>50</sub> shift in the CXCR7-CXCL12 assay. Saponification of the ester to the acid <b>11h</b>, which could have helped to modulate the hERG liability, caused a loss in potency. Interestingly, by the introduction of a dimethyl amide, the potency was regained as shown by compound <b>11i</b> that exhibited an IC<sub>50</sub> of 66 nM in the CXCR7-CXCL12 assay. The shift of the amide group to position 4 of the piperidine core exemplified by the achiral compound <b>11j</b> led to a complete loss in activity.</div><div class="NLM_p">Compound <b>11i</b> was selected for further characterization. Aqueous solubility (192 mg/L at pH 7) and solubilities in FaSSIF and FeSSIF (569 and 652 mg/L) were improved compared to <b>8g</b>. Some ADMET parameters were promising, especially with an intrinsic clearance of 13 μL/min/mg protein in human microsomes and 274 μL/min/mg protein in rat microsomes. Finally, compound <b>11i</b> demonstrated moderate inhibitory potency (IC<sub>50</sub> = 5.5 μM) in the hKV11.1 assay. Separation of the racemate <b>11i</b> by chiral prep. HPLC delivered both enantiomers (<i>R</i>,<i>R</i>)-<b>11i</b> and (<i>S</i>,<i>S</i>)-<b>11i</b>, which, respectively, display IC<sub>50</sub> CXCR7-agonist <b>1</b> assay/IC<sub>50</sub> CXCR7-CXCL12 assay of 1.5 nM/37.6 nM and 7.4 nM/388 nM. A 5-fold shift in the CXCR7-agonist <b>1</b> assay and a 10-fold shift in the CXCR7-CXCL12 assay were observed between both enantiomers, highlighting that the influence of the absolute stereochemistry had to be assessed. The absolute stereochemistry of enantiomers (<i>R</i>,<i>R</i>)-<b>11i</b> and (<i>S</i>,<i>S</i>)-<b>11i</b> was confirmed by an enantioselective synthesis described in the chemistry part.</div><div class="NLM_p">To ensure a sustainable antagonistic effect, the ideal compound should be insurmountable, meaning that its potency should be constant even in the presence of potentially increasing concentrations of the natural ligands. A selection of compounds was tested in an insurmountability assay (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>). Whereas compounds <b>11c</b> and <b>11e</b> were found surmountable, the (<i>R</i>,<i>R</i>)-enantiomer of the dimethyl analog <b>11i</b> was the first compound showing insurmountability. This exciting finding encouraged us to investigate further this exit vector and to produce large amide libraries from the racemic <i>trans</i> carboxylic acid intermediate <b>11h</b>. Some of the most interesting analogs are shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of 3-Carboxamide Moiety of the <i>trans</i> Racemic Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0019.gif" alt="" id="gr18" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0020.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Separated (3<i>R</i>,4<i>R</i>) enantiomer.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Separated (3<i>S</i>,4<i>S</i>) enantiomer. Data are the geometric mean (+/–2-fold) of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_p">The coupling with diverse small alkyl amines (<b>20a–20d</b>) gave compounds with potencies in a similar range than the dimethylamide <b>11i</b> in the CXCR7-CXCL12 assay. The introduction of cyclic secondary amines led to a 3- and 10-fold decrease in potency for the azetidine (<b>20d</b>) and the pyrrolidine (<b>20e</b>), respectively. More hydrophilic groups did not improve potency as shown by compounds <b>20f</b> and <b>20g</b>. Interestingly, the coupling with amines bearing an aromatic group gave a significant increase in potency as depicted by the benzylamide <b>20h</b> with an IC<sub>50</sub> of 36 nM and the pyridin-2-yl-methanamide <b>20j</b> with an IC<sub>50</sub> of 51 nM. The phenylamide <b>20i</b> was less potent. A further surprising breakthrough was achieved with the phenethyl amides <b>20k</b> and <b>20l</b> with low nanomolar potencies for the first time of IC<sub>50</sub> = 10 nM and IC<sub>50</sub> = 2 nM, respectively. Another major improvement was realized when the pyridin-2-yl-methanamide <b>20j</b> was shielded with a methyl group at the benzylic position. Indeed, compound <b>20m</b>, a mixture of four <i>trans</i>-diastereomers showed a 10-fold increase in potency with an IC<sub>50</sub> of 6.7 nM.</div><div class="NLM_p">Having established the absolute stereochemistry of (3<i>S</i>,4<i>S</i>)-<b>11i</b> and (3<i>R</i>,4<i>R</i>)-<b>11i</b>, the same exercise was repeated with both enantiomeric (<i>R</i>)-1-pyridinyl-2-yl-ethylamine and (<i>S</i>)-1-pyridinyl-2-yl-ethylamine that were coupled with both enantiomers (<i>S</i>,<i>S</i>)-<b>19</b> and (<i>R</i>,<i>R</i>)-<b>19</b> intermediates to deliver the four possible <i>trans</i>-enantiomers. The diastereomer <b>20o</b> was the most potent antagonist of this series, followed by <b>20n</b>, then <b>20p</b>, and finally <b>20q</b>. Compound <b>20o</b> was selected for further characterization. Its aqueous solubility was low (4 mg/L at pH 7), whereas solubility values in FaSSIF and FeSSIF were 38 and > 910 mg/L, respectively. Several ADMET parameters were not yet optimal, especially CL<sub>int</sub> in HLM (100 μL/min/mg) and in RLM (823 μL/min/mg). On the other hand, compound <b>20o</b> still demonstrated inhibitory potency (IC<sub>50</sub> = 3.4 μM) in the hERG assay. <b>20o</b> was also found insurmountable. Stereochemistry of the central scaffold appeared to play an important role in combination with the substitution on the 3-carboxamide, a large amide group being more potent when combined with the (<i>S</i>,<i>S</i>) scaffold. On the other hand, a small dimethyl amide combined with the (<i>R</i>,<i>R</i>) scaffold was more potent than the corresponding (<i>S</i>,<i>S</i>) analogue as shown before (compound (<i>R</i>,<i>R</i>)-<b>11i</b>). As replacement of the dimethyl amide with other small amides did not improve the potency, the focus was to further improve potency and properties for oral administration by exploring (<i>S,S</i>)-3-carboxamides containing an aromatic or heteroaromatic ring.</div><div class="NLM_p">The <i>in vitro</i> characteristics of this panel of 3-carboxamides are detailed in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. The (<i>S</i>,<i>S)</i>-benzylic analogue <b>21a</b> displayed the same potency as the racemic <b>20h</b>. Methylation of the benzylic position improved the potency further but increased the lipophilicity, which translated in a decreased metabolic stability. Further structural modifications were attempted to reduce lipophilicity and thereby increase metabolic stability. Hydroxylation on the benzylic methyl group (<b>21c</b>) reduced the potency. Spacer extension was tolerated but <b>21d</b> was rather metabolically unstable. The dimethylated compound <b>21e</b> was very potent. The 1-(pyridin-2-yl)cyclopropyl amide <b>21f</b> was slightly less potent but not inhibiting the hERG channel up to 10 μM in comparison to many analogues of this series, and it exhibited a metabolic stability of 47 μL/min/mg. Finally, the 1-(pyrimidin-2-yl)cyclopropyl amide <b>21g</b> was a very potent antagonist, displaying a metabolic stability of 22 μL/min/mg but inhibiting hERG with an IC<sub>50</sub> of 2.6 μM. Protein binding was measured in human plasma for the most promising antagonists and found to be in a range of 84.1–98.4%. This exploration of the amide substitution of the 3-carboxamide led to the identification of very potent antagonists, however with moderate Cl<sub>int</sub> values in HLM and still showing hERG inhibitory activities.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Structural Modification and Properties: 3-Carboxamide Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0021.gif" alt="" id="gr20" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0022.gif" alt="" id="gr21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">nd: not determined. Data are the geometric mean (+/–2-fold) of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> summarizes the impact of <i>N</i>-substitution on the potency, the Cl<sub>int</sub> in HLM, the IC<sub>50</sub> against the hERG channel, and on some additional physico-chemical properties. These modifications showed that the lipophilicity of substituents was an important feature for low nanomolar potency on the receptor, small substituents like H (<b>27</b>), Me (<b>28a</b>), or ethyl (<b>28b</b>) giving less potent compounds. On the other hand, larger substituents gave compounds that displayed higher Cl<sub>int</sub> values in HLM and had a stronger affinity toward hERG. Basicity of the piperidine nitrogen was measured through the p<i>K</i><sub>a</sub> of the conjugated acid. The nitrogen needed to be basic enough for highly potent CXCR7 antagonism. The corresponding neutral <i>N</i>-acetamide <b>28o</b> was indeed only weakly active. Introduction of fluorine in compounds <b>28k</b>, <b>28l</b>, <b>28m</b>, or of a methoxy group as in derivative <b>28n</b> on the <i>N</i>-alkyl substituent did reduce the basicity and the hERG blockage but at the same time reduced the affinity to the receptor. Protein binding was measured in human plasma for the most promising antagonists and was in a range of 73.1–91.5%. Among all the compounds of <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, the <i>N</i>-cyclopropylmethyl compound <b>28f</b> displayed the most balanced profile<named-content content-type="anchor" rid="sch1" type="simple"></named-content>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of (3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[carboxyamino-3-carbonyl]-amino}-piperidine-3-carboxylic Acid-amide Derivatives (3<i>S</i>,4<i>S</i>)<b>-11i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-toluensulfonic acid, toluene, reflux, 18 h, quantitative; (b) NaBH<sub>4</sub>, isobutyric acid, toluene, 0 °C, 6 h; (c) NaOEt, EtOH, 50 °C, 18 h, then HCl diethylether/dioxane, 16%; (d) 10% Pd/C, HCO<sub>2</sub>NH<sub>4</sub>, MeOH, reflux, 2 h, 82%; (e) 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid, HATU, DIPEA, DMF, rt., 18 h, 51%; (f) HCl 4 N in dioxane, DCM, rt., 30 min, 99%; (g) cyclohexanone, NaBH(OAc)<sub>3</sub>, AcOH, DCM, rt., 24 h, 94%; (h) NaOH aq., THF, rt., 6 h, quantitative; and (i) dimethylamine, (40% in water), HATU, DIPEA, DMF, rt., 6 h, 36%.</p></p></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Structural Modification and Properties: <i>N</i>-1-Piperidine Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0023.gif" alt="" id="gr22" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0024.gif" alt="" id="gr23" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">CXCR7-CXCL12 assay using CXCL12 as a ligand.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">nd: not determined. Data are the geometric mean (+/–2-fold) of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_p">The interesting profile of <b>28f</b> prompted us to confirm the influence of stereochemistry on the antagonist potency. The stereochemistry had a strong impact as the corresponding <i>trans</i>-(3<i>R</i>,4<i>R</i>)-enantiomer <b>29</b>, obtained by the same synthetic approach and is described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> but starting with the chiral auxiliary (<i>R</i>)-(+)-α-methylbenzylamine, was 150 time less potent with an IC<sub>50</sub> of 490 nM. This stereochemical effect was even more pronounced in the case of the <i>cis</i> substitution as both <i>cis</i>-(3<i>R</i>,4<i>S</i>)-<b>30</b> and <i>cis</i>-(3<i>S</i>,4<i>R</i>)-<b>31</b> enantiomers were found to be rather weak antagonists with IC<sub>50</sub> of 2250 nM and above 5500 nM, respectively. The <i>cis</i> enantiomers <b>30</b> and <b>31</b> were obtained from the same synthetic pathway and are described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, starting either from (<i>S</i>)-(−)-α-methylbenzylamine or (<i>R</i>)-(+)-α-methylbenzylamine, without conducting the equilibration step. The structural assignment based on the synthetic access,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> in particular the absolute (3<i>S</i>,4<i>S</i>) stereochemistry, was confirmed by X-ray analysis of crystals of compound <b>28f</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular structure of compound <b>28f</b> as determined by X-ray structural analysis. Anisotropic thermal ellipsoids are drawn at a 50% probability level. The cyclopropyl rest was not refined anisotropically (due to a high disorder present, for details see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>). For clarity, the disordered part and all hydrogen atoms have been omitted. The solvate molecule present (MeOH) was squeezed using software tool Platon SQUEEZE.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 1-Substituted (<i>3S</i>,<i>4S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid (1-Pyrimidin-2-yl-cyclopropyl)-amide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-toluensulfonic acid, toluene, reflux, 18 h, quantitative; (b) NaBH<sub>4</sub>, trifluoracetic acid, THF, −18 °C, 1 h; (c) 20% Pd(OH)<sub>2</sub>/C, H<sub>2</sub>, MeOH, rt., 18 h, quantitative; (d) 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid, T<sub>3</sub>P, DCM, TEA, rt., 18 h, 79%; (e) NaOEt, EtOH, EtOAc, rt., 2 h, chiral chromatography, 63%; (f) NaOH 1 N aq., THF, rt., 8 h, HCl 2 N, rt., 30 min, 98%; (g) 1-pyrimidin-2-yl-cyclopropylamine, HATU, DIPEA, DMF, rt., 18 h, 87%; (h) 4 N HCl in 1,4-dioxane, MeOH, rt., 1 h, NaHCO<sub>3</sub> aq. DCM, 98%; (i) aldehyde or ketone, NaBH(OAc)<sub>3</sub>, AcOH, DCM, rt., 24 h, 94%; and (j) alkyl bromide or iodide, base, acetone.</p></p></figure><div class="NLM_p">To summarize the important features <i>in vitro</i>, potent antagonists required some basic character on N-1 of the piperidine and sufficient lipophilicity to achieve a low nanomolar potency on the target receptor. Ideal basicity values were found to be close to pKa 7.4 to keep potency on the receptor and should not be higher than pKa 7.8 to avoid stronger hERG inhibition. Lipophilicity (log <i>D</i><sub>7.4</sub>) was kept below 2.7 for the same reasons. Despite the surprisingly narrow navigation space between these molecular properties, compound <b>28f</b>, named with the corporate code ACT-1004-1239, fitted most requirements and was therefore selected as the ideal candidate for <i>in vivo</i> evaluation. Compound <b>28f</b> is a weak base (p<i>K</i><sub>a</sub> = 7.7) and displays an aqueous solubility of 374 mg/L at pH 7, whereas solubility values in FaSSIF and FeSSIF were 513 and > 880 mg/L. The capacity of <b>28f</b> to inhibit the cytochrome P450 2C9, 2D6, and 3A4 was assessed <i>in vitro</i> in HLM. All IC<sub>50</sub> values were above 50 μM. ACT-1004-1239 was very potent on CXCR7 from other species and inactive on human CXCR4 (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). ACT-1004-1239 was tested in a panel of 87 enzymatic and radioligand binding assays and was found to be selective for CXCR7 (data not shown).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. <i>In Vitro</i> Pharmacology of ACT-1004-1239 (<b>28f</b>)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human CXCR7<sup>a</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog CXCR7<sup>b</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat CXCR7<sup>c</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse CXCR7<sup>d</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">guinea pig CXCR7<sup>e</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">macaque CXCR7<sup>f</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human CXCR4<sup>g</sup> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Note: <sup>a</sup>CXCR7-CXCL12 assay. <sup>a–f</sup>Assays performed with CXCL12 as a ligand. <sup>b–f</sup>Data are the average of at least five independent experiments and were determined using the DiscoverX assay. <sup>g</sup>Human CXCR4 FlipR assay. For assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Insurmountability Assessment and Binding Kinetic of ACT-1004-1239</h3><div class="NLM_p">We then wished to confirm that ACT-1004-1239 displayed insurmountable antagonism against both CXCR7 ligands, CXCL11 and CXCL12. Thus, the IC<sub>50</sub> of ACT-1004-1239 was determined in the presence of increasing concentrations of CXCL11 or CXCL12 (up to 1 μM). As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the IC<sub>50</sub> values of ACT-1004-1239 fell into a narrow range at different ligand concentrations. The data show that ACT-1004-1239 is a potent insurmountable CXCR7 antagonist against both CXCL11 and CXCL12.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Determination of ACT-1004-1239 insurmountability against CXCL11 (upper panel) and CXCL12 (lower panel) in the CXCR7-agonist <b>1</b> assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the association (<i>K</i><sub>on</sub>) and dissociation (<i>K</i><sub>off</sub>) rate constants of ACT-1004-1239, a HEK293 cell line expressing a SNAP-tag-fused hCXCR7 receptor was established for the binding assay. Cells stably expressing the SNAP-tag-hCXCR7 fusion protein were labelled with SNAP-Lumi4-Tb. A fluorescent derivative of CXCL12, hereafter named “red-CXCL12”, was used. The dissociation constant (<i>K</i><sub>d</sub>) of red-CXCL12 was determined to be 1.33 nM at room temperature (data not shown). Competitive binding assays were carried out using ACT-1004-1239 as a competitor. As expected, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows a decrease of the HTRF signal upon the addition of increasing concentrations of ACT-1004-1239. In this experiment, ACT-1004-1239 had a <i>K</i><sub>i</sub> of 0.53 nM, a <i>K</i><sub>off</sub> of 0.06945 min<sup>–1</sup>, and a <i>K</i><sub>on</sub> of 1.309 10<sup>8</sup> M<sup>–1</sup> min<sup>–1</sup> at room temperature.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Determination of the <i>K</i><sub>i</sub>, <i>K</i><sub>on</sub>, and <i>K</i><sub>off</sub> constants (specific binding) of ACT-1004-1239.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The dissociation rate constant of ACT-1004-1239 (residence time, <i>t</i> = 1/<i>K</i><sub>off</sub>) was 14.4 min, and its half-life (<i>t</i><sub>1/2</sub> = ln2/<i>K</i><sub>off</sub>) was 9.98 min.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>In Vivo</i> Pharmacokinetic Studies</h3><div class="NLM_p">Pharmacokinetic studies were performed in rat and dog after oral (10 and 1 mg/kg) and intravenous (1 mg/kg) dosing. The pharmacokinetic parameters of ACT-1004-1239 are described in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>, which also displays the plasma protein binding and intrinsic clearance in the liver microsomal preparation of each species. After intravenous dosing in the rat, ACT-1004-1239 displayed a systemic plasma clearance of 70 mL/min per kilogram. After correction for blood/plasma partitioning, blood clearance was approximatively 70% of the liver blood flow. Plasma and blood clearances in the dog were 2.8 and 3.8 mL/min per kilogram, the latter representing 9% of the liver blood flow. These data show that ACT-1004-1239 is a high-clearance drug in the rat and a low-clearance drug in the dog. Also, these <i>in vivo</i> clearance data are in line with the <i>in vitro</i> intrinsic clearance values determined in rat and dog liver microsomes, i.e., of 140 versus 5 μ/mL per milligram protein, respectively. The volume of distribution at the steady state (<i>V</i><sub>ss</sub>) in rat and dog was in excess of total body water with 3.6 and 1.6 L per kilogram, respectively. Oral absorption was rapid in the rat with peak plasma concentrations being reached within 0.5 h. In the dog, <i>T</i><sub>max</sub> was around 1.5 h. Bioavailability reached 35% in the rat and was 61% in the dog.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Pharmacokinetic Parameters of ACT-1004-1239 in Rat and Dog<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">AUC<sub>0-last</sub> (ng/h/mL)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/h/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-Inf</sub> (ng/h/mL)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (mL/min/mg)</th><th class="colsep0 rowsep0" align="center">PPB (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">rat, 10 mg/kg</td><td class="colsep0 rowsep0" colspan="3" align="left">rat, 1 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">RLM</td><td class="colsep0 rowsep0" align="left">rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">827</td><td class="colsep0 rowsep0" align="left">600</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">238</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">91.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">dog, 1 mg/kg</td><td class="colsep0 rowsep0" colspan="3" align="left">dog, 1 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DLM</td><td class="colsep0 rowsep0" align="left">dog</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3620</td><td class="colsep0 rowsep0" align="left">314</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">5940</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">83.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Observed pharmacokinetic parameters are average values for rat, p.o. (<i>n</i> = 3), iv (<i>n</i> = 2), dog p.o./iv (<i>n</i> = 2). <i>T</i><sub>max</sub> is given as median. Blood/plasma ratios for rat and dog are 1.1 and 0.7, respectively. Mean conc. 8 h post oral dose was 18.3 ng/mL in the rat and 185 ng/mL in the dog.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Evaluation of <i>in Vivo</i> Target Engagement</h3><div class="NLM_p">The potency and rodent pharmacokinetic properties of compound ACT-1004-1239 administrated orally were suitable for evaluating this compound <i>in vivo</i>. The effect of ACT-1004-1239 on plasma CXCL12 was evaluated in naive male DBA/1 mice at a range of 1–100 mg/kg. Single oral dosing resulted in a rapid, significant, dose-dependent increase in CXCL12 plasma concentrations over 24 h in comparison to vehicle-treated mice. These data demonstrate the inhibition of CXCR7-mediated degradation of circulating CXCL12 with ACT-1004-1239. At the highest dose tested (100 mg/kg), a single oral dose of ACT-1004-1239 induced a 4.1- to 4.9-fold mean CXCL12 plasma elevation relative to control mice, 0.5 and 6 h after dosing, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panels A and B). The duration of this increase was also dose dependent. At doses up to 30 mg/kg, CXCL12 plasma concentrations returned to vehicle levels within 24 h, whereas with 100 mg/kg of ACT-1004-1239, 24 h after administration, CXCL12 plasma levels were still substantially increased (2.6-fold; <i>p</i> < 0.01 vs vehicle-treated mice) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel C). Nevertheless, even at this dose, CXCL12 plasma concentrations returned to levels similar to vehicle-treated mice within 96 h post dosing (data not shown). The second ligand of CXCR7, CXCL11, an inducible chemokine was also measured in plasma but did not significantly increase in naíve mice after a single oral dose (data not shown). The plasma concentrations of ACT-1004-1239 increased in a dose-dependent manner and reached a maximum after 0.5 h, with plasma concentrations ranging from 6 ± 2 ng/mL (1 mg/kg single oral dose) to 4285 ± 579 ng/mL (100 mg/kg single oral dose) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel D). At doses of 30 mg/kg and below, no compound was quantifiable 24 h after oral administration (below the limit of quantification: 1.52 ng/mL) whereas at 100 mg/kg, 14 ± 5 ng/mL of compound was still measured in the plasma (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel F). Based on these results, twice daily oral administration of ACT-1004-1239 might be needed in murine disease models to reach high enough drug plasma concentration at trough, to maintain sustained CXCL12 elevation at all times.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of a single oral administration (p.o.) of ascending doses of ACT-1004-1239 on CXCL12 plasma concentration (upper row) and compound plasma concentration (lower row) in naive male DBA/1 mice. CXCL12 plasma concentration was measured at 0.5 (A), 6 (B), or 24 h (C) after a single oral administration of ACT-1004-1239. Results are expressed as fold change to vehicle-treated mice. ACT-1004-1239 plasma concentration measured 0.5 (D), 6 (E), or 24 h (F) after a single oral administration. Results are expressed as mean + standard error of the mean (SEM) (<i>n</i> = 3–5/dose group). **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001 vs vehicle, using one-way analysis of variance (ANOVA) followed by the Dunnett’s multiple comparisons test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An enantioselective synthesis<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of <i>N</i>-boc-trans-4-aminopiperidine-3-carboxylic acid ethyl ester <b>15</b> employing α-methylbenzylamine as a chiral auxiliary and nitrogen source was used to generate both <i>trans</i> enantiomers (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and allowed the establishment of the absolute stereochemistry of both enantiomers, (3<i>R</i>,4<i>R</i>)-<b>11i</b> and (3<i>S</i>,4<i>S</i>)-<b>11i</b>. This synthetic route further offers the advantage that it can be used to explore stepwise substitution at the three exit vectors of the piperidine scaffold.</div><div class="NLM_p">4-Oxo-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester was reacted with the chiral auxiliary (<i>S</i>)-(−)-α-methylbenzylamine in refluxing toluene containing a catalytic amount of <i>p</i>-toluenesulfonic acid to form enamine <b>12</b>. The enamine was reduced with a mixture of NaBH<sub>4</sub> and isobutyric acid at 0 °C. The resulting 4:1 mixture of the two <i>cis</i>-diastereomers of the β-amino ester <b>13</b> was treated with sodium ethanolate in ethanol causing epimerization to the <i>trans</i>-β-aminoester <b>14</b>. The pure (<i>S</i>,<i>S</i>)-β-aminoester <b>14</b> was isolated from the mixture as the hydrochloride salt in 16% yield. A cleavage of the α-methylbenzyl group was achieved with ammonium formiate in the presence of 10% Pd/C in refluxing MeOH. During this reaction, a transesterification to the methyl ester occurred. The <i>trans</i> primary amine <b>15</b> was acylated with 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid to deliver the <i>trans</i>-(3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-methyl ester <b>16</b>. N-Boc deprotection with HCl in 1,4-dioxane to the secondary amine <b>17</b> followed by <i>N</i>-alkylation with cyclohexanone under reductive amination conditions with sodium triacetoxy borohydride in the presence of acetic acid furnished the amine <b>18</b>. The ester moiety of <b>18</b> was hydrolyzed with NaOH in a THF/water mixture to <b>19</b>. HATU-mediated amide bond formation with aq. dimethyl amine was executed in a moderate yield to furnish the dimethyl amide, which after comparison of the chromatogram on chiral stationary phase was found to correspond to the less potent enantiomer (3<i>S</i>,4<i>S</i>)-<b>11i</b>. Repetition of the same sequence of reactions with (<i>R</i>)-(+)-α-methylbenzylamine as chiral auxiliary delivered the more potent (<i>R</i>,<i>R</i>)-enantiomer (3<i>R</i>,4<i>R</i>)-<b>11i</b>.</div><div class="NLM_p last">Because of the poor isolated yield of the pure diastereomer hydrochloride <b>14</b>, a modified procedure was needed to allow for further structural modifications of the 1-(pyrimidin-2-yl)cyclopropyl amide at 3-position through modification of substituents on <i>N</i>-1 by alkylation of the versatile secondary amine (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Our modified synthetic approach toward the (<i>S</i>,<i>S</i>)-4-aminopiperidine-3-carboxylic ethyl ester followed the strategy we have previously employed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, but equilibration toward the more stable <i>trans</i> isomer was done after introduction of the 4-amide. 4-Oxo-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester was reacted with the chiral auxiliary (<i>S</i>)-(−)-α-methylbenzylamine in refluxing toluene containing catalytic amount of <i>p</i>-toluenesulfonic acid to form enamine <b>12</b>. The enamine was reduced with a mixture of NaBH<sub>4</sub> and 3 eq. trifluoracetic acid in THF at −20 °C to give <b>13</b>. The 4-α-methylbenzylamine was cleaved by hydrogenation with H<sub>2</sub> in the presence of 20% Pd(OH)<sub>2</sub>/C in EtOH and the <i>cis</i> primary amine <b>22</b> was acylated with 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid to deliver the 6:1 mixture of <i>cis</i>-(3<i>R</i>,4<i>S</i>)-and <i>cis</i>-(3<i>S</i>,4<i>R</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>23</b>. Treatment with sodium ethanolate in ethanol and ethyl acetate causing epimerization to the <i>trans</i>-β-aminoesters, followed by chiral chromatography, delivered the pure (3<i>S</i>,4<i>S</i>)-diastereomer <b>24</b>. The ester was hydrolyzed with NaOH in a THF/water mixture. HATU-mediated amide bond formation on <b>25</b> with 1-pyrimidin-2-yl-cyclopropylamine delivered the di-amide <b>26</b>. N-Boc-deprotection with HCl in 1,4-dioxane gave the piperidine <b>27</b>, which was alkylated under reductive amination condition with sodium triacetoxyborohydride in the presence of acetic acid or by reaction with the corresponding alkyl halides in the presence of a base to furnish final compounds <b>28a–28o</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, ACT-1004-1239 (compound <b>28f</b>) was identified and broadly characterized as a potent, insurmountable, selective, and orally bioavailable antagonist of CXCR7, starting from hits obtained in an innovative HTS assay using an in-house agonist of CXCR7 to allow for a different assay window. The introduction of an additional exit vector in position 3 of the 4-amino-piperidine core led to a breakthrough in terms of potency, binding kinetics, and overall physicochemical and ADMET properties. Further studies demonstrated that modulation of lipophilicity and basicity by combination of substituents on this trisubstituted 4-amino-piperidine scaffold yielded compounds with good CXCR7 antagonism. Compound ACT-1004-1239 demonstrated target engagement <i>in vivo</i>. ACT-1004-1239 showed a dose-dependent increase of CXCL12 plasma concentration in mice. Overall, ACT-1004-1239 has favorable ADMET properties. The Cl<sub>int</sub> measured in HLM is low and with the understanding generated in PK studies in rat and dog; the compound has the potential to be well absorbed and to display a low systemic clearance in humans.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Commercially available starting materials were used as received without further purification. All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen or argon. Flash column chromatography (FC) was performed using RediSEp Rf normal-phase silica flash columns on silica gel (average particle size 0.035–0070 mm) from Teledyne Isco.; elution was performed with EtOAc, heptane, DCM, MeOH, or mixture thereof. Analytical LC–MS data were obtained on a binary gradient pump Agilent G4220A with mass spectrometry detection (single-quadrupole mass analyzer, Thermo Finnigan MSQPlus or equivalent); acidic conditions (Method A): column Zorbax SB-aq (3.5 μm, 4.6 × 50 mm); eluents: A, H<sub>2</sub>O + 0.04% TFA. B: MeCN; gradient: 5–95% B over 1.5 min (flow: 4.5 mL/min). Detection: UV/vis + MS or basic conditions (Method B): column Waters BEC C18 (2.5 μm, 3.0 × 50 mm); eluents: A, H<sub>2</sub>O + 0.5% NH<sub>4</sub>OH (25% aq.); B, MeCN gradient: 5% B to 95% B, over 1.5 min (flow: 1.6 mL/min). Detection: UV/vis + MS. Prep-HPLCs were performed on binary gradient pump Gilson 333/334 or equivalent with mass spectrometry detection (single-quadrupole mass analyzer, Thermo Finnigan MSQPlus or equivalent); XBridge Prep C18 columns from Waters. Eluents: A, H<sub>2</sub>O + 0.5% acidic or basic additive (HCO<sub>2</sub>H or NH<sub>4</sub>OH 25% in H<sub>2</sub>O); B, MeCN; gradient 5% B to 95% B over 5 min. Detection: UV/vis and/or MS. Retention time <i>t</i><sub>R</sub> is given in min; molecular weight obtained from the mass spectrum is given in g/mol. Purity of all final compounds was checked by an additional LC–MS analysis (QC LC–MS) on a Waters Acquity UPLC-SQD system equipped with a Waters Acquity binary pump, a Waters SQ Detector, an Acquity UPLC PDA detector; columns: Acquity UPLC CSH C18 1.7 μm, 2.1 mm × 50 mm from Waters, gradient: 2–98% MeCN containing 0.045% formic acid in H<sub>2</sub>O containing 0.05% formic acid over 2 min; flow: 1.0 mL/min; 60 °C. According to these LC–MS analyses, final compounds showed a purity of greater than 95% (UV at 214 and at 230 nm). Most compounds were obtained as lyophilizates or dry films. Chiral integrity was proven by HPLC (chiral stationary phase): Hardware from UltiMate instrument series (Dionex): HPG-3200SD binary pump, WPS-3000 autosampler, TCC-3200 thermostated column compartment, DAD-3000 detector, SRD-3400 degasser; ValveMate 2 (Gilson) solvent valves. Chiral integrity was also proven by SFC: CO<sub>2</sub> supply: Aurora Fusion A5 Evolution; pump: Agilent G4302A; UV detector: Agilent G1315C. Column, solvent, and retention time (<i>t</i><sub>R</sub>) as indicated, flow 1 mL/min. No racemisation/epimerization was observed during the synthesis of the target compounds. Chiral preparative HPLC chromatography were performed with a Varian SD1 pump equipped with a Dionex DAD-3000 UV detector with columns from ChiralPak IA, IB, IC, IE, or IF, 5 μm, 20 × 250 mm, or Regis (<i>R</i>,<i>R</i>) Whelk-O1, 21.1 × 250mm, 5 μm; eluent: appropriate mixture of A (0–90% Hept) and B (10–100% EtOH, 0.1% DEA), flow: appropriate flow of 16, 23, or 34 mL/min. Chiral SFC chromatography was performed with: CO<sub>2</sub> supply: Maximator DLE15-GG-C; pumps: 2 SSI HF CP 300; UV detector: Dionex DAD-3000 with columns Regis (<i>R</i>,<i>R</i>) Whelk-O1, 30 × 250 mm, 5 μm or ChiralPak IC, 30 × 250 mm, 5 μm; eluent: appropriate mixture of A (60–80% CO<sub>2</sub>), and B (30–40% of DCM/EtOH/DEA 50:50:0.1), flow 160 mL/min. LC-HRMS analysis was performed on a Waters Acquity UPLC-SYNAPTG2MS system equipped with a Waters Acquity Binary pump, a SYNAPT G2MS MS Solvent Manager; source temperature: 150 °C, desolvation temperature: 500 °C; desolvation gas flow: 800 L/h; cone gas flow: 20 L/h; extraction cone: 5, RF lens: 0.1 V; sampling cone: 30; capillary: 2.5 kV; high-resolution mode; gain: 1.0; MS function: 0.15 s per scan, 50–1200 amu in full scan, centroid mode. Lock spray: leucine enkephalin 2 ng/mL (556.2771 Da) scan time 0.2 s with interval of 10 s and average of 10 scans; DAD: Acquity UPLC PDA Detector. Column: Acquity UPLC CSH C18 1.7 μm, 2.1 mm × 50 mm from Waters, thermostatted in the Acquity UPLC Column manager at 60 °C. Eluents: H<sub>2</sub>O and 0.05% formic acid; B:CH<sub>3</sub>CN and 0.05% formic acid. Gradient: 2–98% B over 2.0 min; flow: 1.0 mL/min. Detection: UV 214 nm and MS. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at rt. with a Bruker Avance II 400 (400 MHz for <sup>1</sup>H, 100 MHz for <sup>13</sup>C) or a Bruker Avance HD (500 MHz for <sup>1</sup>H; 125 MHz for <sup>13</sup>C). Chemical shifts (δ) are reported in parts per million (ppm) relative to the deuterated solvent as the internal standard (δ H: CDCl<sub>3</sub> 7.26 ppm, <i>d</i><sub>6</sub>-DMSO 2.50 ppm); multiplicities, s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, br = broad signal; coupling constants are given in Hz. X-ray structure analysis: crystals are sensitive to the solvate loss and therefore to the loss of crystallinity. To avoid solvent loss, the crystals were treated, picked, and mounted at low temperature (approx. 243 K) using an inert gas (N<sub>2</sub>) device to protect and cool down the crystals. A single crystal (0.112 × 0.036 × 0.020 mm<sup>3</sup>) was mounted on a Rigaku-Oxford Diffraction XtaLAB Synergy-S dual source diffractometer equipped with a kappa-axis four-circle goniometer and a Dectris Pilatus3 R 200 K HPC (Hybrid Photon Counting) detector and Cu and Mo PhotonJet microfocus X-ray sources. Reflections were collected at 253 K using monochromatic Cu Kα radiation. For the structure solution, the program SHELXT<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> implemented in the APEX-III Bruker AXS, V.2018.7-2 software was used. The structure refinement was done with SHELXL<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> as implemented in APEX-III software. Full matrix least-squares refinement was performed with anisotropic temperature factors for all the nondisordered atoms. The disordered part (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a> for details) was refined with isotropic temperature factors to achieve stability of the refinement cycles and avoid the introduction of constrains in the molecule. The solvate molecule present (MeOH) is disordered over at least 3 positions. Due to the “not so good” data quality, the solvate positions cannot be fully refined, nor found completely. Therefore, to avoid such problems and instability of the refinement, the MeOH solvate was SQUEEZED out using the program Platon<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Squeeze. Most of the hydrogen atoms present were fixed in the refinement, the two hydrogen atoms involved in donor-acceptor hydrogen bonds were refined freely. Coordinates, anisotropic temperature factors, bond lengths, angles, and special refinement issues are deposited with the Cambridge Crystallographic Data Centre, CCDC 1993933.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>3S</i>,<i>4S</i>)-4-Amino-piperidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Methyl Ester (<b>15</b>)</h3><div class="NLM_p last">A solution of (3<i>S</i>,4<i>S</i>)-4-((<i>S</i>)-1-phenyl-ethylamino)-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>14</b><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (2.41 g, 6.66 mmol) in MeOH (10 mL) was added to a suspension of palladium on activated charcoal (10%) (250 mg) and ammonium formate (3.35 g, 53.28 mmol) in MeOH (60 mL) under N<sub>2</sub>. The mixture was refluxed for 6 h. After the reaction was complete (disappearance of the starting material but also exchange of the ethyl– for the methyl ester), the cooled solution was filtered through Celite and the filtrate was concentrated to obtain the title product (1.48 g, 86%) as a slightly yellow oil. LC–MS method A: <i>t</i><sub>R</sub> = 0.53 min; [M + H]<sup>+</sup> = 259.23. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.32–4.58 (m, 1H), 4.16–4.25 (m, 1H), 3.77 (s, 3H), 3.41 (td, <i>J</i><sub>1</sub> = 11.2 Hz, <i>J</i><sub>2</sub> = 4.1 Hz, 1H), 2.67–2.89 (m, 3H), 2.10 (dd, <i>J</i><sub>1</sub> = 13.1 Hz, <i>J</i><sub>2</sub> = 3.5 Hz, 1H), 1.64 (m, 1H), 1.48 (m, 11H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3<b>-</b>dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Methyl Ester (<b>16</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>S</i>)-4-amino-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-methyl ester <b>15</b> (1.463 g, 5.37 mmol) in DMF (17 mL) at rt. was added 5-(2,4-difluorophenyl)isoxazole-3-carboxylic acid (1.21 g, 5.37 mmol). DIPEA (2.3 mL, 13.34 mmol) was then added followed by HATU (2.451 g, 6.44 mmol). The reaction mixture was stirred overnight at rt. The reaction mixture was concentrated, dissolved in DCM (100 mL), and washed twice with aq. sat. NaHCO<sub>3</sub> (2 × 100 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated. The crude residue was purified by flash chromatography over 40 g of silica gel with heptane/EtOAc (1:0 to 3:1) as eluent to yield <b>16</b> (2.38 g, 95%) as a white powder; LC–MS method A: <i>t</i><sub>R</sub> = 0.94 min; [M + H]<sup>+</sup> = 466.04. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 8.90 (d, <i>J</i> = 8.8 Hz, 1H), 8.06 (td, <i>J</i><sub>1</sub> = 6.5 Hz, <i>J</i><sub>2</sub> = 8.7 Hz, 1H), 7.58 (m, 1H), 7.33 (td, <i>J</i><sub>1</sub> = 2.3 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 1H), 7.13 (d, <i>J</i> = 2.9 Hz, 1H), 4.26 (m, 1H), 4.04–4.10 (m, 1H), 3.94 (d, <i>J</i> = 11.8 Hz, 1H), 3.56 (s, 3H), 2.86–3.04 (m, 2H), 2.66 (td, <i>J</i><sub>1</sub> = 11.0 Hz, <i>J</i><sub>2</sub> = 4.1 Hz, 1H), 1.80 (dd, <i>J</i><sub>1</sub> = 13.6 Hz, <i>J</i><sub>2</sub> = 4.5 Hz, 1H), 1.53 (m, 1H), 1.42 (m, 9H)<b>.</b></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid Methyl Ester Hydrochloride (<b>17</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-methyl ester <b>16</b> (1.13 g, 2.42 mmol) was dissolved in MeOH (12 mL). HCl in dioxane 4 M (12 mL, 48 mmol) was added dropwise. The mixture was stirred at rt. for 1 h. The solvents were evaporated, and the residue was dried on HV to deliver the title crude compound <b>17</b>, (0.97 g, quantitative) as a white powder. LC–MS method A: <i>t</i><sub>R</sub> = 0.61 min; [M + H]<sup>+</sup> = 366.18. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 9.21 (d, <i>J</i> = 8.6 Hz, 1H), 9.09–9.10 (m, 1H), 8.08 (m, 1H), 7.60 (m, 1H), 7.35 (td, <i>J</i><sub>1</sub> = 2.2 Hz, <i>J</i><sub>2</sub> = 8.6 Hz, 1H), 7.19 (d, <i>J</i> = 2.9 Hz, 1H), 4.34 (m, 1H), 3.58 (s, 5H), 3.47–3.50 (m, 1H), 3.14 (dd, <i>J</i><sub>1</sub> = 0.9 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 2H), 3.03 (m, 1H), 1.97 (d, <i>J</i> = 2.9 Hz, 2H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid Methyl Ester (<b>18</b>)</h3><div class="NLM_p last">To a suspension of (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid methyl ester hydrochloride <b>17</b> (0.95 g, 2.36 mmol) in DCM (20 mL) at rt. was added cyclohexanone (0.57 mL, 5.47 mmol) followed by acetic acid (0.35 mL, 6.13 mmol) and sodium triacetoxyborohydride (1.23 g, 5.93 mmol). The reaction mixture was stirred overnight at rt. The reaction mixture was diluted with DCM (30 mL) and washed twice with aq. sat. NaHCO<sub>3</sub> (2 × 50 mL). The organic phase was dried over MgSO<sub>4</sub> and evaporated. Purification by flash chromatography over 40 g of silica gel with heptane/EtOAc (1:0 to 0:1) as eluent yielded <b>18</b>, (1.00 g, 95%) as an off-white solid. LC–MS method A: <i>t</i><sub>R</sub> = 0.71 min; [M + H]<sup>+</sup> = 448.17. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 8.87–8.92 (m, 1H), 8.06 (q, <i>J</i> = 7.7 Hz, 1H), 7.59 (t, <i>J</i> = 10.2 Hz, 1H), 7.34 (t, <i>J</i> = 8.5 Hz, 1H), 7.13 (s, 1H), 3.96–4.10 (m, 1H), 3.54 (s, 3H), 2.96–3.07 (m, 1H), 2.68–2.89 (m, 2H), 2.34–2.42 (m, 3H), 1.73–1.81 (m, 5H), 1.56–1.64 (m, 2H), 1.14–1.20 (m, 4H), 1.04–1.10 (m, 1H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid Hydrochloride (<b>19</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid methyl ester <b>18</b> (0.95 g, 2.11 mmol) was dissolved in THF (14 mL), and 1 M aq. LiOH solution (5.27 mL, 5.27 mmol) was added. The mixture was stirred overnight at rt., 1 M aq. HCl solution (5.27 mL, 5.27 mmol) was added, and the reaction was stirred for 5 min. THF was evaporated and the product <b>19</b> precipitated. The resulting white solid was filtered off and dried <i>in vacuo</i> to yield <b>19</b>, (0.788 g, 86%) as a white powder. LC–MS method A: <i>t</i><sub>R</sub> = 0.66 min; [M + H]<sup>+</sup> = 434.06. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 12.86 (d, 1H), 10.36–10.38 (m, 1H), 9.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.07 (q, <i>J</i> = 7.8 Hz, 1H), 7.60 (t, <i>J</i> = 10.4 Hz, 1H), 7.35 (t, <i>J</i> = 8.4 Hz, 1H), 7.19 (s, 1H), 4.36 (d, <i>J</i> = 7.5 Hz, 1H), 3.60 (d, <i>J</i> = 8.0 Hz, 1H), 3.42 (m, 1H), 3.18–3.26 (m, 4H), 2.07–2.12 (m, 3H), 2.02 (m, 1H), 1.82 (d, <i>J</i> = 11.8 Hz, 2H), 1.61 (m, 1H), 1.43 (q, <i>J</i> = 11.3 Hz, 2H), 1.26 (q, <i>J</i> = 12.2 Hz, 2H), 1.12 (td, <i>J</i> = 12.8 Hz, 1H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid Dimethylamide ((3<i>S</i>,4<i>S</i>)<b>-11i</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>S</i>)-1-cyclohexyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid hydrochloride <b>19</b> (0.102 g, 0.23 mmol) in DMF (5 mL) was added dimethylamine 2 M in THF (0.177 mL, 0.35 mmol). DIPEA (0.13 mL, 0.75 mmol) was then added followed by HATU (0.144 g, 0.38 mmol). The reaction mixture was stirred overnight at rt. The crude mixture was directly purified by prep. HPLC to yield (3<i>S</i>,4<i>S</i>)-<b>11i</b> (0.040 g, 37%) as a white powder. LC–MS method A: <i>t</i><sub>R</sub> = 0.71 min; [M + H]<sup>+</sup> = 461.22. Chiral HPLC: <i>t</i><sub>R</sub> = 6.8 min; 99% <i>ee</i>; column: Regis (<i>R</i>,<i>R</i>) Whelk-O1, 4.6 × 250 mm, 5 μm; Detector wavelength: 254 nm; Eluent: 30% heptane 0.05% DEA; 70% ethanol 0.05% DEA; flow: 0.8 mL/min; BPR: 150 bar; temperature: 25 °C. Injection volume: 2.5 μL. LC-HRMS: <i>t</i><sub>R</sub> = 0.59 min; <i>m</i>/<i>z</i> = 460.2285, found = 461.2373 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, D<sub>6</sub>-DMSO) δ: 8.69 (d, <i>J</i> = 8.6 Hz, 1H), 8.05 (td, <i>J</i><sub>1</sub> = 8.7 Hz, <i>J</i><sub>2</sub> = 6.4 Hz, 1H), 7.58 (m, 1H), 7.33 (m, <i>J</i><sub>1</sub> = 8.1 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 7.09 (d, <i>J</i> = 2.9 Hz, 1H), 4.08 (m, 1H), 3.13 (td, <i>J</i><sub>1</sub> = 10.7 Hz, <i>J</i><sub>2</sub> = 3.6 Hz, 1H), 3.06 (s, 3H), 2.82–2.88 (m, 2H), 2.77 (s, 3H), 2.24–2.32 (m, 2H), 2.19 (t, <i>J</i> = 11.3 Hz, 1H), 1.81–1.85 (m, 1H), 1.73 (d, <i>J</i> = 8.0 Hz, 4H), 1.58 (m, 2H), 1.19 (m, 4H), 1.05–1.09 (m, 1H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (3<i>R</i>,4<i>S</i>)-4-((<i>S</i>)-1-Phenyl-ethylamino)-piperidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Ethyl Ester (<b>13</b>)</h3><div class="NLM_p last">Sodium borohydride (1.43 g, 37.85 mmol) was dissolved in THF (100 mL) at −15 °C under N<sub>2</sub>. TFA (10.7 mL, 0.14 mmol) was added dropwise over 20 min. 4-((<i>S</i>)-1-Phenyl-ethylamino)-5,6-dihydro-2<i>H</i>-pyridine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><b>12</b> (10.5 g, 28 mmol) was added over 10 min at −14 to −18 °C. The resulting mixture was stirred for 60 min at 0 °C. Iced water (100 mL) was added carefully, and the reaction mixture was stirred for 10 min at rt. A 3 M aq. NaOH solution was added to bring the mixture to pH 11. The reaction mixture was extracted with DCM (2 × 100 mL), the combined organic layers were washed with brine (2 × 100 mL) and dried over MgSO<sub>4</sub>, and the solvent was evaporated under reduced pressure. The resulting oil was purified by flash chromatography over 120 g of silica gel with heptane/EtOAc (1:0 to 4:1) as eluent to give the title product <b>13</b> as a yellowish oil, (9.6 g, 91%). The title compound was contaminated by ∼10% of the corresponding (3<i>S</i>,4<i>R</i>)-isomer. LC–MS method A: <i>t</i><sub>R</sub> = 0.71 min; [M + H]<sup>+</sup> = 377.33. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.32–7.35 (m, 4H), 7.29–7.30 (m, 1H), 7.24 (m, 1H), 4.19 (q, <i>J</i> = 7.3 Hz, 2H), 4.00 (d, <i>J</i> = 9.2 Hz, 1H), 3.88 (q, <i>J</i> = 6.8 Hz, 1H), 3.69–3.76 (m, 1H), 3.19 (dd, <i>J</i><sub>1</sub> = 13.8 Hz, <i>J</i><sub>2</sub> = 3.9 Hz, 1H), 3.01 (m, 1H), 2.87 (m, 1H), 2.79 (s, 1H), 1.81 (s, 1H), 1.76 (m, 1H), 1.51 (m, 1H), 1.44 (m, 9H), 1.28–1.33 (m, 5H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (3<i>R</i>,4<i>S</i>)-4-Amino-piperidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Ethyl Ester (<b>22</b>)</h3><div class="NLM_p last">A solution of (3<i>R</i>,4<i>S</i>)-4-((<i>S</i>)-1-phenyl-ethylamino)-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>13</b> (9.6 g, 25.5 mmol) in MeOH (250 mL) was added to a suspension of Pd(OH)<sub>2</sub>/C 20% (1 g) under H<sub>2</sub>. The mixture was stirred for 18 h at rt. The suspension was filtered through Celite, and the filtrate is concentrated under <i>vacuo</i> to obtain the title product as a slightly yellow oil <b>22</b>, (6.94 g. quantitative). The title compound contained ∼10% of the corresponding (3<i>S</i>,4<i>R</i>)-isomer. LC–MS method A: <i>t</i><sub>R</sub> = 0.54 min; [M + H]<sup>+</sup> = 273.26. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 4.07 (q, <i>J</i> = 7.0 Hz, 2H), 3.28–3.36 (m, 5H), 2.57–2.61 (m, 1H), 1.54–1.68 (m, 2H), 1.34–1.41 (m, 11 H), 1.20 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (3<i>R</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3<b>-</b>dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Ethyl Ester (<b>23</b>)</h3><div class="NLM_p last">To a solution of (3<i>R</i>,4<i>S</i>)-4-amino-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>22</b> (7.44 g, 27.2 mmol) in DCM (200 mL) at rt. was added 5-(2,4-difluorophenyl)isoxazole-3-carboxylic acid (6.12 g, 27.3 mmol). TEA (15.2 mL, 109 mmol) was then added followed by T<sub>3</sub>P 50% in DCM (32.4 mL, 54.4 mmol). The reaction mixture was stirred for 24 h at rt. The reaction mixture was washed twice with sat. aq. NaHCO<sub>3</sub> (2 × 100 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated. The crude residue was purified by flash chromatography over 100 g of silica gel with heptane/EtOAc (1:0 to 85:15) as eluent to yield the title compound <b>23</b>, as a white powder (10.25 g, 79%). The title compound contains ∼10% of the corresponding (3<i>S</i>,4<i>R</i>)-isomer; LC–MS method A: <i>t</i><sub>R</sub> = 1.15 min; [M + H]<sup>+</sup> = 480.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.92 (d, <i>J</i> = 8.9 Hz, 1H), 8.06 (m, 1H), 7.60 (ddd, <i>J</i><sub>1</sub> = 11.5 Hz, <i>J</i><sub>2</sub> = 9.3 Hz, <i>J</i><sub>3</sub> = 2.5 Hz, 1H), 7.33 (td, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 2.2 Hz, 1H), 7.13 (d, <i>J =</i> 2.9 Hz, 1H), 4.35–4.47 (m, 1H), 3.96–4.11 (m, 3H), 3.63–3.82 (m, 1H), 3.38–3.44 (m, 1H), 3.06–3.16 (m, 1H), 2.97–3.01 (m, 1H), 1.90–1.99 (m, 1H), 1.65–1.72 (m, 1H), 1.40 (s, 9H), 1.16 (t, <i>J =</i> 6.9 Hz, 3H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3<b>-</b>dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Ethyl Ester (<b>24</b>)</h3><div class="NLM_p last">Sodium ethoxide 95% (4.086 g, 57 mmol) was added portion wise to a solution of (3<i>R</i>,4<i>S</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>23</b> (6.837 g, 14.3 mmol) in a mixture of EtOH (80 mL) and EtOAc (40 mL). The mixture was stirred at rt. for 1 day. Sat. aq. NH<sub>4</sub>Cl (50 mL) was added to the reaction mixture. EtOH and EtOAc were evaporated at reduced pressure. DCM (150 mL) was added. The organic phase was separated, and the aq. layer extracted thrice with DCM (3 × 100 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude residue was purified by prep-HPLC with basic conditions. The title compound was obtained as a colorless powder (5.04 g, 74%), containing ∼10% of the corresponding (3<i>S</i>,4<i>R</i>)-isomer. The enantiomerically pure title compound was obtained by chiral preparative SFC of the mixture of (3<i>S</i>,<i>4</i>S)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester containing ∼10% of (3<i>R</i>,4<i>R</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester using a column ChiralPak IC, 5 μm, 30 × 250 mm; with a mixture of A (80% CO<sub>2</sub>) and B (20%: DCM (50%), MeOH (50%), 0.1% DEA) as eluent and a flow of 160 mL/min.; BPR: 100 bar; temperature = 40 °C to deliver <b>24</b> (4.32 g, 63%) as a light yellow powder. Chiral SFC HPLC: <i>t</i><sub>R</sub> = 3.24 min; 99% <i>ee</i>; column: ChiralPak IC 4.6 × 250 mm, 5 μm; detector wavelength: 254 nm; eluent A (80% CO<sub>2</sub>) and eluent B (20%: DCM (50%), MeOH (50%), 0.1% DEA) and a flow of 4.0 mL/min.; BPR: 150 bar; temperature = 40 °C; Flow: 0.8 mL/min; BPR: 150 bar; temperature: 25 °C. Injection volume: 4 μL. LC–MS method A: <i>t</i><sub>R</sub> = 1.06 min; [M + H]<sup>+</sup> = 480.08. <sup>1</sup>H NMR (D<sub>6</sub>-DMSO) δ: 8.93 (d, <i>J =</i> 8.9 Hz, 1H), 8.05–8.10 (m, 1H), 7.59 (ddd, <i>J</i><sub>1</sub> = 11.5 Hz, <i>J</i><sub>2</sub> = 9.5 Hz, <i>J</i><sub>3</sub> = 2.3 Hz, 1H), 7.34 (td, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 2.2 Hz, 1H), 7.14 (d, <i>J =</i> 2.9 Hz, 1H), 4.23–4.32 (m, 1H), 4.03 (q, <i>J =</i> 7.1 Hz, 3H), 3.90–3.98 (m, 1H), 2.82–3.03 (m, 2H), 2.59–2.61 (m, 1H), 1.77–1.81 (m, 1H), 1.48–1.59 (m, 1H), 1.43 (s, 9H), 1.08 (t, <i>J =</i> 7.1 Hz, 3H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>3S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester (<b>25</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester <b>24</b> (4.98 g, 10.7 mmol) was dissolved in THF (80 mL). Aq. 1 M NaOH solution (20 mL, 20 mmol) was added, and the mixture stirred at rt. for 3 h. The reaction mixture was acidified to around pH = 3 with 2 M aq. HCl solution (10 mL) and extracted thrice with DCM (3 × 50 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated. The title compound <b>25</b> was obtained as a white powder (4.73 g, 98%); LC–MS method A: <i>t</i><sub>R</sub> = 0.99 min; [M + H]<sup>+</sup> = 452.33. <sup>1</sup>H NMR (500 MHz, D<sub>6</sub>-DMSO) δ: 12.51 (s, 1H), 8.06 (td, <i>J</i><sub>1</sub> = 8.7 Hz, <i>J</i><sub>2</sub> = 6.4 Hz, 1H), 7.59 (m, 1H), 7.34 (td, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.14 (d, <i>J =</i> 2.9 Hz, 1H), 4.25 (m, 1H), 4.05–4.16 (m, 1H), 3.92–3.94 (m, 1H), 2.79–3.00 (m, 2H), 2.59 (td, <i>J</i><sub>1</sub> = 11.0 Hz, <i>J</i><sub>2</sub> = 4.1 Hz, 1H), 1.78–1.82 (m, 1H), 1.49 (m, 2H), 1.42 (m, 9H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>3S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-3-(1-pyrimidin-2-yl-cyclopropylcarbamoyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>26</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester <b>25</b> (2.5 g, 5.54 mmol) in DMF (25 mL) were added 1-(pyrimidin-2-yl)cyclopropan-1-amine hydrochloride (0.97 g, 5.54 mmol), DIPEA (2.37 mL, 13.8 mmol), and HATU (2.527 g, 6.65 mmol). The reaction mixture was stirred at rt. for 4 h. The volatiles were evaporated, and the crude mixture purified by flash chromatography over 40 g of silica gel with heptane/EtOAc (1:1 to 0:1) as eluent to yield <b>26</b> as a white powder (2.74 g, 87%); LC–MS method A: <i>t</i><sub>R</sub> = 0.95 min; [M + H]<sup>+</sup> = 568.97. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 8.63 (d, <i>J</i> = 8.6 Hz, 1H), 8.53 (d, <i>J</i> = 4.9 Hz, 3H), 8.08 (td, <i>J</i><sub>1</sub> = 8.7 Hz, <i>J</i><sub>2</sub> = 6.4 Hz, 1H), 7.57 (ddd, <i>J</i><sub>1</sub> = 11.5 Hz, <i>J</i><sub>2</sub> = 9.3 Hz, <i>J</i><sub>3</sub> = 2.5 Hz, 1H), 7.34 (td, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 2.1 Hz, 1H), 7.19 (t, <i>J</i> = 4.9 Hz, 1H), 7.17 (d, <i>J</i> = 3.0 Hz, 1H), 4.12–4.25 (m, 2H), 3.96–3.99 (m, 1H), 2.77–2.99 (m, 2H), 2.58 (td, <i>J</i><sub>1</sub> = 11.2 Hz, <i>J</i><sub>2</sub> = 4.0 Hz, 1H) 1.82–1.86 (m, 1H), 1.44–1.53 (m, 11 H), 1.35–1.39 (m, 1H), 1.03–1.13 (m, 2H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid (1-Pyrimidin-2-yl-cyclopropyl)-amide Hydrochloride (<b>27</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-3-(1-pyrimidin-2-yl-cyclopropylcarbamoyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester <b>26</b> (1.81 g, 3.18 mmol) was dissolved in dioxane (10 mL). HCl in dioxane 4 M (4 mL, 16 mmol) was added dropwise. The mixture was stirred at rt. for 1 h. The solvents were evaporated, and the residue dried in HV to deliver crude <b>27</b> as a white powder (1.57 g, 98%). LC–MS method A: <i>t</i><sub>R</sub> = 0.64 min; [M + H]<sup>+</sup> = 469.17. <sup>1</sup>H NMR (400 MHz, D<sub>6</sub>-DMSO) δ: 8.54 (d, <i>J</i> = 8.2 Hz, 1H), 8.50 (d, <i>J</i> = 4.8 Hz, 2H), 8.41 (s, 1H), 8.07 (q, <i>J</i> = 8.8 Hz, 1H), 7.59 (m, 1H), 7.33 (td, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 7.18 (m, 2H), 4.03–4.11 (m, 1H), 3.11 (d, <i>J</i> = 9.5 Hz, 1H), 2.96 (d, <i>J</i> = 11.9 Hz, 1H), 2.59 (m, 2H), 1.81 (d, <i>J</i> = 9.5 Hz, 1H), 1.35–1.50 (m, 4H), 1.24 (m, 1H), 1.04–1.14 (m, 3H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (3<i>S</i>,4<i>S</i>)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid (1-Pyrimidin-2-yl-cyclopropyl)-amide (<b>28f</b>)</h3><div class="NLM_p last">To a suspension of (3<i>S</i>,4<i>S</i>)-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid methyl ester hydrochloride <b>27</b> (0.200 g, 0.396 mmol) in DCM (20 mL) at rt. was added cyclopropanecarboxaldehyde (0.03 mL, 0.396 mmol) followed by DIPEA (0.2 mL, 1.2 mmol) and sodium triacetoxyborohydride (0.221 g, 1 mmol). The reaction mixture was stirred for 2 h at rt. The reaction mixture was washed twice with aq. sat. NaHCO<sub>3</sub> (2 × 50 mL). The organic phase was dried over MgSO<sub>4</sub> and evaporated. The crude residue was purified by prep. HPLC under basic conditions to yield <b>28f</b> (0.148 g, 72%) as a colorless solid, which can be crystallized from MeCN or MeCN/H<sub>2</sub>O. LC–MS method A: <i>t</i><sub>R</sub> = 0.69 min; [M + H]<sup>+</sup> = 523.04. Chiral HPLC: <i>t</i><sub>R</sub> = 7.0 min; >99% <i>ee</i>; column: ChiralPak IC 4.6 × 250 mm, 5 μm; Detector wavelength: 254 nm; eluent: 10% heptane 0.05% DEA; 90% ethanol 0.05% DEA; Flow: 1.2 mL/min; BPR: 150 bar; temperature: 25 °C. Injection volume: 2 μL. LC-HRMS: <i>t</i><sub>R</sub> = 0.57 min; <i>m</i>/<i>z</i> = 522.2191, found = 523.2265 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, D<sub>6</sub>-DMSO) δ: 8.54 (d, <i>J</i> = 8.5 Hz, 1H), 8.51 (d, <i>J</i> = 4.8 Hz, 2H), 8.45 (s, 1H), 8.08 (td, 1H), 7.59 (ddd, <i>J</i><sub>1</sub> = 11.4 Hz, <i>J</i><sub>2</sub> = 9.4 Hz, <i>J</i><sub>3</sub> = 2.4 Hz, 1H), 7.34 (td, <i>J</i><sub>1</sub> = 2.1 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 1H), 7.18 (t, <i>J</i> = 4.8 Hz, 1H), 7.16 (d, <i>J</i> = 2.9 Hz, 1H), 3.99 (m, 1H), 3.14 (d, <i>J</i> = 9.5 Hz, 1H), 2.99 (d, <i>J</i> = 11.3 Hz, 1H), 2.72 (td, <i>J</i><sub>1</sub> = 3.6 Hz, <i>J</i><sub>2</sub> = 11.0 Hz, 1H), 2.23 (m, 2H), 2.12 (t, <i>J</i> = 11.4 Hz, 1H), 2.01 (t, <i>J</i> = 10.5 Hz 1H), 1.84–1.87 (d, <i>J</i> = 8.7 Hz 1H), 1.62 (m, 1H), 1.48–1.51 (m, 1H), 1.35–1.39 (m, 1H), 1.05–1.12 (m, 2H), 0.83–0.88 (m, 1H), 0.47–0.50 (m, 2H), 0.10 (m, 2H). <sup>13</sup>C NMR (125 MHz, D<sub>6</sub>-DMSO) δ: 172.5 (s), 170.2 (s), 164.2 (dd, <i>J</i><sub>1</sub> = 252 Hz, <i>J</i><sub>2</sub> = 13 Hz), 160.2 (s), 159.4 (dd, <i>J</i><sub>1</sub> = 256 Hz, <i>J</i><sub>2</sub> = 13 Hz), 157.8 (s), 157.3 (s), 130.2 (dd, <i>J</i><sub>1</sub> = 3 Hz, <i>J</i><sub>2</sub> = 10 Hz), 118.7 (s), 113.5 (dd, <i>J</i><sub>1</sub> = 3 Hz, <i>J</i><sub>2</sub> = 22 Hz), 111.9 (dd, <i>J</i><sub>1</sub> = 4 Hz, <i>J</i><sub>2</sub> = 12 Hz), 106.0 (t, <i>J</i> = 26 Hz), 103.0 (d, <i>J</i> = 8 Hz), 63.0 (s), 55.7 (s), 52.5 (s), 49.2 (s), 47.8 (s), 36.5 (s), 31.5 (s), 19.5 (d, <i>J</i> = 17 Hz), 9.0 (s), 4.3 (d, <i>J</i> = 12 Hz).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01588" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01588?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01588</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed experimental procedures and analytical data of HTS hits <b>2–6</b>; synthesized compounds <b>7a–31</b> and respective precursors; X-ray crystallographic structure parameters of compound <b>28f</b>; method for the determination of the melting point by differential scanning calorimetry (DSC); method for the determination of log <i>D</i><sub>7.4</sub> and p<i>K</i><sub>a</sub> values; method describing the CXCR7-agonist <b>1</b> assay, including insurmountability determination; method describing the CXCR7-CXCL12 assay; experimental details for the biological assays to assess the potency of <b>28f</b> on CXCR7 from various species, on human CXCR4 and to determine its <i>K</i><sub>i</sub>, <i>K</i><sub>on</sub>, and <i>K</i><sub>off</sub> constants; and experimental details for the cytochrome P450 enzyme inhibition assays, for the metabolic stability studies, the detailed description of the pharmacokinetic studies in rat and dog, and the target engagement <i>in vivo</i> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf">jm0c01588_si_001.pdf (4.49 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_002.csv">jm0c01588_si_002.csv (11.97 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The corresponding data set has been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam" class="extLink">http://www.ccdc.cam</a>. c.uk/, under the following deposition number: CCDC 1993933 (compound <b>28f</b>, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01588" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvia Richard-Bildstein</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6588-1599" title="Orcid link">http://orcid.org/0000-0001-6588-1599</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d1a2a8bda7b8b0ffa3b8b2b9b0a3b591b8b5bea3a2b8b0ffb2bebc"><span class="__cf_email__" data-cfemail="ed9e94819b848cc39f848e858c9f89ad8489829f9e848cc38e8280">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Guerry</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5631-1279" title="Orcid link">http://orcid.org/0000-0001-5631-1279</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1e6e767772776e6e7b30796b7b6c6c675e777a716c6d777f307d7173"><span class="__cf_email__" data-cfemail="3c4c545550554c4c59125b49594e4e457c5558534e4f555d125f5351">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hamed Aissaoui</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julien Pothier</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriel Schäfer</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7792-9542" title="Orcid link">http://orcid.org/0000-0002-7792-9542</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmela Gnerre</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleanor Lindenberg</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">François Lehembre</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laetitia Pouzol</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, Allschwil CH-4123, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>No funding was provided.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Eric A. Ertel and Dr. Martin Holdener for helpful discussions, Viktor Ribic, Siefke Siefken, Clément Popineau, Pascal Rebmann, Audrey Izard, Aurelien Mérot, Philippe Risch, Mélanie Garnier, Ann Natalie de Leon for the synthesis and characterization of the compounds, Julien Grimont, François Le Goff and Marco Caldarone for the analysis of the compounds, Benedicte Haenig, Panja Strickner and Manon Kiry for performing the biological assays, Romain Sube, Camille Forni and Cédric Etien for hERG blockage measurements, the DMPK as well as the preformulation and preclinical galenics groups for their continuous support with routine <i>in vitro</i> and <i>in vivo</i> experiments, Anna Sassi, Nadège Baumlin and Mélanie Tunis for performing <i>in vivo</i> experiments and biomarker analysis, Dr. G. Santiso-Quinones from Crystallise AG for crystallization experiments and preparation of files for the CSD, and Dr. Gianvito Vilé for the synthesis of some key intermediates by continuous flow chemistry.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">BPR</td><td class="NLM_def"><p class="first last">back pressure regulator</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">clog <i>D</i><sub>7.4</sub></td><td class="NLM_def"><p class="first last">calculated log <i>D</i> at pH 7.4</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal (peak) plasma concentration</p></td></tr><tr><td class="NLM_term">Compd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DLM</td><td class="NLM_def"><p class="first last">dog liver microsomes</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go related gene (also called hKV11.1)</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time resolved technology</p></td></tr><tr><td class="NLM_term">hPPB</td><td class="NLM_def"><p class="first last">human plasma protein binding</p></td></tr><tr><td class="NLM_term">HV</td><td class="NLM_def"><p class="first last">high vacuum</p></td></tr><tr><td class="NLM_term">KO<i><sup>t</sup></i>Bu</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">log <i>D</i><sub>7.4</sub></td><td class="NLM_def"><p class="first last">measured log <i>D</i> at pH 7.4</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">NaBH(OAc)<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium triacetoxyborohydride</p></td></tr><tr><td class="NLM_term">NaOAc</td><td class="NLM_def"><p class="first last">sodium acetate</p></td></tr><tr><td class="NLM_term">NaOEt</td><td class="NLM_def"><p class="first last">sodium ethanolate</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photo diode array</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl<sub>2</sub>·DCM</td><td class="NLM_def"><p class="first last">(1,1′-bis(diphenylphosphino)ferrocene) dichloropalladium (II) dichloromethane</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">prep.</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">quality control</p></td></tr><tr><td class="NLM_term"><i>rac</i></td><td class="NLM_def"><p class="first last">racemic</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,2,3,3-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">terminal half-life</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time of maximal plasma concentration</p></td></tr><tr><td class="NLM_term">T<sub>3</sub>P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">UAS</td><td class="NLM_def"><p class="first last">Upstream Activation Sequence</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMaster, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">A Novel Chemokine Receptor for SDF-1 and I-TAC Involved in Cell Survival, Cell Adhesion, and Tumor Development</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">2201</span>– <span class="NLM_lpage">2213</span>, <span class="refDoi"> DOI: 10.1084/jem.20052144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1084%2Fjem.20052144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=16940167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2201-2213&author=J.+M.+Burnsauthor=B.+C.+Summersauthor=Y.+Wangauthor=A.+Melikianauthor=R.+Berahovichauthor=Z.+Miaoauthor=M.+E.+T.+Penfoldauthor=M.+J.+Sunshineauthor=D.+R.+Littmanauthor=C.+J.+Kuoauthor=K.+Weiauthor=B.+E.+McMasterauthor=K.+Wrightauthor=M.+C.+Howardauthor=T.+J.+Schall&title=A+Novel+Chemokine+Receptor+for+SDF-1+and+I-TAC+Involved+in+Cell+Survival%2C+Cell+Adhesion%2C+and+Tumor+Development&doi=10.1084%2Fjem.20052144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development</span></div><div class="casAuthors">Burns, Jennifer M.; Summers, Bretton C.; Wang, Yu; Melikian, Anita; Berahovich, Rob; Miao, Zhenhua; Penfold, Mark E. T.; Sunshine, Mary Jean; Littman, Dan R.; Kuo, Calvin J.; Wei, Kevin; McMaster, Brian E.; Wright, Kim; Howard, Maureen C.; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2201-2213</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor (SDF-1; also known as chemokine ligand 12 [CXCL12]) regulates many essential biol. processes, including cardiac and neuronal development, stem cell motility, neovascularization, angiogenesis, apoptosis, and tumorigenesis.  It is generally believed that SDF-1 mediates these many disparate processes via a single cell surface receptor known as chemokine receptor 4 (CXCR4).  This paper characterizes an alternate receptor, CXCR7, which binds with high affinity to SDF-1 and to a second chemokine, interferon-inducible T cell α chemoattractant (I-TAC; also known as CXCL11).  Membrane-assocd. CXCR7 is expressed on many tumor cell lines, on activated endothelial cells, and on fetal liver cells, but on few other cell types.  Unlike many other chemokine receptors, ligand activation of CXCR7 does not cause Ca2+ mobilization or cell migration.  However, expression of CXCR7 provides cells with a growth and survival advantage and increased adhesion properties.  Consistent with a role for CXCR7 in cell survival and adhesion, a specific, high affinity small mol. antagonist to CXCR7 impedes in vivo tumor growth in animal models, validating this new receptor as a target for development of novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0-DTHy18ELVg90H21EOLACvtfcHk0lhmgiihNdgKmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlSgsL0%253D&md5=ea363d64668e8d780f94dea24c6c5d56</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1084%2Fjem.20052144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20052144%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DJ.%2BM.%26aulast%3DSummers%26aufirst%3DB.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMelikian%26aufirst%3DA.%26aulast%3DBerahovich%26aufirst%3DR.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DWei%26aufirst%3DK.%26aulast%3DMcMaster%26aufirst%3DB.%2BE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DHoward%26aufirst%3DM.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DA%2520Novel%2520Chemokine%2520Receptor%2520for%2520SDF-1%2520and%2520I-TAC%2520Involved%2520in%2520Cell%2520Survival%252C%2520Cell%2520Adhesion%252C%2520and%2520Tumor%2520Development%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2201%26epage%3D2213%26doi%3D10.1084%2Fjem.20052144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banisadr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podojil, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span> <span> </span><span class="NLM_article-title">Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions</span>. <i>J. Neuroimmune Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1007/s11481-015-9616-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1007%2Fs11481-015-9616-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25997895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BC2Mfmt1amtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=26-35&author=G.+Banisadrauthor=J.+R.+Podojilauthor=S.+D.+Millerauthor=R.+J.+Miller&title=Pattern+of+CXCR7+Gene+Expression+in+Mouse+Brain+Under+Normal+and+Inflammatory+Conditions&doi=10.1007%2Fs11481-015-9616-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions</span></div><div class="casAuthors">Banisadr Ghazal; Miller Richard J; Podojil Joseph R; Miller Stephen D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The chemokine stromal cell-derived factor-1 (SDF-1)/CXCL12 acting via its G-protein coupled receptor (GPCR) CXCR4 has been implicated in neurogenesis, neuromodulation, brain inflammation, HIV-1 encephalopathy and tumor growth.  CXCR7 was identified as an alternate receptor for SDF-1/CXCL12.  Characterization of CXCR7-deficient mice demonstrated a role for CXCR7 in fetal endothelial biology, cardiac development, and B-cell localization.  Despite its ligand binding properties, CXCR7 does not seem to signal like a conventional GPCR.  It has been suggested that CXCR7 may not function alone but in combination with CXCR4.  Here, we investigated the regional localization of CXCR7 receptors in adult mouse brain using CXCR7-EGFP transgenic mice.  We found that the receptors were expressed in various brain regions including olfactory bulb, cerebral cortex, hippocampus, subventricular zone (SVZ), hypothalamus and cerebellum.  Extensive CXCR7 expression was associated with cerebral blood vessels.  Using cell type specific markers, CXCR7 expression was found in neurons, astrocytes and oligodendrocyte progenitors.  GAD-expressing neurons exhibited CXCR7 expression in the hippocampus.  Expression of CXCR7 in the dentate gyrus included cells that expressed nestin, GFAP and cells that appeared to be immature granule cells.  In mice with Experimental Autoimmune Encephalomyelitis (EAE), CXCR7 was expressed by migrating oligodendrocyte progenitors in the SVZ.  We then compared the distribution of SDF-1/CXCL12 and CXCR7 using bitransgenic mice expressing both CXCR7-EGFP and SDF-1-mRFP.  Enhanced expression of SDF-1/CXCL12 and CXCR7 was observed in the corpus callosum, SVZ and cerebellum.  Overall, the expression of CXCR7 in normal and pathological nervous system suggests CXCR4-independent functions of SDF-1/CXCL12 mediated through its interaction with CXCR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSN5VxVyhJaE7xanA7vODO6fW6udTcc2eahxiT3ULVF_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mfmt1amtA%253D%253D&md5=0281dcef20eaba8750ca5c616785e13a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11481-015-9616-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11481-015-9616-y%26sid%3Dliteratum%253Aachs%26aulast%3DBanisadr%26aufirst%3DG.%26aulast%3DPodojil%26aufirst%3DJ.%2BR.%26aulast%3DMiller%26aufirst%3DS.%2BD.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DPattern%2520of%2520CXCR7%2520Gene%2520Expression%2520in%2520Mouse%2520Brain%2520Under%2520Normal%2520and%2520Inflammatory%2520Conditions%26jtitle%3DJ.%2520Neuroimmune%2520Pharmacol.%26date%3D2016%26volume%3D11%26spage%3D26%26epage%3D35%26doi%3D10.1007%2Fs11481-015-9616-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balabanian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moepps, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenzana-Seisdedos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachelerie, F.</span></span> <span> </span><span class="NLM_article-title">The Chemokine SDF-1/CXCL12 Binds to and Signals Through the Orphan Receptor RDC1 in T lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">35760</span>– <span class="NLM_lpage">35766</span>, <span class="refDoi"> DOI: 10.1074/jbc.M508234200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1074%2Fjbc.M508234200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=16107333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35760-35766&author=K.+Balabanianauthor=B.+Laganeauthor=S.+Infantinoauthor=K.+Y.+C.+Chowauthor=J.+Harriagueauthor=B.+Moeppsauthor=F.+Arenzana-Seisdedosauthor=M.+Thelenauthor=F.+Bachelerie&title=The+Chemokine+SDF-1%2FCXCL12+Binds+to+and+Signals+Through+the+Orphan+Receptor+RDC1+in+T+lymphocytes&doi=10.1074%2Fjbc.M508234200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes</span></div><div class="casAuthors">Balabanian, Karl; Lagane, Bernard; Infantino, Simona; Chow, Ken Y. C.; Harriague, Julie; Moepps, Barbara; Arenzana-Seisdedos, Fernando; Thelen, Marcus; Bachelerie, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">35760-35766</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Combined phylogenetic and chromosomal location studies suggest that the orphan receptor RDC1 is related to CXC chemokine receptors.  RDC1 provides a co-receptor function for a restricted no. of human immunodeficiency virus (HIV) isolates, in particular for the CXCR4-using HIV-2 ROD strain.  Here the authors show that CXCL12, the only known natural ligand for CXCR4, binds to and signals through RDC1.  The authors demonstrate that RDC1 is expressed in T lymphocytes and that CXCL12-promoted chemotaxis is inhibited by an anti-RDC1 monoclonal antibody.  Concomitant blockade of RDC1 and CXCR4 produced additive inhibitory effects in CXCL12-induced T cell migration.  Furthermore, the authors provide evidence that interaction of CXCL12 with RDC1 is specific, saturable, and of high affinity (apparent KD ≈ 0.4 nM).  In CXCR4-neg. cells expressing RDC1, CXCL12 promotes internalization of the receptor and chemotactic signals through RDC1.  Collectively, the data indicate that RDC1, which the authors propose to rename as CXCR7, is a receptor for CXCL12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLkIE0FYknbVg90H21EOLACvtfcHk0lg4s0sKBtPbOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurjO&md5=4f7e4ebfefc83383f8223e243e70a4cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508234200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508234200%26sid%3Dliteratum%253Aachs%26aulast%3DBalabanian%26aufirst%3DK.%26aulast%3DLagane%26aufirst%3DB.%26aulast%3DInfantino%26aufirst%3DS.%26aulast%3DChow%26aufirst%3DK.%2BY.%2BC.%26aulast%3DHarriague%26aufirst%3DJ.%26aulast%3DMoepps%26aufirst%3DB.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DBachelerie%26aufirst%3DF.%26atitle%3DThe%2520Chemokine%2520SDF-1%252FCXCL12%2520Binds%2520to%2520and%2520Signals%2520Through%2520the%2520Orphan%2520Receptor%2520RDC1%2520in%2520T%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D35760%26epage%3D35766%26doi%3D10.1074%2Fjbc.M508234200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruenster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahabaleshwar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Functions as a Scavenger for CXCL12 and CXCL11</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e9175</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0009175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1371%2Fjournal.pone.0009175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=20161793" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=U.+Naumannauthor=E.+Cameroniauthor=M.+Pruensterauthor=H.+Mahabaleshwarauthor=E.+Razauthor=H.+G.+Zerwesauthor=A.+Rotauthor=M.+Thelen&title=CXCR7+Functions+as+a+Scavenger+for+CXCL12+and+CXCL11&doi=10.1371%2Fjournal.pone.0009175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009175%26sid%3Dliteratum%253Aachs%26aulast%3DNaumann%26aufirst%3DU.%26aulast%3DCameroni%26aufirst%3DE.%26aulast%3DPruenster%26aufirst%3DM.%26aulast%3DMahabaleshwar%26aufirst%3DH.%26aulast%3DRaz%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DThelen%26aufirst%3DM.%26atitle%3DCXCR7%2520Functions%2520as%2520a%2520Scavenger%2520for%2520CXCL12%2520and%2520CXCL11%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0009175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Alcañiz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haege, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Bendito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, O.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Controls Neuronal Migration by Regulating Chemokine Responsiveness</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2010.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.neuron.2010.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=21220100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=77-90&author=J.+A.+S%C3%A1nchez-Alca%C3%B1izauthor=S.+Haegeauthor=W.+Muellerauthor=R.+Plaauthor=F.+Mackayauthor=S.+Schulzauthor=G.+L%C3%B3pez-Benditoauthor=R.+Stummauthor=O.+Mar%C3%ADn&title=CXCR7+Controls+Neuronal+Migration+by+Regulating+Chemokine+Responsiveness&doi=10.1016%2Fj.neuron.2010.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness</span></div><div class="casAuthors">Sanchez-Alcaniz, Juan Antonio; Haege, Sammy; Mueller, Wiebke; Pla, Ramon; MacKay, Fabienne; Schulz, Stefan; Lopez-Bendito, Guillermina; Stumm, Ralf; Marin, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-90</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The chemokine Cxcl12 binds Cxcr4 and Cxcr7 receptors to control cell migration in multiple biol. contexts, including brain development, leukocyte trafficking, and tumorigenesis.  Both receptors are expressed in the CNS, but how they cooperate during migration has not been elucidated.  Here, we used the migration of cortical interneurons as a model to study this process.  We found that Cxcr4 and Cxcr7 are coexpressed in migrating interneurons, and that Cxcr7 is essential for chemokine signaling.  Intriguingly, this process does not exclusively involve Cxcr7, but most critically the modulation of Cxcr4 function.  Thus, Cxcr7 is necessary to regulate Cxcr4 protein levels, thereby adapting chemokine responsiveness in migrating cells.  This demonstrates that a chemokine receptor modulates the function of another chemokine receptor by controlling the amt. of protein that is made available for signaling at the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQA038tiZ7gbVg90H21EOLACvtfcHk0lhtQm9LbGBzXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFSjtw%253D%253D&md5=ad8edbbf347a87b133d73596ba67f56a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Alca%25C3%25B1iz%26aufirst%3DJ.%2BA.%26aulast%3DHaege%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DPla%26aufirst%3DR.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DSchulz%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Bendito%26aufirst%3DG.%26aulast%3DStumm%26aufirst%3DR.%26aulast%3DMar%25C3%25ADn%26aufirst%3DO.%26atitle%3DCXCR7%2520Controls%2520Neuronal%2520Migration%2520by%2520Regulating%2520Chemokine%2520Responsiveness%26jtitle%3DNeuron%26date%3D2011%26volume%3D69%26spage%3D77%26epage%3D90%26doi%3D10.1016%2Fj.neuron.2010.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zohar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildbaum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsheshet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, N.</span></span> <span> </span><span class="NLM_article-title">CXCL11-Dependent Induction of FOXP3-Negative Regulatory T Cells Suppresses Autoimmune Encephalomyelitis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2009</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1172/JCI71951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1172%2FJCI71951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24713654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2009-2022&author=Y.+Zoharauthor=G.+Wildbaumauthor=R.+Novakauthor=A.+L.+Salzmanauthor=M.+Thelenauthor=R.+Alonauthor=Y.+Barsheshetauthor=C.+L.+Karpauthor=N.+Karin&title=CXCL11-Dependent+Induction+of+FOXP3-Negative+Regulatory+T+Cells+Suppresses+Autoimmune+Encephalomyelitis&doi=10.1172%2FJCI71951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis</span></div><div class="casAuthors">Zohar, Yaniv; Wildbaum, Gizi; Novak, Rostislav; Salzman, Andrew L.; Thelen, Marcus; Alon, Ronen; Barsheshet, Yiftah; Karp, Christopher L.; Karin, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2009-2022</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A single G protein-coupled receptor (GPCR) can activate multiple signaling cascades based on the binding of different ligands.  The biol. relevance of this feature in immune regulation has not been evaluated.  The chemokine-binding GPCR CXCR3 is preferentially expressed on CD4+ T cells, and canonically binds 3 structurally related chemokines: CXCL9, CXCL10, and CXCL11.  Here we have shown that CXCL10/CXCR3 interactions drive effector Th1 polarization via STAT1, STAT4, and STAT5 phosphorylation, while CXCL11/CXCR3 binding induces an immunotolerizing state that is characterized by IL-10hi (Tr1) and IL-4hi (Th2) cells, mediated via p70 kinase/mTOR in STAT3- and STAT6-dependent pathways.  CXCL11 binds CXCR3 with a higher affinity than CXCL10, suggesting that CXCL11 has the potential to restrain inflammatory autoimmunity.  We generated a CXCL11-Ig fusion mol. and evaluated its use in the EAE model of inflammatory autoimmune disease.  Administration of CXCL11-Ig during the first episode of relapsing EAE in SJL/J mice not only led to rapid remission, but also prevented subsequent relapse.  Using GFP-expressing effector CD4+ T cells, we obsd. that successful therapy was assocd. with reduced accumulation of these cells at the autoimmune site.  Finally, we showed that very low doses of CXCL11 rapidly suppress signs of EAE in C57BL/6 mice lacking functional CXCL11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4s5KlJQicp7Vg90H21EOLACvtfcHk0lhtQm9LbGBzXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVSnsLk%253D&md5=4da3ef37793be83b27f4be45a0727c03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI71951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71951%26sid%3Dliteratum%253Aachs%26aulast%3DZohar%26aufirst%3DY.%26aulast%3DWildbaum%26aufirst%3DG.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DSalzman%26aufirst%3DA.%2BL.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DAlon%26aufirst%3DR.%26aulast%3DBarsheshet%26aufirst%3DY.%26aulast%3DKarp%26aufirst%3DC.%2BL.%26aulast%3DKarin%26aufirst%3DN.%26atitle%3DCXCL11-Dependent%2520Induction%2520of%2520FOXP3-Negative%2520Regulatory%2520T%2520Cells%2520Suppresses%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2009%26epage%3D2022%26doi%3D10.1172%2FJCI71951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naseem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puccini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSkane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span> <span> </span><span class="NLM_article-title">CXCL9, CXCL10, CXCL11/CXCR3 Axis for Immune Activation - a Target for Novel Cancer Therapy</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.ctrv.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29207310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFemtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2018&pages=40-47&author=R.+Tokunagaauthor=W.+Zhangauthor=M.+Naseemauthor=A.+Pucciniauthor=M.+D.+Bergerauthor=S.+Soniauthor=M.+McSkaneauthor=H.+Babaauthor=H.+J.+Lenz&title=CXCL9%2C+CXCL10%2C+CXCL11%2FCXCR3+Axis+for+Immune+Activation+-+a+Target+for+Novel+Cancer+Therapy&doi=10.1016%2Fj.ctrv.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy</span></div><div class="casAuthors">Tokunaga, Ryuma; Zhang, Wu; Naseem, Madiha; Puccini, Alberto; Berger, Martin D.; Soni, Shivani; McSkane, Michelle; Baba, Hideo; Lenz, Heinz-Josef</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells, and cause tissue extravasation.  Given these properties, their role in anti-tumor immune response in the cancer environment is of great interest.  Although immunotherapy has shown clin. benefit for some cancer patients, other patients do not respond.  One of the mechanisms of resistance to checkpoint inhibitors may be chemokine signaling.  The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis).  However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis).  Thus, a better understanding of CXCL9, -10, -11/CXCR3 axis is necessary to develop effective cancer control.  In this article, we summarize recent evidence regarding CXCL9, CXCL10, CXCL11/CXCR3 axis in the immune system and discuss their potential role in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohPDQ1JldLTbVg90H21EOLACvtfcHk0lg61_3y6XwXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFemtrbO&md5=b8b5a8bab310dc632dde12ee4c86e5ad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DTokunaga%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNaseem%26aufirst%3DM.%26aulast%3DPuccini%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DM.%2BD.%26aulast%3DSoni%26aufirst%3DS.%26aulast%3DMcSkane%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DCXCL9%252C%2520CXCL10%252C%2520CXCL11%252FCXCR3%2520Axis%2520for%2520Immune%2520Activation%2520-%2520a%2520Target%2520for%2520Novel%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D63%26spage%3D40%26epage%3D47%26doi%3D10.1016%2Fj.ctrv.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torraca, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebelman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaink, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, A. H.</span></span> <span> </span><span class="NLM_article-title">The CXCR3-CXCL11 Signaling Axis Mediates Macrophage Recruitment and Dissemination of Mycobacterial Infection</span>. <i>Dis. Model Mech.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1242/dmm.017756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1242%2Fdmm.017756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25573892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BC2MvltF2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=253-269&author=V.+Torracaauthor=C.+Cuiauthor=R.+Bolandauthor=J.+P.+Bebelmanauthor=A.+M.+van+der+Sarauthor=M.+J.+Smitauthor=M.+Sideriusauthor=H.+P.+Spainkauthor=A.+H.+Meijer&title=The+CXCR3-CXCL11+Signaling+Axis+Mediates+Macrophage+Recruitment+and+Dissemination+of+Mycobacterial+Infection&doi=10.1242%2Fdmm.017756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection</span></div><div class="casAuthors">Torraca Vincenzo; Cui Chao; Boland Ralf; Spaink Herman P; Meijer Annemarie H; Bebelman Jan-Paul; Smit Martine J; Siderius Marco; van der Sar Astrid M</div><div class="citationInfo"><span class="NLM_cas:title">Disease models & mechanisms</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The recruitment of leukocytes to infectious foci depends strongly on the local release of chemoattractant mediators.  The human CXC chemokine receptor 3 (CXCR3) is an important node in the chemokine signaling network and is expressed by multiple leukocyte lineages, including T cells and macrophages.  The ligands of this receptor originate from an ancestral CXCL11 gene in early vertebrates.  Here, we used the optically accessible zebrafish embryo model to explore the function of the CXCR3-CXCL11 axis in macrophage recruitment and show that disruption of this axis increases the resistance to mycobacterial infection.  In a mutant of the zebrafish ortholog of CXCR3 (cxcr3.2), macrophage chemotaxis to bacterial infections was attenuated, although migration to infection-independent stimuli was unaffected.  Additionally, attenuation of macrophage recruitment to infection could be mimicked by treatment with NBI74330, a high-affinity antagonist of CXCR3.  We identified two infection-inducible CXCL11-like chemokines as the functional ligands of Cxcr3.2, showing that the recombinant proteins exerted a Cxcr3.2-dependent chemoattraction when locally administrated in vivo.  During infection of zebrafish embryos with Mycobacterium marinum, a well-established model for tuberculosis, we found that Cxcr3.2 deficiency limited the macrophage-mediated dissemination of mycobacteria.  Furthermore, the loss of Cxcr3.2 function attenuated the formation of granulomatous lesions, the typical histopathological features of tuberculosis, and led to a reduction in the total bacterial burden.  Prevention of mycobacterial dissemination by targeting the CXCR3 pathway, therefore, might represent a host-directed therapeutic strategy for treatment of tuberculosis.  The demonstration of a conserved CXCR3-CXCL11 signaling axis in zebrafish extends the translational applicability of this model for studying diseases involving the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ6Lw5ZIsGDFvAgqb2vdc5fW6udTcc2eapogC7spXc87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvltF2gtg%253D%253D&md5=436a2874590a1cee94baa749b07855c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fdmm.017756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.017756%26sid%3Dliteratum%253Aachs%26aulast%3DTorraca%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DC.%26aulast%3DBoland%26aufirst%3DR.%26aulast%3DBebelman%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DSiderius%26aufirst%3DM.%26aulast%3DSpaink%26aufirst%3DH.%2BP.%26aulast%3DMeijer%26aufirst%3DA.%2BH.%26atitle%3DThe%2520CXCR3-CXCL11%2520Signaling%2520Axis%2520Mediates%2520Macrophage%2520Recruitment%2520and%2520Dissemination%2520of%2520Mycobacterial%2520Infection%26jtitle%3DDis.%2520Model%2520Mech.%26date%3D2015%26volume%3D8%26spage%3D253%26epage%3D269%26doi%3D10.1242%2Fdmm.017756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, K. M.</span></span> <span> </span><span class="NLM_article-title">Emerging Roles of Atypical Chemokine Receptor 3 (ACKR3) in Normal Development and Physiology</span>. <i>Cytokine+</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2018.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.cyto.2018.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29903572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=17-23&author=K.+E.+Quinnauthor=D.+I.+Mackieauthor=K.+M.+Caron&title=Emerging+Roles+of+Atypical+Chemokine+Receptor+3+%28ACKR3%29+in+Normal+Development+and+Physiology&doi=10.1016%2Fj.cyto.2018.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology</span></div><div class="casAuthors">Quinn, K. E.; Mackie, D. I.; Caron, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine+</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">CYTIE9</span>;
        ISSN:<span class="NLM_cas:issn">1043-4666</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The discovery that atypical chemokine receptors (ACKRs) can initiate alternative signaling pathways rather than classical G-protein coupled receptor (GPCR) signaling has changed the paradigm of chemokine receptors and their roles in modulating chemotactic responses.  The ACKR family has grown over the years, with discovery of new functions and roles in a variety of pathophysiol. conditions.  However, the extent to which these receptors regulate normal physiol. is still continuously expanding.  In particular, atypical chemokine receptor 3 (ACKR3) has proven to be an important receptor in mediating normal biol. functions, including cardiac development and migration of cortical neurons.  In this review, we illustrate the versatile and intriguing role of ACKR3 in physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Mfs54z0rSbVg90H21EOLACvtfcHk0ljDtJgkHwwmQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWlu77K&md5=6494d1fa58bbe5f991306ee513ebd7e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2018.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2018.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DK.%2BE.%26aulast%3DMackie%26aufirst%3DD.%2BI.%26aulast%3DCaron%26aufirst%3DK.%2BM.%26atitle%3DEmerging%2520Roles%2520of%2520Atypical%2520Chemokine%2520Receptor%25203%2520%2528ACKR3%2529%2520in%2520Normal%2520Development%2520and%2520Physiology%26jtitle%3DCytokine%252B%26date%3D2018%26volume%3D109%26spage%3D17%26epage%3D23%26doi%3D10.1016%2Fj.cyto.2018.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.2174/138945012799201603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.2174%2F138945012799201603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22204316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=166-172&author=Y.+Wangauthor=J.+Huangauthor=Y.+Liauthor=G.+Y.+Yang&title=Roles+of+Chemokine+CXCL12+and+its+Receptors+in+Ischemic+Stroke&doi=10.2174%2F138945012799201603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of chemokine CXCL12 and its receptors in ischemic stroke</span></div><div class="casAuthors">Wang, Yongting; Huang, Jun; Li, Yaning; Yang, Guo-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-172</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemokine CXC ligand 12 (CXCL12), originally named stromal cell-derived factor-1 (SDF-1), is a member of the CXC chemokine subfamily.  CXCL12 is found to be expressed by all cell types that are presented in the central nervous system (CNS).  It works in conjunction with the G-protein coupled receptor CXCR4, which is found at the surface of a variety of cells including neurons, astrocytes, microglia, bone marrow-derived cells, as well as other progenitor cells.  Recent studies revealed that CXCL12 could also bind and signal through receptor CXCR7.  CXCL12 and CXCR4 are constitutively expressed in the brain but are up-regulated in the ischemic penumbra regions following ischemic stroke.  CXCL12/CXCR4 play important roles in multiple processes after ischemic stroke, which include inflammatory response, focal angiogenesis, and the recruitment of bone marrow-derived cells (BMCs) and neural progenitor cell (NPC) to injury.  In addn. to its roles in stroke pathol., CXCL12 is also thought to be a key regulator in stroke repairing.  This review will focus on the function of CXCL12/CXCR4 in post-stroke inflammation and neurovascular repairing.  The potential application of CXCL12 modulation in clin. stroke treatment is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Z33EdXjs8LVg90H21EOLACvtfcHk0ljDtJgkHwwmQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSls7g%253D&md5=13aca9d2d5fa00b412bc5b864ceb28eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138945012799201603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012799201603%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DRoles%2520of%2520Chemokine%2520CXCL12%2520and%2520its%2520Receptors%2520in%2520Ischemic%2520Stroke%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D166%26epage%3D172%26doi%3D10.2174%2F138945012799201603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puchert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelkner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelov, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odoardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flügel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streit, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engele, J.</span></span> <span> </span><span class="NLM_article-title">Astrocytic Expression of the CXCL12 Receptor, CXCR7/ACKR3 is a Hallmark of the Diseased, but not Developing CNS</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2017.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.mcn.2017.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28889992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=105-118&author=M.+Puchertauthor=F.+Pelknerauthor=G.+Steinauthor=D.+N.+Angelovauthor=J.+Boltzeauthor=D.+C.+Wagnerauthor=F.+Odoardiauthor=A.+Fl%C3%BCgelauthor=W.+J.+Streitauthor=J.+Engele&title=Astrocytic+Expression+of+the+CXCL12+Receptor%2C+CXCR7%2FACKR3+is+a+Hallmark+of+the+Diseased%2C+but+not+Developing+CNS&doi=10.1016%2Fj.mcn.2017.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocytic expression of the CXCL12 receptor, CXCR7/ACKR3 is a hallmark of the diseased, but not developing CNS</span></div><div class="casAuthors">Puchert, Malte; Pelkner, Fabian; Stein, Gregor; Angelov, Doychin N.; Boltze, Johannes; Wagner, Daniel-Christoph; Odoardi, Francesca; Fluegel, Alexander; Streit, Wolfgang J.; Engele, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-118</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous demonstration of CXCR7 as the major mediator of CXCL12 signaling in cultured astrocytes, we have now compared astrocytic expression of the CXCL12 receptors, CXCR7 and CXCR4, during CNS development and disease.  In addn., we asked whether disease-assocd. conditions/factors affect expression of CXCL12 receptors in astrocytes.  In the late embryonic rat brain, CXCR7+/GFAP+ cells were restricted to the ventricular/subventricular zone while CXCR4 was widely absent from GFAP-pos. cells.  In the early postnatal and adult brain, CXCR7 and CXCR4 were almost exclusively expressed by GFAP-immunoreactive astrocytes forming the superficial glia limitans.  Contrasting the situation in the intact CNS, a striking increase in astrocytic CXCR7 expression was detectable in the cortex of rats with exptl. brain infarcts, in the spinal cord of rats with exptl. autoimmune encephalomyelitis (EAE) and after mech. compression, as well as in the in infarcted human cerebral cortex and in the hippocampus of Alzheimer's disease patients.  None of these pathologies was assocd. with substantial increases in astrocytic CXCR4 expression.  Screening of various disease-assocd. factors/conditions further revealed that CXCR7 expression of cultured cortical astrocytes increases with IFNγ as well as under hypoxic conditions whereas CXCR7 expression is attenuated following treatment with IFNβ.  Again, none of the treatments affected CXCR4 expression in cultured astrocytes.  Together, these findings support the hypothesis of a crucial role of astrocytic CXCR7 in the progression of various CNS pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNqWvYYzSp7Vg90H21EOLACvtfcHk0liTN0ANZlyP3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjurbE&md5=ed5df5d5c9ae85bd7492906402b32187</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2017.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DPuchert%26aufirst%3DM.%26aulast%3DPelkner%26aufirst%3DF.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DAngelov%26aufirst%3DD.%2BN.%26aulast%3DBoltze%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DD.%2BC.%26aulast%3DOdoardi%26aufirst%3DF.%26aulast%3DFl%25C3%25BCgel%26aufirst%3DA.%26aulast%3DStreit%26aufirst%3DW.%2BJ.%26aulast%3DEngele%26aufirst%3DJ.%26atitle%3DAstrocytic%2520Expression%2520of%2520the%2520CXCL12%2520Receptor%252C%2520CXCR7%252FACKR3%2520is%2520a%2520Hallmark%2520of%2520the%2520Diseased%252C%2520but%2520not%2520Developing%2520CNS%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D85%26spage%3D105%26epage%3D118%26doi%3D10.1016%2Fj.mcn.2017.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Regulates Epileptic Seizures by Controlling the Synaptic Activity of Hippocampal Granule Cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">825</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-2052-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fs41419-019-2052-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=31672961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BB3MjjslymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=825&author=T.+Xuauthor=X.+Yuauthor=J.+Dengauthor=S.+Ouauthor=X.+Liuauthor=T.+Wangauthor=Y.+Liuauthor=J.+Yangauthor=C.+Tanauthor=J.+Yuanauthor=Y.+Chen&title=CXCR7+Regulates+Epileptic+Seizures+by+Controlling+the+Synaptic+Activity+of+Hippocampal+Granule+Cells&doi=10.1038%2Fs41419-019-2052-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 regulates epileptic seizures by controlling the synaptic activity of hippocampal granule cells</span></div><div class="casAuthors">Xu Tao; Yu Xinyuan; Deng Jing; Ou Shu; Liu Xi; Wang Teng; Liu Ying; Yang Juan; Tan Changhong; Yuan Jinxian; Chen Yangmei</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">825</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">C-X-C motif chemokine receptor 7 (CXCR7), which mediates the immune response in the brain, was recently reported to regulate neurological functions.  However, the role of CXCR7 in epilepsy remains unclear.  Here, we found that CXCR7 was upregulated in the hippocampal dentate gyrus (DG) of mice subjected to kainic acid (KA)-induced epilepsy and in the brain tissues of patients with temporal lobe epilepsy.  Silencing CXCR7 in the hippocampal DG region exerted an antiepileptic effect on the KA-induced mouse model of epilepsy, whereas CXCR7 overexpression produced a seizure-aggravating effect.  Mechanistically, CXCR7 selectively regulated N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic neurotransmission in hippocampal dentate granule cells by modulating the cell membrane expression of the NMDAR subunit2A, which requires the activation of extracellular signal-regulated kinase 1/2 (ERK1/2).  Thus, CXCR7 may regulate epileptic seizures and represents a novel target for antiepileptic treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkZZ3vAQF35WgRQsDqrjW_fW6udTcc2eYoE047GziddLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjjslymsQ%253D%253D&md5=e148e5b25cd73b130313e7f528029bee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-2052-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-2052-9%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DOu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DCXCR7%2520Regulates%2520Epileptic%2520Seizures%2520by%2520Controlling%2520the%2520Synaptic%2520Activity%2520of%2520Hippocampal%2520Granule%2520Cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D825%26doi%3D10.1038%2Fs41419-019-2052-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trojan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ślusarczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamera, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basta-Kaim, A.</span></span> <span> </span><span class="NLM_article-title">The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">779</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.3389%2Ffphar.2017.00779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29163165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFegsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=779&author=E.+Trojanauthor=J.+%C5%9Alusarczykauthor=K.+Chameraauthor=K.+Kotarskaauthor=K.+Glombikauthor=M.+Kuberaauthor=A.+Basta-Kaim&title=The+Modulatory+Properties+of+Chronic+Antidepressant+Drugs+Treatment+on+the+Brain+Chemokine+-+Chemokine+Receptor+Network%3A+A+Molecular+Study+in+an+Animal+Model+of+Depression&doi=10.3389%2Ffphar.2017.00779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The modulatory properties of chronic antidepressant drugs treatment on the brain chemokine - chemokine receptor network: a molecular study in an animal model of depression</span></div><div class="casAuthors">Trojan, Ewa; Slusarczyk, Joanna; Chamera, Katarzyna; Kotarska, Katarzyna; Glombik, Katarzyna; Kubera, Marta; Basta-Kaim, Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">779/1-779/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">An increasing no. of studies indicate that the chemokine system may be the third major communication system of the brain.  Therefore, the role of the chemokine system in the development of brain disorders, including depression, has been recently proposed.  However, little is known about the impact of the administration of various antidepressant drugs on the brain chemokine - chemokine receptor axis.  In the present study, we used an animal model of depression based on the prenatal stress procedure.  We detd. whether chronic treatment with tianeptine, venlafaxine, or fluoxetine influenced the evoked by prenatal stress procedure changes in the mRNA and protein levels of the homeostatic chemokines, CXCL12 (SDF-1α), CX3CL1 (fractalkine) and their receptors, in the hippocampus and frontal cortex.  Moreover, the impact of mentioned antidepressants on the TGF-β, a mol. pathway related to fractalkine receptor (CX3CR1), was explored.  We found that prenatal stress caused anxiety and depressive-like disturbances in adult offspring rats, which were normalized by chronic antidepressant treatment.  Furthermore, we showed the stress-evoked CXCL12 upregulation while CXCR4 downregulation in hippocampus and frontal cortex.  CXCR7 expression was enhanced in frontal cortex but not hippocampus.  Furthermore, the levels of CX3CL1 and CX3CR1 were diminished by prenatal stress in the both examd. brain areas.  The mentioned changes were normalized with various potency by chronic administration of tested antidepressants.  All drugs in hippocampus, while tianeptine and venlafaxine in frontal cortex normalized the CXCL12 level in prenatally stressed offspring.  Moreover, in hippocampus only fluoxetine enhanced CXCR4 level, while fluoxetine and tianeptine diminished CXCR7 level in frontal cortex.  Addnl., the diminished by prenatal stress levels of CX3CL1 and CX3CR1 in the both examd. brain areas were normalized by chronic tianeptine and partially fluoxetine administration.  Tianeptine modulate also brain TGF-β signaling in the prenatal stress-induced animal model of depression.  Our results provide new evidence that not only prenatal stress-induced behavioral disturbances but also changes of CXCL12 and their receptor and at less extend in CX3CL1-CX3CR1 expression may be normalized by chronic antidepressant drug treatment.  In particular, the effect on the CXCL12 and their CXCR4 and CXCR7 receptors requires addnl. studies to elucidate the possible biol. consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXAsQ2AbIrZ7Vg90H21EOLACvtfcHk0lj8K4QB5re6fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFegsLvN&md5=436751a9f294bd9a64d9e231a265c363</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00779%26sid%3Dliteratum%253Aachs%26aulast%3DTrojan%26aufirst%3DE.%26aulast%3D%25C5%259Alusarczyk%26aufirst%3DJ.%26aulast%3DChamera%26aufirst%3DK.%26aulast%3DKotarska%26aufirst%3DK.%26aulast%3DGlombik%26aufirst%3DK.%26aulast%3DKubera%26aufirst%3DM.%26aulast%3DBasta-Kaim%26aufirst%3DA.%26atitle%3DThe%2520Modulatory%2520Properties%2520of%2520Chronic%2520Antidepressant%2520Drugs%2520Treatment%2520on%2520the%2520Brain%2520Chemokine%2520-%2520Chemokine%2520Receptor%2520Network%253A%2520A%2520Molecular%2520Study%2520in%2520an%2520Animal%2520Model%2520of%2520Depression%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D779%26doi%3D10.3389%2Ffphar.2017.00779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woerner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2008.070918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.2353%2Fajpath.2008.070918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=18276777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=799-808&author=E.+E.+McCandlessauthor=L.+Piccioauthor=B.+M.+Woernerauthor=R.+E.+Schmidtauthor=J.+B.+Rubinauthor=A.+H.+Crossauthor=R.+S.+Klein&title=Pathological+Expression+of+CXCL12+at+the+Blood-Brain+Barrier+Correlates+with+Severity+of+Multiple+Sclerosis&doi=10.2353%2Fajpath.2008.070918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span></div><div class="casAuthors">McCandless Erin E; Piccio Laura; Woerner B Mark; Schmidt Robert E; Rubin Joshua B; Cross Anne H; Klein Robyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Dysregulation of blood-brain barrier (BBB) function and transendothelial migration of leukocytes are essential components of the development and propagation of active lesions in multiple sclerosis (MS).  Animal studies indicate that polarized expression of the chemokine CXCL12 at the BBB prevents leukocyte extravasation into the central nervous system (CNS) and that disruption of CXCL12 polarity promotes entry of autoreactive leukocytes and inflammation.  In the present study, we examined expression of CXCL12 and its receptor, CXCR4, within CNS tissues from MS and non-MS patients.  Immunohistochemical analysis of CXCL12 expression at the BBB revealed basolateral localization in tissues derived from non-MS patients and at uninvolved sites in tissues from MS patients.  In contrast, within active MS lesions, CXCL12 expression was redistributed toward vessel lumena and was associated with CXCR4 activation in infiltrating leukocytes, as revealed by phospho-CXCR4-specific antibodies.  Quantitative assessment of CXCL12 expression by the CNS microvasculature established a positive correlation between CXCL12 redistribution, leukocyte infiltration, and severity of histological disease.  These results suggest that CXCL12 normally functions to localize infiltrating leukocytes to perivascular spaces, preventing CNS parenchymal infiltration.  In the patient cohort studied, altered patterns of CXCL12 expression at the BBB were specifically associated with MS, possibly facilitating trafficking of CXCR4-expressing mononuclear cells into and out of the perivascular space and leading to progression of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQozRdQ6NLRap0d-O_J5C0AfW6udTcc2eZruBSazvtj3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D&md5=d232e834a7fc299e534176a1cbdcb24e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.070918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.070918%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPiccio%26aufirst%3DL.%26aulast%3DWoerner%26aufirst%3DB.%2BM.%26aulast%3DSchmidt%26aufirst%3DR.%2BE.%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DPathological%2520Expression%2520of%2520CXCL12%2520at%2520the%2520Blood-Brain%2520Barrier%2520Correlates%2520with%2520Severity%2520of%2520Multiple%2520Sclerosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D172%26spage%3D799%26epage%3D808%26doi%3D10.2353%2Fajpath.2008.070918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moll, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossoy, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staugaitis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucky, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietsch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span> <span> </span><span class="NLM_article-title">Imaging Correlates of Leukocyte Accumulation and CXCR4/CXCL12 in Multiple Sclerosis</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1001/archneurol.2008.512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1001%2Farchneurol.2008.512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19139298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fms12jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=44-53&author=N.+M.+Mollauthor=M.+B.+Cossoyauthor=E.+Fisherauthor=S.+M.+Staugaitisauthor=B.+H.+Tuckyauthor=A.+M.+Rietschauthor=A.+Changauthor=R.+J.+Foxauthor=B.+D.+Trappauthor=R.+M.+Ransohoff&title=Imaging+Correlates+of+Leukocyte+Accumulation+and+CXCR4%2FCXCL12+in+Multiple+Sclerosis&doi=10.1001%2Farchneurol.2008.512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis</span></div><div class="casAuthors">Moll Natalia M; Cossoy Michael B; Fisher Elizabeth; Staugaitis Susan M; Tucky Barbara H; Rietsch Anna M; Chang Ansi; Fox Robert J; Trapp Bruce D; Ransohoff Richard M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To compare leukocyte accumulation and expression of the chemokine receptor/ligand pair CXCR4/CXCL12 in magnetic resonance imaging-defined regions of interest (ROIs) in brains from patients with chronic multiple sclerosis.  We studied the following ROIs: normal-appearing white matter (NAWM); regions abnormal only on T2-weighted images (T2 only); and regions abnormal on T2- and T1-weighted images with an abnormal magnetization transfer ratio (T2/T1/MTR).  DESIGN:  Case-control study.  SETTING:  Cleveland Clinic.  PATIENTS:  Brain tissue was acquired from 5 patients with secondary progressive multiple sclerosis (MS) and 5 nonneurological controls.  INTERVENTION:  Magnetic resonance imaging pathological correlations were performed on the 5 cases.  Based on imaging characteristics, 30 ROIs were excised.  MAIN OUTCOME MEASURE:  Using immunohistochemical analysis, we evaluated myelin status, leukocyte accumulation, and CXCR4/CXCL12 expression in the MS ROIs and white matter regions from the 5 nonneurological controls.  RESULTS:  Eight of 10 T2/T1/MTR regions were chronic active or chronic inactive demyelinated lesions, whereas only 2 of 10 T2-only regions were demyelinated and characterized as active or chronic active lesions.  Equivalent numbers of CD68+ leukocytes (the predominant cell type) were present in myelinated T2-only regions as compared with NAWM.  Parenchymal T cells were significantly increased in T2/T1/MTR ROIs as compared with T2-only regions and NAWM.  Expression of CXCR4 and phospho-CXCR4 were found on reactive microglia and macrophages in T2-only and T2/T1/MTR lesions.  CXCL12 immunoreactivity was detected in astrocytes, astrocytic processes, and vascular elements in inflamed MS lesions.  CONCLUSIONS:  Inflammatory leukocyte accumulation was not increased in myelinated MS ROIs with abnormal T2 signal as compared with NAWM.  Robust expression of CXCR4/CXCL12 on inflammatory elements in MS lesions highlights a role of this chemokine/receptor pair in central nervous system inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMaDdIOGB_U5I8NvIb08rbfW6udTcc2eYMNeN1Bf7XFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fms12jtg%253D%253D&md5=abea2af47af5147b60d75c27824a63a4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2008.512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2008.512%26sid%3Dliteratum%253Aachs%26aulast%3DMoll%26aufirst%3DN.%2BM.%26aulast%3DCossoy%26aufirst%3DM.%2BB.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DStaugaitis%26aufirst%3DS.%2BM.%26aulast%3DTucky%26aufirst%3DB.%2BH.%26aulast%3DRietsch%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DR.%2BJ.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DImaging%2520Correlates%2520of%2520Leukocyte%2520Accumulation%2520and%2520CXCR4%252FCXCL12%2520in%2520Multiple%2520Sclerosis%26jtitle%3DArch.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D44%26epage%3D53%26doi%3D10.1001%2Farchneurol.2008.512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Orengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Influences Leukocyte Entry into the CNS Parenchyma by Controlling Abluminal CXCL12 Abundance During Autoimmunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1084/jem.20102010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1084%2Fjem.20102010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=21300915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlCjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=327-339&author=L.+Cruz-Orengoauthor=D.+W.+Holmanauthor=D.+Dorseyauthor=L.+Zhouauthor=P.+Zhangauthor=M.+Wrightauthor=E.+E.+McCandlessauthor=J.+R.+Patelauthor=G.+D.+Lukerauthor=D.+R.+Littmanauthor=J.+H.+Russellauthor=R.+S.+Klein&title=CXCR7+Influences+Leukocyte+Entry+into+the+CNS+Parenchyma+by+Controlling+Abluminal+CXCL12+Abundance+During+Autoimmunity&doi=10.1084%2Fjem.20102010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity</span></div><div class="casAuthors">Cruz-Orengo, Lillian; Holman, David W.; Dorsey, Denise; Zhou, Liang; Zhang, Penglie; Wright, Melissa; McCandless, Erin E.; Patel, Jigisha R.; Luker, Gary D.; Littman, Dan R.; Russell, John H.; Klein, Robyn S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">208</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-339</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Loss of CXCL12, a leukocyte localizing cue, from abluminal surfaces of the blood-brain barrier occurs in multiple sclerosis (MS) lesions.  However, the mechanisms and consequences of reduced abluminal CXCL12 abundance remain unclear.  Here, we show that activation of CXCR7, which scavenges CXCL12, is essential for leukocyte entry via endothelial barriers into the central nervous system (CNS) parenchyma during exptl. autoimmune encephalomyelitis (EAE), a model for MS.  CXCR7 expression on endothelial barriers increased during EAE at sites of inflammatory infiltration.  Treatment with a CXCR7 antagonist ameliorated EAE, reduced leukocyte infiltration into the CNS parenchyma and parenchymal VCAM-1 expression, and increased abluminal levels of CXCL12.  Interleukin 17 and interleukin 1β increased, whereas interferon-γ decreased, CXCR7 expression on and CXCL12 internalization in primary brain endothelial cells in vitro.  These findings identify mol. requirements for the transvascular entry of leukocytes into the CNS and suggest that CXCR7 blockade may have therapeutic utility for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEE4dyczoX7Vg90H21EOLACvtfcHk0lhDDEzceQu6_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlCjs7Y%253D&md5=0c92141bcdd0e13efb610e2971a80a76</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1084%2Fjem.20102010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20102010%26sid%3Dliteratum%253Aachs%26aulast%3DCruz-Orengo%26aufirst%3DL.%26aulast%3DHolman%26aufirst%3DD.%2BW.%26aulast%3DDorsey%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPatel%26aufirst%3DJ.%2BR.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DCXCR7%2520Influences%2520Leukocyte%2520Entry%2520into%2520the%2520CNS%2520Parenchyma%2520by%2520Controlling%2520Abluminal%2520CXCL12%2520Abundance%2520During%2520Autoimmunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D327%26epage%3D339%26doi%3D10.1084%2Fjem.20102010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyanagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanki, T.</span></span> <span> </span><span class="NLM_article-title">Pathogenic Role of CXCR7 in Rheumatoid Arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3211</span>– <span class="NLM_lpage">3220</span>, <span class="refDoi"> DOI: 10.1002/art.27650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1002%2Fart.27650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=20617529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3211-3220&author=K.+Watanabeauthor=M.+E.+T.+Penfoldauthor=A.+Matsudaauthor=N.+Ohyanagiauthor=K.+Kanekoauthor=Y.+Miyabeauthor=K.+Matsumotoauthor=T.+J.+Schallauthor=N.+Miyasakaauthor=T.+Nanki&title=Pathogenic+Role+of+CXCR7+in+Rheumatoid+Arthritis&doi=10.1002%2Fart.27650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenic role of CXCR7 in rheumatoid arthritis</span></div><div class="casAuthors">Watanabe, Kaori; Penfold, Mark E. T.; Matsuda, Akio; Ohyanagi, Naho; Kaneko, Kayoko; Miyabe, Yoshishige; Matsumoto, Kenji; Schall, Thomas J.; Miyasaka, Nobuyuki; Nanki, Toshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3211-3220</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. The interaction between CXCL12 and its receptor, CXCR4, in the synovium of patients with rheumatoid arthritis (RA) is important for local inflammatory cell recruitment, angiogenesis, and cytokine prodn.  CXCR7 was recently identified as an alternative receptor for CXCL12.  We undertook this study to analyze the expression of CXCR7 in RA synovium and the pathogenic role of the CXCL12/CXCR7 pathway in RA.  Methods. CXCR7 expression in RA synovial tissue was analyzed using immunohistochem., while expression of CXCR4 and CXCR7 on human umbilical vein endothelial cells (HUVECs) was examd. using quant. reverse transcription-polymerase chain reaction, and CXCR7 expression was also analyzed by flow cytometry.  Tube formation and rat aortic ring angiogenesis assays were used to assess the effects of CCX733 (a CXCR7 antagonist) and AMD3100 (a CXCR4 antagonist) on CXCL12-induced angiogenesis.  The effect of anti-CXCR4 monoclonal antibody (mAb) was also analyzed using a tube formation assay.  The effects of CCX733 in a murine model of collagen-induced arthritis (CIA) were also evaluated.  Results. CXCR7 was expressed on endothelial cells in RA synovium and also on unstimulated HUVECs.  The expression of CXCR7 on HUVECs was markedly up-regulated by interleukin-1β (IL-1β) stimulation, and this overexpression was further enhanced by CXCL12 treatment.  Incubation with CXCL12 also promoted angiogenic activity, with addn. of IL-1β again augmenting the effect.  CXCL12-induced angiogenesis was inhibited by both CXCR4 and CXCR7 antagonists and by anti-CXCR4 mAb.  Furthermore, treatment with CCX773 significantly reduced the clin. arthritis scores and the nos. of vessels in the inflamed synovial tissue in mice with CIA.  Conclusion. CXCR7 and CXCR4 are both important for angiogenesis in RA synovium, making CXCR7 another potential target mol. for novel RA angiogenesis-blocking therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAwhZAzOb-bVg90H21EOLACvtfcHk0lhmncLxQPVS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrvN&md5=e68229b6aeb3086580808a77d054c627</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.27650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27650%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DOhyanagi%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DMiyabe%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DMiyasaka%26aufirst%3DN.%26aulast%3DNanki%26aufirst%3DT.%26atitle%3DPathogenic%2520Role%2520of%2520CXCR7%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D3211%26epage%3D3220%26doi%3D10.1002%2Fart.27650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meichssner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngamsri, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutershan, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SDF-1 Receptors CXCR4 and CXCR7 Attenuates Acute Pulmonary Inflammation via the Adenosine A2B-Receptor on Blood Cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2832</span> <span class="refDoi"> DOI: 10.1038/cddis.2016.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fcddis.2016.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28542132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosV2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=F.+M.+Konradauthor=N.+Meichssnerauthor=A.+Buryauthor=K.+C.+Ngamsriauthor=J.+Reutershan&title=Inhibition+of+SDF-1+Receptors+CXCR4+and+CXCR7+Attenuates+Acute+Pulmonary+Inflammation+via+the+Adenosine+A2B-Receptor+on+Blood+Cells&doi=10.1038%2Fcddis.2016.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells</span></div><div class="casAuthors">Konrad, Franziska Magdalena; Meichssner, Nadine; Bury, Annette; Ngamsri, Kristian-Christos; Reutershan, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2832</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils into the different compartments of the lung.  Recent studies showed evidence that the chemokine stromal cell-derived factor (SDF)-1 and its receptors CXCR4 and CXCR7 influence migration of immune cells and their activity was linked to adenosine concns.  We investigated the particular role of CXCR4- and CXCR7-inhibition and the potential link to the adenosine A2B-receptor, which plays an important anti-inflammatory role in the lung.  After LPS-inhalation for 45 min, administration of the CXCR4-inhibitor (AMD3100) decreased transendothelial and transepithelial migration, whereas CXCR7-antagonism influenced epithelial migration exclusively.  In A2B-/- mice, no anti-inflammatory effects were detectible through either one of the agents.  Using chimeric mice, we identified A2B on hematopoietic cells to be crucial for these anti-inflammatory effects of CXCR4/7-inhibition.  Both inhibitors decreased TNFα, IL6, CXCL1 and CXCL2/3 levels in the bronchoalveolar lavage of wild type mice, while not influencing the chemokine release in A2B-/- mice.  Inflammation augmented the expression of both receptors and their inhibition increased A2B-levels upon inflammation.  In vitro assays with human epithelium/endothelium confirmed our in vivo findings.  During inflammation, inhibition of CXCR4- and CXCR7-receptors prevented microvascular permeability in wild type but not in A2B-/- mice, highlighting the pivotal role of an active A2B-receptor in this setting.  The combination of both inhibitors had a synergistic effect in preventing capillary leakage.  In conclusion, we detd. the pivotal role of CXCR4- and CXCR7-inhibition in acute pulmonary inflammation, which depended on A2B-receptor signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrBrujqVh7LbVg90H21EOLACvtfcHk0lhmncLxQPVS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosV2qtbk%253D&md5=5ebf2bfdc0e2b242c91a02c4b7b77c2d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.482%26sid%3Dliteratum%253Aachs%26aulast%3DKonrad%26aufirst%3DF.%2BM.%26aulast%3DMeichssner%26aufirst%3DN.%26aulast%3DBury%26aufirst%3DA.%26aulast%3DNgamsri%26aufirst%3DK.%2BC.%26aulast%3DReutershan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520SDF-1%2520Receptors%2520CXCR4%2520and%2520CXCR7%2520Attenuates%2520Acute%2520Pulmonary%2520Inflammation%2520via%2520the%2520Adenosine%2520A2B-Receptor%2520on%2520Blood%2520Cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2016.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngamsri, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bösmüller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamper-Tsigaras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutershan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, F. M.</span></span> <span> </span><span class="NLM_article-title">The Pivotal Role of CXCR7 in Stabilization of the Pulmonary Epithelial Barrier in Acute Pulmonary Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">2403</span>– <span class="NLM_lpage">2413</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4049%2Fjimmunol.1601682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28188248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=2403-2413&author=K.-C.+Ngamsriauthor=A.+M%C3%BCllerauthor=H.+B%C3%B6sm%C3%BCllerauthor=J.+Gamper-Tsigarasauthor=J.+Reutershanauthor=F.+M.+Konrad&title=The+Pivotal+Role+of+CXCR7+in+Stabilization+of+the+Pulmonary+Epithelial+Barrier+in+Acute+Pulmonary+Inflammation&doi=10.4049%2Fjimmunol.1601682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Pivotal Role of CXCR7 in Stabilization of the Pulmonary Epithelial Barrier in Acute Pulmonary Inflammation</span></div><div class="casAuthors">Ngamsri, Kristian-Christos; Mueller, Anika; Boesmueller, Hans; Gamper-Tsigaras, Jutta; Reutershan, Joerg; Konrad, Franziska M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2403-2413</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Acute pulmonary inflammation is still a frightening complication in intensive care units and has a high mortality.  Specific treatment is not available, and many details of the pathomechanism remain unclear.  The recently discovered chemokine receptor CXCR7 and its ligand stromal cell-derived factor (SDF)-1 are known to be involved in inflammation.  We chose to investigate the detailed role of CXCR7 in a murine model of LPS inhalation.  Inflammation increased pulmonary expression of CXCR7, and the receptor was predominantly expressed on pulmonary epithelium and on polymorphonuclear neutrophil (PMNs) after transepithelial migration into the alveolar space.  Specific inhibition of CXCR7 reduced transepithelial PMN migration by affecting the expression of adhesion mols.  CXCR7 antagonism reduced the most potent PMN chemoattractants CXCL1 and CXCL2/3.  After inhibiting CXCR7, NF-κB phosphorylation was reduced in lungs of mice, tight junction formation increased, and protein concn. in the bronchoalveolar lavage diminished, showing the impact of CXCR7 on stabilizing microvascular permeability.  In vitro studies with human cells confirmed the pivotal role of CXCR7 in pulmonary epithelium.  Immunofluorescence of human lungs confirmed our in vivo data and showed an increase of the expression of CXCR7 in pulmonary epithelium.  Highlighting the clin. potential of CXCR7 antagonism, nebulization of the agent before and after the inflammation showed impressive anti-inflammatory effects.  Addnl. CXCR7 inhibition potentiated the effect of SDF-1 antagonism, most probably by downregulating SDF-1 and the second receptor of the chemokine (CXCR4) expression.  In conclusion, our data identified the pivotal role of the receptor CXCR7 in pulmonary inflammation with a predominant effect on the pulmonary epithelium and PMNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqGeBrOssP7Vg90H21EOLACvtfcHk0lhLdmLNaFESHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOmtbw%253D&md5=ed2c4cfca6be21b3ae4d9a02690dde4d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601682%26sid%3Dliteratum%253Aachs%26aulast%3DNgamsri%26aufirst%3DK.-C.%26aulast%3DM%25C3%25BCller%26aufirst%3DA.%26aulast%3DB%25C3%25B6sm%25C3%25BCller%26aufirst%3DH.%26aulast%3DGamper-Tsigaras%26aufirst%3DJ.%26aulast%3DReutershan%26aufirst%3DJ.%26aulast%3DKonrad%26aufirst%3DF.%2BM.%26atitle%3DThe%2520Pivotal%2520Role%2520of%2520CXCR7%2520in%2520Stabilization%2520of%2520the%2520Pulmonary%2520Epithelial%2520Barrier%2520in%2520Acute%2520Pulmonary%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D2403%26epage%3D2413%26doi%3D10.4049%2Fjimmunol.1601682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syu, F.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-C.</span></span> <span> </span><span class="NLM_article-title">Critical Involvement of Atypical Chemokine Receptor CXCR7 in Allergic Airway Inflammation</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1111/imm.12881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1111%2Fimm.12881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29250768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=274-284&author=H.-C.+Changauthor=P.-H.+Huangauthor=F.-S.+Syuauthor=C.-H.+Hsiehauthor=S.+L.-Y.+Changauthor=J.+Luauthor=H.-C.+Chen&title=Critical+Involvement+of+Atypical+Chemokine+Receptor+CXCR7+in+Allergic+Airway+Inflammation&doi=10.1111%2Fimm.12881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Critical involvement of atypical chemokine receptor CXCR7 in allergic airway inflammation</span></div><div class="casAuthors">Chang, Hung-Chih; Huang, Po-Han; Syu, Fu-Sheng; Hsieh, Chia-Hung; Chang, Sunny Li-Yun; Lu, Jean; Chen, Hui-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">274-284</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Trafficking and recruitment of immune cells to the site of inflammation with spatial and temporal synchronization is crucial for the development of allergic airway inflammation.  Particularly, chemokines are known to be key players in these processes.  Previous studies revealed that the CXCL12/CXCR4 axis plays an important role in regulating allergic airway inflammation.  However, the role of CXCR7, a recently discovered second receptor for CXCL12, in regulating airway inflammation has not been explored.  Initially, CXCR7 was considered as a decoy receptor; however, numerous subsequent studies revealed that engagement of CXCR7 triggered its own signalling or modulated CXCR4-mediated signalling.  In the present study, we detected the expression of CXCR7 in airway epithelial cells.  Use of a lentiviral delivery system to knock down the expression of CXCR7 in the lung of sensitized mice abrogated the cardinal features of asthma, indicating that CXCR7 plays a role in regulating allergic airway inflammation.  The activation of mitogen-activated protein kinase and Akt signalling in response to CXCL12 in the mouse epithelial cell line MLE-12 was reduced when CXCR7 expression was knocked down.  However, either knockdown or overexpression of CXCR7 in MLE-12 did not affect CXCL12-mediated calcium influx, indicating that CXCR7 does not modulate CXCR4-mediated signalling, and that it functions as a signalling receptor rather than a decoy receptor.  Finally, we found that the expression of chemokine CCL2 is regulated by CXCR7/CXCL12-mediated signalling through β-arrestin in airway epithelial cells.  Hence, regulating the expression of CCL2 in airway epithelial cells may be one mechanism by which CXCR7 participates in regulating allergic airway inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOjlqwCxrhmbVg90H21EOLACvtfcHk0lhLdmLNaFESHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVKqsA%253D%253D&md5=5eccd848aa6aa9c760ffd2042ee02465</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fimm.12881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12881%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-C.%26aulast%3DHuang%26aufirst%3DP.-H.%26aulast%3DSyu%26aufirst%3DF.-S.%26aulast%3DHsieh%26aufirst%3DC.-H.%26aulast%3DChang%26aufirst%3DS.%2BL.-Y.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.-C.%26atitle%3DCritical%2520Involvement%2520of%2520Atypical%2520Chemokine%2520Receptor%2520CXCR7%2520in%2520Allergic%2520Airway%2520Inflammation%26jtitle%3DImmunology%26date%3D2018%26volume%3D154%26spage%3D274%26epage%3D284%26doi%3D10.1111%2Fimm.12881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Targeting and Its Major Disease Relevance</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">641</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.3389%2Ffphar.2018.00641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29977203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ahsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=641&author=C.+Wangauthor=W.+Chenauthor=J.+Shen&title=CXCR7+Targeting+and+Its+Major+Disease+Relevance&doi=10.3389%2Ffphar.2018.00641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 targeting and its major disease relevance</span></div><div class="casAuthors">Wang, Chuan; Chen, Weilin; Shen, Jianzhong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">641/1-641/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Chemokine receptors are the target of small peptide chemokines.  They play various important roles in physiol. and pathol. processes.  CXCR7, later renamed ACKR3, is a non-classical seven transmembrane-spanning receptor whose function as a signaling or non-signaling scavenger/decoy receptor is currently under debate.  Even for cell signaling mechanisms, there has been inconsistency on whether CXCR7 couples to G-proteins or β-arrestins.  Several reasons may contribute to this uncertainty or controversy.  In one hand, it has been neglected that CXCR7 has more than five natural ligands and unfortunately, most of the prior research only studied SDF-1 (CXCL12) and/or I-TAC (CXCL11); on the other hand, there are mounting evidence supporting ligand and tissue bias for receptor signaling, but limited such information is available for CXCR7.  In this review we focus on summarizing the endogenous and exogenous ligands of CXCR7, the main diseases related to CXCR7 and the biased signaling events happening on CXCR7.  These three aspects of CXCR7 pharmacol. properties may explain why the contradicting opinions of whether CXCR7 is a signaling or non-signaling receptor exist.  Further, potential new direction and perspective for the study of CXCR7 biol. and pharmacol. are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD3SaGRfdfPLVg90H21EOLACvtfcHk0lgBnKI8SjHw5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ahsbo%253D&md5=ea92d28be028cc6e08f63faadc650230</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00641%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DCXCR7%2520Targeting%2520and%2520Its%2520Major%2520Disease%2520Relevance%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D641%26doi%3D10.3389%2Ffphar.2018.00641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebsworth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Omran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kioi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernikova, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulkearns-Hubert, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinyuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathia, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamchandani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, H. E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CXCR7 Extends Survival Following Irradiation of Brain Tumours in Mice and Rats</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1038/bjc.2013.830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2013.830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24423923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2014&pages=1179-1188&author=M.+J.+Waltersauthor=K.+Ebsworthauthor=R.+D.+Berahovichauthor=M.+E.+T.+Penfoldauthor=S.-C.+Liuauthor=R.+Al+Omranauthor=M.+Kioiauthor=S.+B.+Chernikovaauthor=D.+Tsengauthor=E.+E.+Mulkearns-Hubertauthor=M.+Sinyukauthor=R.+M.+Ransohoffauthor=J.+D.+Lathiaauthor=J.+Karamchandaniauthor=H.+E.+K.+Kohrtauthor=P.+Zhangauthor=J.+P.+Powersauthor=J.+C.+Jaenauthor=T.+J.+Schallauthor=M.+Merchantauthor=L.+Rechtauthor=J.+M.+Brown&title=Inhibition+of+CXCR7+Extends+Survival+Following+Irradiation+of+Brain+Tumours+in+Mice+and+Rats&doi=10.1038%2Fbjc.2013.830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats</span></div><div class="casAuthors">Walters, M. J.; Ebsworth, K.; Berahovich, R. D.; Penfold, M. E. T.; Liu, S-C.; Al Omran, R.; Kioi, M.; Chernikova, S. B.; Tseng, D.; Mulkearns-Hubert, E. E.; Sinyuk, M.; Ransohoff, R. M.; Lathia, J. D.; Karamchandani, J.; Koort, H. E. K.; Zhang, P.; Powers, J. P.; Jaen, J. C.; Schall, T. J.; Merchant, M.; Recht, L.; Brown, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: In exptl. models of glioblastoma multiforme (GBM), irradn. (IR) induces local expression of the chemokine CXCL12/SDF-1, which promotes tumor recurrence.  The role of CXCR7, the high-affinity receptor for CXCL12, in the tumor's response to IR has not been addressed.  Methods: We tested CXCR7 inhibitors for their effects on tumor growth and/or animal survival post IR in three rodent GBM models.  We used immunohistochem. to det. where CXCR7 protein is expressed in the tumors and in human GBM samples.  We used neurosphere formation assays with human GBM xenografts to det. whether CXCR7 is required for cancer stem cell (CSC) activity in vitro.  Results: CXCR7 was detected on tumor cells and/or tumor-assocd. vasculature in the rodent models and in human GBM.  In human GBM, CXCR7 expression increased with glioma grade and was spatially assocd. with CXCL12 and CXCL11/I-TAC.  In the rodent GBM models, pharmacol. inhibition of CXCR7 post IR caused tumor regression, blocked tumor recurrence, and/or substantially prolonged survival.  CXCR7 expression levels on human GBM xenograft cells correlated with neurosphere-forming activity, and a CXCR7 inhibitor blocked sphere formation by sorted CSCs.  Conclusions: These results indicate that CXCR7 inhibitors could block GBM tumor recurrence after IR, perhaps by interfering with CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3mXhvIVB3X7Vg90H21EOLACvtfcHk0lgBnKI8SjHw5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyhsr0%253D&md5=e6cf80995426e58cc61998de1866aa90</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.830%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DEbsworth%26aufirst%3DK.%26aulast%3DBerahovich%26aufirst%3DR.%2BD.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DLiu%26aufirst%3DS.-C.%26aulast%3DAl%2BOmran%26aufirst%3DR.%26aulast%3DKioi%26aufirst%3DM.%26aulast%3DChernikova%26aufirst%3DS.%2BB.%26aulast%3DTseng%26aufirst%3DD.%26aulast%3DMulkearns-Hubert%26aufirst%3DE.%2BE.%26aulast%3DSinyuk%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DLathia%26aufirst%3DJ.%2BD.%26aulast%3DKaramchandani%26aufirst%3DJ.%26aulast%3DKohrt%26aufirst%3DH.%2BE.%2BK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520CXCR7%2520Extends%2520Survival%2520Following%2520Irradiation%2520of%2520Brain%2520Tumours%2520in%2520Mice%2520and%2520Rats%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D110%26spage%3D1179%26epage%3D1188%26doi%3D10.1038%2Fbjc.2013.830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimdjee-Soilihi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchetrit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goguet-Surmenian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Antomarchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Alliana, A.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Receptors Facilitate the Progression of Colon Carcinoma within Lung not within Liver</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1944</span>– <span class="NLM_lpage">1949</span>, <span class="refDoi"> DOI: 10.1038/bjc.2012.503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2012.503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=23169289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSntbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1944-1949&author=E.+Guillemotauthor=B.+Karimdjee-Soilihiauthor=E.+Pradelliauthor=M.+Benchetritauthor=E.+Goguet-Surmenianauthor=M.+A.+Milletauthor=F.+Larbretauthor=J.+F.+Michielsauthor=D.+Birnbaumauthor=P.+Alemannoauthor=H.+Schmid-Antomarchiauthor=A.+Schmid-Alliana&title=CXCR7+Receptors+Facilitate+the+Progression+of+Colon+Carcinoma+within+Lung+not+within+Liver&doi=10.1038%2Fbjc.2012.503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver</span></div><div class="casAuthors">Guillemot, E.; Karimdjee-Soilihi, B.; Pradelli, E.; Benchetrit, M.; Goguet-Surmenian, E.; Millet, M.-A.; Larbret, F.; Michiels, J.-F.; Birnbaum, D.; Alemanno, P.; Schmid-Antomarchi, H.; Schmid-Alliana, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1944-1949</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Liver and lung metastases are the predominant cause of colorectal cancer (CRC)-related mortality.  Chemokine-receptor pairs have a crit. role in detg. the metastatic progression of tumors.  Our hypothesis was that disruption of CXCR7/CXCR7 ligands axis could lead to a decrease in CRC metastases.  Methods: Primary tumors and metastatic tissues from patients with CRC were tested for the expression of CXCR7 and its ligands.  Relevance of CXCR7/CXCR7 ligands for CRC metastasis was then investigated in mice using small pharmacol. CXCR7 antagonists and CRC cell lines of human and murine origins, which - injected into mice - enable the development of lung and liver metastases.  Results: Following injection of CRC cells, mice treated daily with CXCR7 antagonists exhibited a significant redn. in lung metastases.  However, CXCR7 antagonists failed to reduce the extent of liver metastasis.  Moreover, there were subtle differences in the expression of CXCR7 and its ligands between lung and liver metastases.  Conclusion: Our study suggests that the activation of CXCR7 on tumor blood vessels by its ligands may facilitate the progression of CRC within lung but not within liver.  Moreover, we provide evidence that targeting the CXCR7 axis may be beneficial to limit metastasis from colon cancer within the lungs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1p2PoWH-YbVg90H21EOLACvtfcHk0lgqLfKcnXMAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSntbjP&md5=cee6a363511bf6d92c53f3e4552a00a3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.503%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemot%26aufirst%3DE.%26aulast%3DKarimdjee-Soilihi%26aufirst%3DB.%26aulast%3DPradelli%26aufirst%3DE.%26aulast%3DBenchetrit%26aufirst%3DM.%26aulast%3DGoguet-Surmenian%26aufirst%3DE.%26aulast%3DMillet%26aufirst%3DM.%2BA.%26aulast%3DLarbret%26aufirst%3DF.%26aulast%3DMichiels%26aufirst%3DJ.%2BF.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DAlemanno%26aufirst%3DP.%26aulast%3DSchmid-Antomarchi%26aufirst%3DH.%26aulast%3DSchmid-Alliana%26aufirst%3DA.%26atitle%3DCXCR7%2520Receptors%2520Facilitate%2520the%2520Progression%2520of%2520Colon%2520Carcinoma%2520within%2520Lung%2520not%2520within%2520Liver%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D1944%26epage%3D1949%26doi%3D10.1038%2Fbjc.2012.503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihalko, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggins, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-Positive Breast Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">4750</span>– <span class="NLM_lpage">4758</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fonc.2011.633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22266857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=4750-4758&author=K.+E.+Lukerauthor=S.+A.+Lewinauthor=L.+A.+Mihalkoauthor=B.+T.+Schmidtauthor=J.+S.+Winklerauthor=N.+L.+Cogginsauthor=D.+G.+Thomasauthor=G.+D.+Luker&title=Scavenging+of+CXCL12+by+CXCR7+Promotes+Tumor+Growth+and+Metastasis+of+CXCR4-Positive+Breast+Cancer+Cells&doi=10.1038%2Fonc.2011.633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells</span></div><div class="casAuthors">Luker, K. E.; Lewin, S. A.; Mihalko, L. A.; Schmidt, B. T.; Winkler, J. S.; Coggins, N. L.; Thomas, D. G.; Luker, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">4750-4758</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokine CXCL12 and receptor CXCR4 control multiple steps in primary tumor growth and metastasis in breast cancer and >20 other human malignancies.  Mechanisms that regulate availability of CXCL12 in tumor microenvironments will substantially impact cancer progression and ongoing efforts to target the CXCL12-CXCR4 pathway for cancer chemotherapy.  Dual luciferase imaging was used to study CXCR7-dependent scavenging of CXCL12 in breast tumors in vivo and quantify effects of CXCR7 on tumor growth and metastasis of a sep. population of CXCR4+ breast cancer cells.  In a mouse xenograft model of human breast cancer, in vivo imaging showed that malignant cells expressing CXCR7 reduced bioluminescent CXCL12 secreted in the primary tumor microenvironment.  Capitalizing on sensitive detection of bioluminescent CXCL12, also CXCR7+ cells reduced amts. of chemokine released from orthotopic tumors into the circulation.  Immunofluorescence staining of human primary breast cancers showed expression of CXCR4 and CXCR7 on malignant cells in ≈30% of cases.  In most cases, CXCR4 and CXCR7 predominantly were expressed on sep. populations of malignant cells in a tumor.  The authors modeled these cases of human breast cancer by co-implanting tumor xenografts with CXCR4+ breast cancer cells, human mammary fibroblasts secreting CXCL12, and CXCR7+ or control breast cancer cells.  Bioluminescence imaging showed that CXCR7+ breast cancer cells enhanced proliferation of CXCR4+ breast cancer cells in orthotopic tumors and spontaneous metastases.  Treatment with a small-mol. inhibitor of CXCR7 chemokine limited the growth of CXCR4+ breast cancer cells in tumors that also contained malignant CXCR7+ cells.  These studies establish a new in vivo imaging method to quantify chemokine scavenging by CXCR7 in the tumor microenvironment and identify that CXCR7+ cells promote growth and metastasis of CXCR4+ breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX_3TeuDDs17Vg90H21EOLACvtfcHk0ljiY1AevCnTZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eltrjK&md5=61ebfb979de0826cb08e73908ee9b33c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.633%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DLewin%26aufirst%3DS.%2BA.%26aulast%3DMihalko%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DB.%2BT.%26aulast%3DWinkler%26aufirst%3DJ.%2BS.%26aulast%3DCoggins%26aufirst%3DN.%2BL.%26aulast%3DThomas%26aufirst%3DD.%2BG.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DScavenging%2520of%2520CXCL12%2520by%2520CXCR7%2520Promotes%2520Tumor%2520Growth%2520and%2520Metastasis%2520of%2520CXCR4-Positive%2520Breast%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D4750%26epage%3D4758%26doi%3D10.1038%2Fonc.2011.633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goguet-Surmenian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard-Fiardo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchetrit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Brouchet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzzo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimdjee-Soilihi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Alliana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Antomarchi, H.</span></span> <span> </span><span class="NLM_article-title">CXCR7-Mediated Progression of Osteosarcoma in the Lungs</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1579</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1038/bjc.2013.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2013.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24002596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=1579-1585&author=E.+Goguet-Surmenianauthor=P.+Richard-Fiardoauthor=E.+Guillemotauthor=M.+Benchetritauthor=A.+Gomez-Brouchetauthor=P.+Buzzoauthor=B.+Karimdjee-Soilihiauthor=P.+Alemannoauthor=J.+F.+Michielsauthor=A.+Schmid-Allianaauthor=H.+Schmid-Antomarchi&title=CXCR7-Mediated+Progression+of+Osteosarcoma+in+the+Lungs&doi=10.1038%2Fbjc.2013.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7-mediated progression of osteosarcoma in the lungs</span></div><div class="casAuthors">Goguet-Surmenian, E.; Richard-Fiardo, P.; Guillemot, E.; Benchetrit, M.; Gomez-Brouchet, A.; Buzzo, P.; Karimdjee-Soilihi, B.; Alemanno, P.; Michiels, J.-F.; Schmid-Alliana, A.; Schmid-Antomarchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1579-1585</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Osteosarcoma (OS) is the most frequent primary malignant bone tumor in children and adolescents with a high propensity for lung metastasis.  Chemokines and chemokine receptors have been described to have an important role in many malignancies including OS.  The aim of this study was to investigate the expression of CXCR7 receptor in OS tissues and its role in the progression of the disease in the lungs.  Methods: Immunohistochem. was used to study CXCR7 expression in primary tumors and metastatic tissues from patients with OS.  Its contribution to tumor expansion in the lungs has been also assessed using animal models and synthetic-specific CXCR7 ligands.  Results: CXCR7 was expressed on human primary bone tumors and on lung metastases.  Its expression was predominantly located on tumor-assocd. blood vessels.  Mice challenged with OS cells and systematically treated with synthetic CXCR7 ligands presented a significant redn. of lung nodules compared with untreated mice.  Conclusion: This study shows that CXCR7 has a crit. role in OS progression in the lungs, where are expressed CXCR7 ligands, esp. CXCL12.  Moreover, we highlight that synthetic CXCR7 ligands could represent a powerful therapeutic tool to impede lung OS progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg-4DcvJD0CLVg90H21EOLACvtfcHk0ljiY1AevCnTZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqu7nN&md5=66a4ba7381b179ceca86dee5e1ad72a3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.482%26sid%3Dliteratum%253Aachs%26aulast%3DGoguet-Surmenian%26aufirst%3DE.%26aulast%3DRichard-Fiardo%26aufirst%3DP.%26aulast%3DGuillemot%26aufirst%3DE.%26aulast%3DBenchetrit%26aufirst%3DM.%26aulast%3DGomez-Brouchet%26aufirst%3DA.%26aulast%3DBuzzo%26aufirst%3DP.%26aulast%3DKarimdjee-Soilihi%26aufirst%3DB.%26aulast%3DAlemanno%26aufirst%3DP.%26aulast%3DMichiels%26aufirst%3DJ.%2BF.%26aulast%3DSchmid-Alliana%26aufirst%3DA.%26aulast%3DSchmid-Antomarchi%26aufirst%3DH.%26atitle%3DCXCR7-Mediated%2520Progression%2520of%2520Osteosarcoma%2520in%2520the%2520Lungs%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D109%26spage%3D1579%26epage%3D1585%26doi%3D10.1038%2Fbjc.2013.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wani, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahirwar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, R. K.</span></span> <span> </span><span class="NLM_article-title">C-X-C Motif Chemokine 12/C-X-C Chemokine Receptor Type 7 Signaling Regulates Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">R54</span>, <span class="refDoi"> DOI: 10.1186/bcr3665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1186%2Fbcr3665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24886617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFShtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=R54&author=N.+A.+Waniauthor=M.+W.+Nasserauthor=D.+K.+Ahirwarauthor=H.+Zhaoauthor=Z.+Miaoauthor=K.+Shiloauthor=R.+K.+Ganju&title=C-X-C+Motif+Chemokine+12%2FC-X-C+Chemokine+Receptor+Type+7+Signaling+Regulates+Breast+Cancer+Growth+and+Metastasis+by+Modulating+the+Tumor+Microenvironment&doi=10.1186%2Fbcr3665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment</span></div><div class="casAuthors">Wani, Nissar Ahmad; Nasser, Mohd W.; Ahirwar, Dinesh K.; Zhao, Helong; Miao, Zhenhua; Shilo, Konstantin; Ganju, Ramesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R54/1-R54/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Although C-X-C motif chemokine 12 (CXCL12) has been shown to bind to C-X-C chemokine receptor type 7 (CXCR7), the exact mol. mechanism regulations by CXCL12/CXCR7 axis in breast tumor growth and metastasis are not well understood.  CXCR7 expression has been shown to be upregulated during pathol. processes such as inflammation and cancer.  Breast cancer cell lines were genetically silenced or pharmacol. inhibited for CXCR7 and/or its downstream target signal transducer and activator of transcription 3 (STAT3). 4T1 or 4T1 downregulated for CXCR7 and 4T1.2 breast cancer cell lines were injected in mammary gland of BALB/c mice to form tumors and the mol. pathways regulating tumor growth and metastasis were assessed.  In this study, we obsd. that CXCL12 enhances CXCR7-mediated breast cancer migration.  Furthermore, genetic silencing or pharmacol. inhibition of CXCR7 reduced breast tumor growth and metastasis.  Further elucidation of mechanisms revealed that CXCR7 mediates tumor growth and metastasis by activating pro-inflammatory STAT3 signaling and angiogenic markers.  Furthermore, enhanced breast tumorigenicity and invasiveness were assocd. with macrophage infiltration.  CXCR7 recruits tumor promoting macrophages (M2) to the tumor site through regulation of macrophage colony-stimulating factor (MCSF)/macrophage colony-stimulating factor receptor (MCSF-R) signaling pathway.  In addn., CXCR7 regulated breast cancer metastasis by enhancing expression of metalloproteinases (MMP-9, MMP-2) and vascular cell adhesion mol.-1 (VCAM-1).  We also obsd. that CXCR7 is highly expressed in invasive ductal carcinoma (IDC) and metastatic breast tissue in human patient samples.  In addn., high CXCR7 expression in tumors correlates with worse prognosis of both overall survival and lung metastasis free survival in IDC patients.  These observations reveal that CXCR7 enhances breast cancer growth and metastasis via a novel pathway by modulating the tumor microenvironment.  These findings identify CXCR7-mediated STAT3 activation and modulation of tumor microenvironment as novel regulation of breast cancer growth and metastasis.  These studies indicate that new strategies using CXCR7 inhibitors could be developed for anti-metastatic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjiY1MKjaBbVg90H21EOLACvtfcHk0liJON44QB1VrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFShtbs%253D&md5=e81a1b88d2627245a6bea61830c45402</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Fbcr3665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr3665%26sid%3Dliteratum%253Aachs%26aulast%3DWani%26aufirst%3DN.%2BA.%26aulast%3DNasser%26aufirst%3DM.%2BW.%26aulast%3DAhirwar%26aufirst%3DD.%2BK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShilo%26aufirst%3DK.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DC-X-C%2520Motif%2520Chemokine%252012%252FC-X-C%2520Chemokine%2520Receptor%2520Type%25207%2520Signaling%2520Regulates%2520Breast%2520Cancer%2520Growth%2520and%2520Metastasis%2520by%2520Modulating%2520the%2520Tumor%2520Microenvironment%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2014%26volume%3D16%26spage%3DR54%26doi%3D10.1186%2Fbcr3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biben, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woehl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-A, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span> <span> </span><span class="NLM_article-title">Disrupted Cardiac Development But Normal Hematopoiesis in Mice Deficient in the Second CXCL12/SDF-1 Receptor, CXCR7</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">14759</span>– <span class="NLM_lpage">14764</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702229104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1073%2Fpnas.0702229104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=17804806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOns7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=14759-14764&author=F.+Sierroauthor=C.+Bibenauthor=L.+Martinez-Munozauthor=M.+Melladoauthor=R.+M.+Ransohoffauthor=M.+Liauthor=B.+Woehlauthor=H.+Leungauthor=J.+Groomauthor=M.+Battenauthor=R.+P.+Harveyauthor=C.+Martinez-Aauthor=C.+R.+Mackayauthor=F.+Mackay&title=Disrupted+Cardiac+Development+But+Normal+Hematopoiesis+in+Mice+Deficient+in+the+Second+CXCL12%2FSDF-1+Receptor%2C+CXCR7&doi=10.1073%2Fpnas.0702229104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7</span></div><div class="casAuthors">Sierro, Frederic; Biben, Christine; Martinez-Munoz, Laura; Mellado, Mario; Ransohoff, Richard M.; Li, Meizhang; Woehl, Blanche; Leung, Helen; Groom, Joanna; Batten, Marcel; Harvey, Richard P.; Martinez-A, Carlos; Mackay, Charles R.; Mackay, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">14759-14764</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chemotactic cytokines (chemokines) attract immune cells, although their original evolutionary role may relate more closely with embryonic development.  The authors noted differential expression of the chemokine receptor CXCR7 (RDC-1) on marginal zone B cells, a cell type assocd. with autoimmune diseases.  The authors generated Cxcr7-/- mice but found that CXCR7 deficiency had little effect on B cell compn.  However, most Cxcr7-/- mice died at birth with ventricular septal defects and semilunar heart valve malformation.  Conditional deletion of Cxcr7 in endothelium, using Tie2-Cre transgenic mice, recapitulated this phenotype.  Gene profiling of Cxcr7-/- heart valve leaflets revealed a defect in the expression of factors essential for valve formation, vessel protection, or endothelial cell growth and survival.  The authors confirmed that the principal chemokine ligand for CXCR7 was CXCL12/SDF-1, which also binds CXCR4.  CXCL12 did not induce signaling via CXCR7; however, CXCR7 formed functional heterodimers with CXCR4 and enhanced CXCL12-induced signaling.  These results reveal a specialized role for CXCR7 in endothelial biol. and valve development and highlight the distinct developmental role of evolutionary conserved chemokine receptors such as CXCR7 and CXCR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWt3RDix4v7Vg90H21EOLACvtfcHk0liJON44QB1VrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOns7nO&md5=8f0189651d065aec51747df0d148399d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702229104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702229104%26sid%3Dliteratum%253Aachs%26aulast%3DSierro%26aufirst%3DF.%26aulast%3DBiben%26aufirst%3DC.%26aulast%3DMartinez-Munoz%26aufirst%3DL.%26aulast%3DMellado%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWoehl%26aufirst%3DB.%26aulast%3DLeung%26aufirst%3DH.%26aulast%3DGroom%26aufirst%3DJ.%26aulast%3DBatten%26aufirst%3DM.%26aulast%3DHarvey%26aufirst%3DR.%2BP.%26aulast%3DMartinez-A%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26aulast%3DMackay%26aufirst%3DF.%26atitle%3DDisrupted%2520Cardiac%2520Development%2520But%2520Normal%2520Hematopoiesis%2520in%2520Mice%2520Deficient%2520in%2520the%2520Second%2520CXCL12%252FSDF-1%2520Receptor%252C%2520CXCR7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D14759%26epage%3D14764%26doi%3D10.1073%2Fpnas.0702229104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menhaji-Klotz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesp, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canterbury, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagley, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdziorko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerin, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3685</span>– <span class="NLM_lpage">3696</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00190</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00190" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntF2ntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3685-3696&author=E.+Menhaji-Klotzauthor=K.+D.+Hespauthor=A.+T.+Londreganauthor=A.+S.+Kalgutkarauthor=D.+W.+Piotrowskiauthor=M.+Boehmauthor=K.+Songauthor=T.+Ryderauthor=K.+Beaumontauthor=R.+M.+Jonesauthor=K.+Atkinsonauthor=J.+A.+Brownauthor=J.+Litchfieldauthor=J.+Xiaoauthor=D.+P.+Canterburyauthor=K.+Burfordauthor=B.+A.+Thumaauthor=C.+Limberakisauthor=W.+Jiaoauthor=S.+W.+Bagleyauthor=S.+Agarwalauthor=D.+Crowellauthor=S.+Pazdziorkoauthor=J.+Wardauthor=D.+A.+Priceauthor=V.+Clerin&title=Discovery+of+a+Novel+Small-Molecule+Modulator+of+C-X-C+Chemokine+Receptor+Type+7+as+a+Treatment+for+Cardiac+Fibrosis&doi=10.1021%2Facs.jmedchem.8b00190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis</span></div><div class="casAuthors">Menhaji-Klotz, Elnaz; Hesp, Kevin D.; Londregan, Allyn T.; Kalgutkar, Amit S.; Piotrowski, David W.; Boehm, Markus; Song, Kun; Ryder, Tim; Beaumont, Kevin; Jones, Rhys M.; Atkinson, Karen; Brown, Janice A.; Litchfield, John; Xiao, Jun; Canterbury, Daniel P.; Burford, Kristen; Thuma, Benjamin A.; Limberakis, Chris; Jiao, Wenhua; Bagley, Scott W.; Agarwal, Saket; Crowell, Danielle; Pazdziorko, Stephen; Ward, Jessica; Price, David A.; Clerin, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3685-3696</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-X-C chemokine receptor type 7 (CXCR7) is involved in cardiac and immune pathophysiol.  We report the discovery of a novel 1,4-diazepine CXCR7 modulator, demonstrating for the first time the role of pharmacol. CXCR7 intervention in cardiac repair.  Structure-activity-relationship (SAR) studies demonstrated that a net redn. in lipophilicity (log D) and an incorporation of satd. ring systems yielded compds. with good CXCR7 potencies and improvements in oxidative metabolic stability in human-liver microsomes (HLM).  Tethering an ethylene amide further improved the selectivity profile (e.g., for compd. 18, CXCR7 Ki = 13 nM, adrenergic α 1a Kb > 10,000 nM, and adrenergic β 2 Kb > 10,000 nM).  The s.c. administration of 18 in mice led to a statistically significant increase in circulating concns. of plasma stromal-cell-derived factor 1α (SDF-1α) of approx. 2-fold.  Chronic dosing of compd. 18 in a mouse model of isoproterenol-induced cardiac injury further resulted in a statistically significant redn. of cardiac fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2P-nnsmcbbVg90H21EOLACvtfcHk0liYe524XO-bzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntF2ntLw%253D&md5=edaa64c4edbe27d8fcfca0067dac1cd1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00190%26sid%3Dliteratum%253Aachs%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DHesp%26aufirst%3DK.%2BD.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DCanterbury%26aufirst%3DD.%2BP.%26aulast%3DBurford%26aufirst%3DK.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DBagley%26aufirst%3DS.%2BW.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DCrowell%26aufirst%3DD.%26aulast%3DPazdziorko%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DClerin%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Small-Molecule%2520Modulator%2520of%2520C-X-C%2520Chemokine%2520Receptor%2520Type%25207%2520as%2520a%2520Treatment%2520for%2520Cardiac%2520Fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3685%26epage%3D3696%26doi%3D10.1021%2Facs.jmedchem.8b00190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolkkonen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. S.</span></span> <span> </span><span class="NLM_article-title">Effects of CXCR7-Neutralizing Antibody on Neurogenesis in the Hippocampal Dentate Gyrus and Cognitive Function in the Chronic Phase of Cerebral Ischemia</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1079</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.270416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4103%2F1673-5374.270416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=31823888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BB3MfovVWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1079-1085&author=B.+C.+Dongauthor=M.+X.+Liauthor=X.+Y.+Wangauthor=X.+Chengauthor=Y.+Wangauthor=T.+Xiaoauthor=J.+Jolkkonenauthor=C.+S.+Zhaoauthor=S.+S.+Zhao&title=Effects+of+CXCR7-Neutralizing+Antibody+on+Neurogenesis+in+the+Hippocampal+Dentate+Gyrus+and+Cognitive+Function+in+the+Chronic+Phase+of+Cerebral+Ischemia&doi=10.4103%2F1673-5374.270416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of CXCR7-neutralizing antibody on neurogenesis in the hippocampal dentate gyrus and cognitive function in the chronic phase of cerebral ischemia</span></div><div class="casAuthors">Dong Bing-Chao; Li Mei-Xuan; Wang Xiao-Yin; Cheng Xi; Wang Yu; Zhao Chuan-Sheng; Zhao Shan-Shan; Xiao Ting; Jolkkonen Jukka</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1079-1085</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">Stromal cell-derived factor-1 and its receptor CXCR4 are essential regulators of the neurogenesis that occurs in the adult hippocampal dentate gyrus.  However, the effects of CXCR7, a new atypical receptor of stromal cell-derived factor-1, on hippocampal neurogenesis after a stroke remain largely unknown.  Our study is the first to investigate the effect of a CXCR7-neutralizing antibody on neurogenesis in the dentate gyrus and the associated recovery of cognitive function of rats in the chronic stage of cerebral ischemia.  The rats were randomly divided into sham, sham + anti-CXCR7, ischemia and ischemia + anti-CXCR7 groups.  Endothelin-1 was injected in the ipsilateral motor cortex and striatum to induce focal cerebral ischemia.  Sham group rats were injected with saline instead of endothelin-1 via intracranial injection.  Both sham and ischemic rats were treated with intraventricular infusions of CXCR7-neutralizing antibodies for 6 days 1 week after surgery.  Immunofluorescence staining with doublecortin, a marker for neuronal precursors, was performed to assess the neurogenesis in the dentate gyrus.  We found that anti-CXCR7 antibody infusion enhanced the proliferation and dendritic development of doublecortin-labeled cells in the dentate gyrus in both ischemic and sham-operated rats.  Spatial learning and memory functions were assessed by Morris water maze tests 30-32 days after ischemia.  CXCR7-neutralizing antibody treatment significantly reduced the escape latency of the spatial navigation trial and increased the time spent in the target quadrant of spatial probe trial in animals that received ischemic insult, but not in sham operated rats.  These results suggest that CXCR7-neutralizing antibody enhances the neurogenesis in the dentate gyrus and improves the cognitive function after cerebral ischemia in rats.  All animal experimental protocols and procedures were approved by the Institutional Animal Care and Use Committee of China Medical University (CMU16089R) on December 8, 2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShcsaZQZ7B8kh5eUSa2oe_fW6udTcc2eZuks8VGePEMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfovVWjsw%253D%253D&md5=92a955cb02a50110b2fee6c3de7acf37</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.270416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.270416%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DM.%2BX.%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DJolkkonen%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%2BS.%26aulast%3DZhao%26aufirst%3DS.%2BS.%26atitle%3DEffects%2520of%2520CXCR7-Neutralizing%2520Antibody%2520on%2520Neurogenesis%2520in%2520the%2520Hippocampal%2520Dentate%2520Gyrus%2520and%2520Cognitive%2520Function%2520in%2520the%2520Chronic%2520Phase%2520of%2520Cerebral%2520Ischemia%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2020%26volume%3D15%26spage%3D1079%26epage%3D1085%26doi%3D10.4103%2F1673-5374.270416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Suppression Modulates Microglial Chemotaxis to Ameliorate Experimentally-Induced Autoimmune Encephalomyelitis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>469</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.bbrc.2015.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=26607112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2jsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2016&pages=1-7&author=J.+Baoauthor=J.+Zhuauthor=S.+Luoauthor=Y.+Chengauthor=S.+Zhou&title=CXCR7+Suppression+Modulates+Microglial+Chemotaxis+to+Ameliorate+Experimentally-Induced+Autoimmune+Encephalomyelitis&doi=10.1016%2Fj.bbrc.2015.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis</span></div><div class="casAuthors">Bao, Jianhong; Zhu, Jinying; Luo, Sheng; Cheng, Ying; Zhou, Saijun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disease of the central nervous system (CNS).  Exptl. autoimmune encephalomyelitis (EAE), widely used as an animal model of MS, classically manifests as an ascending paralysis that is characterized by extensive infiltration of the CNS by inflammatory cells.  Although several studies uncover the significant role of microglia in the development of EAE, the cellular mechanisms of microglia that govern EAE pathogenesis remain unknown.  In the current study, we report that CXCR7 expression is dynamic regulated in activated microglia during CNS autoimmunity and pos. correlates with the clin. severity of EAE.  In addn., microglial chemotaxis is mediated by CXCR7 during CNS autoimmunity, signaling through extracellular signal-regulated kinase (ERK)1/2 activation, whereas p38 mitogen-activated protein kinase (MAPK) and (c-Jun N-terminal kinase) JNK are not involved.  Most importantly, CXCR7 neutralizing treatment ameliorates the clin. severity of EAE along with ERK1/2 phosphorylation redn.  Collectively, our data demonstrate that CXCR7 suppression modulates microglial chemotaxis to ameliorate EAE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQn62BIqPJmbVg90H21EOLACvtfcHk0ljYSz_c5A5Ahg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2jsr%252FO&md5=7723255b0253c48ff567c7003a7b476e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DS.%26atitle%3DCXCR7%2520Suppression%2520Modulates%2520Microglial%2520Chemotaxis%2520to%2520Ameliorate%2520Experimentally-Induced%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D469%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.bbrc.2015.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Blocking CXCR7-Mediated Adipose Tissue Macrophages Chemotaxis Attenuates Insulin Resistance and Inflammation in Obesity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>479</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.09.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.bbrc.2016.09.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=27693695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2016&pages=649-655&author=H.+Pengauthor=H.+Zhangauthor=H.+Zhu&title=Blocking+CXCR7-Mediated+Adipose+Tissue+Macrophages+Chemotaxis+Attenuates+Insulin+Resistance+and+Inflammation+in+Obesity&doi=10.1016%2Fj.bbrc.2016.09.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity</span></div><div class="casAuthors">Peng, Hongxia; Zhang, Hu; Zhu, Honglei</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">649-655</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipose tissue macrophages (ATMs) have been considered to have a pivotal role in the chronic inflammation development during obesity.  Although chemokine-chemokine receptor interaction has been studied in ATMs infiltration, most chemokine receptors remain incompletely understood and little is known about their mechanism of actions that lead to ATMs chemotaxis and pathogenesis of insulin resistance during obesity.  In this study, we reported that CXCR7 expression is upregulated in adipose tissue, and specifically in ATMs during obesity.  In addn., CXCL11 or CXCL12-induced ATMs chemotaxis is mediated by CXCR7 in obesity but not leanness, whereas CXCR3 and CXCR4 are not involved.  Addnl. mechanism study shows that NF-κB activation is essential in ATMs chemotaxis, and manipulates chemotaxis of ATMs via CXCR7 expression regulation in obesity.  Most importantly, CXCR7 neutralizing therapy dose dependently leads to less infiltration of macrophages into adipose tissue and thus reduces inflammation and improves insulin sensitivity in obesity.  In conclusion, these findings demonstrated that blocking CXCR7-mediated ATMs chemotaxis ameliorates insulin resistance and inflammation in obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptL6sFubXESrVg90H21EOLACvtfcHk0ljYSz_c5A5Ahg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsrfK&md5=09275ac0f68bf282a7c9edd4c7b63471</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.09.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.09.158%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DBlocking%2520CXCR7-Mediated%2520Adipose%2520Tissue%2520Macrophages%2520Chemotaxis%2520Attenuates%2520Insulin%2520Resistance%2520and%2520Inflammation%2520in%2520Obesity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D479%26spage%3D649%26epage%3D655%26doi%3D10.1016%2Fj.bbrc.2016.09.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oderup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabel, B. A.</span></span> <span> </span><span class="NLM_article-title">A Chimeric Antibody Against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1016/j.ymthe.2018.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.ymthe.2018.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29606504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1354-1365&author=N.+Salazarauthor=J.+C.+Carlsonauthor=K.+Huangauthor=Y.+Zhengauthor=C.+Oderupauthor=J.+Grossauthor=A.+D.+Jangauthor=T.+M.+Burkeauthor=S.+Lew%C3%A9nauthor=A.+Scholzauthor=S.+Huangauthor=L.+Neaseauthor=J.+Kosekauthor=M.+Mittelbronnauthor=E.+C.+Butcherauthor=H.+Tuauthor=B.+A.+Zabel&title=A+Chimeric+Antibody+Against+ACKR3%2FCXCR7+in+Combination+with+TMZ+Activates+Immune+Responses+and+Extends+Survival+in+Mouse+GBM+Models&doi=10.1016%2Fj.ymthe.2018.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models</span></div><div class="casAuthors">Salazar, Nicole; Carlson, Jeffrey C.; Huang, Kexin; Zheng, Yayue; Oderup, Cecilia; Gross, Julia; Jang, Andrew D.; Burke, Thomas M.; Lewen, Susanna; Scholz, Alexander; Huang, Serina; Nease, Leona; Kosek, Jon; Mittelbronn, Michel; Butcher, Eugene C.; Tu, Hua; Zabel, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1354-1365</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0024</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the least treatable type of brain tumor, afflicting over 15,000 people per yr in the United States.  Patients have a median survival of 16 mo, and over 95% die within 5 years.  The chemokine receptor ACKR3 is selectively expressed on both GBM cells and tumor-assocd. blood vessels.  High tumor expression of ACKR3 correlates with poor prognosis and potential treatment resistance, making it an attractive therapeutic target.  We engineered a single chain FV-human FC-IgG1 (IgG1) antibody, X7Ab, to target ACKR3 in human and mouse GBM cells.  We used hydrodynamic gene transfer to overexpress the antibody, with efficacy in vivo.  X7Ab kills GBM tumor cells and ACKR3-expressing vascular endothelial cells by engaging the cytotoxic activity of natural killer (NK) cells and complement and the phagocytic activity of macrophages.  Combining X7Ab with TMZ allows the TMZ dosage to be lowered, without compromising therapeutic efficacy.  Mice treated with X7Ab and in combination with TMZ showed significant tumor redn. by MRI and longer survival overall.  Brain-tumor-infiltrating leukocyte anal. revealed that X7Ab enhances the activation of M1 macrophages to support anti-tumor immune response in vivo.  Targeting ACKR3 with immunotherapeutic monoclonal antibodies (mAbs) in combination with std. of care therapies may prove effective in treating GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTs6mwLAJuBLVg90H21EOLACvtfcHk0li07CgXq2ohIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVagt7o%253D&md5=2d08ccbf5f3432e67a46a6c9887ccbb8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ymthe.2018.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymthe.2018.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DN.%26aulast%3DCarlson%26aufirst%3DJ.%2BC.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DOderup%26aufirst%3DC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DA.%2BD.%26aulast%3DBurke%26aufirst%3DT.%2BM.%26aulast%3DLew%25C3%25A9n%26aufirst%3DS.%26aulast%3DScholz%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DKosek%26aufirst%3DJ.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DTu%26aufirst%3DH.%26aulast%3DZabel%26aufirst%3DB.%2BA.%26atitle%3DA%2520Chimeric%2520Antibody%2520Against%2520ACKR3%252FCXCR7%2520in%2520Combination%2520with%2520TMZ%2520Activates%2520Immune%2520Responses%2520and%2520Extends%2520Survival%2520in%2520Mouse%2520GBM%2520Models%26jtitle%3DMol.%2520Ther.%26date%3D2018%26volume%3D26%26spage%3D1354%26epage%3D1365%26doi%3D10.1016%2Fj.ymthe.2018.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maussang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujić-Delić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descamps, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanlandschoot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsum, M. S.-v.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Roy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Pajuelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchiers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rompaey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span> <span> </span><span class="NLM_article-title">Llama-Derived Single Variable Domains (Nanobodies) Directed Against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">29562</span>– <span class="NLM_lpage">29572</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.498436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1074%2Fjbc.M113.498436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=23979133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Shs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=29562-29572&author=D.+Maussangauthor=A.+Muji%C4%87-Deli%C4%87author=F.+J.+Descampsauthor=C.+Stortelersauthor=P.+Vanlandschootauthor=M.+S.-v.+Walsumauthor=H.+F.+Vischerauthor=M.+van+Royauthor=M.+Vosjanauthor=M.+Gonzalez-Pajueloauthor=G.+A.+van+Dongenauthor=P.+Merchiersauthor=P.+van+Rompaeyauthor=M.+J.+Smit&title=Llama-Derived+Single+Variable+Domains+%28Nanobodies%29+Directed+Against+Chemokine+Receptor+CXCR7+Reduce+Head+and+Neck+Cancer+Cell+Growth+in+vivo&doi=10.1074%2Fjbc.M113.498436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Llama-derived single domain antibodies (Nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo</span></div><div class="casAuthors">Maussang, David; Mujic-Delic, Azra; Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; Stigter-van Walsum, Marijke; Vischer, Henry F.; van Roy, Maarten; Vosjan, Maria; Gonzalez-Pajuelo, Maria; van Dongen, Guus A. M. S.; Merchiers, Pascal; van Rompaey, Philippe; Smit, Martine J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">29562-29572</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR7, belonging to the is expressed in several tumor types.  Inhibition of CXCR7 with either small mols. or small interference (si)RNA has shown promising therapeutic benefits in several tumor models.  With the increased interest and effectiveness of biologicals inhibiting membrane-bound receptors we made use of the "Nanobody platform" to target CXCR7.  Previously we showed that Nanobodies, i.e. Ig single variable domains derived from naturally occurring heavy chain-only camelids antibodies, represent new biol. tools to efficiently tackle difficult drug targets such as G protein-coupled receptors.  In this study we developed and characterized highly selective and potent Nanobodies against CXCR7.  Interestingly, the CXCR7-targeting Nanobodies displayed antagonistic properties in contrast with previously reported CXCR7-targeting agents.  Several high affinity CXCR7-specific Nanobodies potently inhibited CXCL12-induced β-arrestin2 recruitment in vitro.  A wide variety of tumor biopsies was profiled, showing for the first time high expression of CXCR7 in head and neck cancer.  Using a patient-derived CXCR7-expressing head and neck cancer xenograft model in nude mice, tumor growth was inhibited by CXCR7-targeting Nanobody therapy.  Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.  Hence, with this novel class of CXCR7 inhibitors, we further substantiate the therapeutic relevance of targeting CXCR7 in head and neck cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGe5r9V21RZLVg90H21EOLACvtfcHk0li07CgXq2ohIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Shs7vF&md5=3b519bc099d0d326a109d7f346cbd0ea</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.498436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.498436%26sid%3Dliteratum%253Aachs%26aulast%3DMaussang%26aufirst%3DD.%26aulast%3DMuji%25C4%2587-Deli%25C4%2587%26aufirst%3DA.%26aulast%3DDescamps%26aufirst%3DF.%2BJ.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DVanlandschoot%26aufirst%3DP.%26aulast%3DWalsum%26aufirst%3DM.%2BS.-v.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dvan%2BRoy%26aufirst%3DM.%26aulast%3DVosjan%26aufirst%3DM.%26aulast%3DGonzalez-Pajuelo%26aufirst%3DM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%26aulast%3DMerchiers%26aufirst%3DP.%26aulast%3Dvan%2BRompaey%26aufirst%3DP.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26atitle%3DLlama-Derived%2520Single%2520Variable%2520Domains%2520%2528Nanobodies%2529%2520Directed%2520Against%2520Chemokine%2520Receptor%2520CXCR7%2520Reduce%2520Head%2520and%2520Neck%2520Cancer%2520Cell%2520Growth%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D29562%26epage%3D29572%26doi%3D10.1074%2Fjbc.M113.498436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zabel, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowska-Wieczorek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">3204</span>– <span class="NLM_lpage">3211</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4049%2Fjimmunol.0900269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19641136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWrs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=3204-3211&author=B.+A.+Zabelauthor=Y.+Wangauthor=S.+Lew%C3%A9nauthor=R.+D.+Berahovichauthor=M.+E.+T.+Penfoldauthor=P.+Zhangauthor=J.+Powersauthor=B.+C.+Summersauthor=Z.+Miaoauthor=B.+Zhaoauthor=A.+Jaliliauthor=A.+Janowska-Wieczorekauthor=J.+C.+Jaenauthor=T.+J.+Schall&title=Elucidation+of+CXCR7-Mediated+Signaling+Events+and+Inhibition+of+CXCR4-Mediated+Tumor+Cell+Transendothelial+Migration+by+CXCR7+Ligands&doi=10.4049%2Fjimmunol.0900269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands</span></div><div class="casAuthors">Zabel, Brian A.; Wang, Yu; Lewen, Susanna; Berahovich, Robert D.; Penfold, Mark E. T.; Zhang, Penglie; Powers, Jay; Summers, Bretton C.; Miao, Zhenhua; Zhao, Bin; Jalili, Ali; Janowska-Wieczorek, Anna; Jaen, Juan C.; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3204-3211</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">CXCR7 binds chemokines CXCL11 (I-TAC) and CXCL12 (SDF-1) but does not act as a classical chemoattractant receptor.  Using CCX771, a novel small mol. with high affinity and selectivity for CXCR7, the authors found that, although CXCR7 is dispensable for "bare filter" in vitro chemotaxis, CXCR7 plays an essential role in the CXCL12/CXCR4-mediated transendothelial migration (TEM) of CXCR4+CXCR7+ human tumor cells.  Importantly, although CXCL11 is unable to stimulate directly the migration of these cells, it acts as a potent antagonist of their CXCL12-induced TEM.  Furthermore, even though this TEM is driven by CXCR4, the CXCR7 ligand CCX771 is substantially more potent at inhibiting it than the CXCR4 antagonist AMD3100, which is more than 100 times weaker at inhibiting TEM when compared with its ability to block bare filter chemotaxis.  Far from being a "silent" receptor, the authors show that CXCR7 displays early hallmark events assocd. with intracellular signaling.  Upon cognate chemokine binding, CXCR7 assocs. with β-arrestin2, an interaction that can be blocked by CXCR7-specific mAbs.  Remarkably, the synthetic CXCR7 ligand CCX771 also potently stimulates β-arrestin2 recruitment to CXCR7, with greater potency and efficacy than the endogenous chemokine ligands.  These results indicate that CXCR7 can regulate CXCL12-mediated migratory cues, and thus may play a crit. role in driving CXCR4+CXCR7+ tumor cell metastasis and tissue invasion.  CXCR7 ligands, such as the chemokine CXCL11 and the newly described synthetic mol. CCX771, may represent novel therapeutic opportunities for the control of such cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngb3AyBsAqrVg90H21EOLACvtfcHk0lhytelQRu45fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWrs7rP&md5=eb3dd5400f39f4e0245d6bc9efe68065</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900269%26sid%3Dliteratum%253Aachs%26aulast%3DZabel%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLew%25C3%25A9n%26aufirst%3DS.%26aulast%3DBerahovich%26aufirst%3DR.%2BD.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DSummers%26aufirst%3DB.%2BC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DJalili%26aufirst%3DA.%26aulast%3DJanowska-Wieczorek%26aufirst%3DA.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DElucidation%2520of%2520CXCR7-Mediated%2520Signaling%2520Events%2520and%2520Inhibition%2520of%2520CXCR4-Mediated%2520Tumor%2520Cell%2520Transendothelial%2520Migration%2520by%2520CXCR7%2520Ligands%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D3204%26epage%3D3211%26doi%3D10.4049%2Fjimmunol.0900269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Imaging Chemokine Receptor Dimerization with Firefly Luciferase Complementation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1096/fj.08-116749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1096%2Ffj.08-116749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19001056" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=823-834&author=K.+E.+Lukerauthor=M.+Guptaauthor=G.+D.+Luker&title=Imaging+Chemokine+Receptor+Dimerization+with+Firefly+Luciferase+Complementation&doi=10.1096%2Ffj.08-116749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1096%2Ffj.08-116749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.08-116749%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DImaging%2520Chemokine%2520Receptor%2520Dimerization%2520with%2520Firefly%2520Luciferase%2520Complementation%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D23%26spage%3D823%26epage%3D834%26doi%3D10.1096%2Ffj.08-116749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gils, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handel, T. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Ligand Interaction with Atypical Chemokine Receptor 3</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14135</span>, <span class="refDoi"> DOI: 10.1038/ncomms14135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fncomms14135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28098154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14135&author=M.+Gustavssonauthor=L.+Wangauthor=N.+van+Gilsauthor=B.+S.+Stephensauthor=P.+Zhangauthor=T.+J.+Schallauthor=S.+Yangauthor=R.+Abagyanauthor=M.+R.+Chanceauthor=I.+Kufarevaauthor=T.+M.+Handel&title=Structural+Basis+of+Ligand+Interaction+with+Atypical+Chemokine+Receptor+3&doi=10.1038%2Fncomms14135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand interaction with atypical chemokine receptor 3</span></div><div class="casAuthors">Gustavsson, Martin; Wang, Liwen; van Gils, Noortje; Stephens, Bryan S.; Zhang, Penglie; Schall, Thomas J.; Yang, Sichun; Abagyan, Ruben; Chance, Mark R.; Kufareva, Irina; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14135</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokines drive cell migration through their interactions with seven-transmembrane (7TM) chemokine receptors on cell surfaces.  The atypical chemokine receptor 3 (ACKR3) binds chemokines CXCL11 and CXCL12 and signals exclusively through β-arrestin-mediated pathways, without activating canonical G-protein signalling.  This receptor is upregulated in numerous cancers making it a potential drug target.  Here we collected over 100 distinct structural probes from radiolytic footprinting, disulfide trapping, and mutagenesis to map the structures of ACKR3:CXCL12 and ACKR3:small-mol. complexes, including dynamic regions that proved unresolvable by X-ray crystallog. in homologous receptors.  The data are integrated with mol. modeling to produce complete and cohesive exptl. driven models that confirm and expand on the existing knowledge of the architecture of receptor:chemokine and receptor:small-mol. complexes.  Addnl., we detected and characterized ligand-induced conformational changes in the transmembrane and intracellular regions of ACKR3 that elucidate fundamental structural elements of agonism in this atypical receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyVMT01L6lqbVg90H21EOLACvtfcHk0ljmsmD4Hnd-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7c%253D&md5=fb81a7d54258325919c1febb4be3ce16</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fncomms14135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14135%26sid%3Dliteratum%253Aachs%26aulast%3DGustavsson%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3Dvan%2BGils%26aufirst%3DN.%26aulast%3DStephens%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520Basis%2520of%2520Ligand%2520Interaction%2520with%2520Atypical%2520Chemokine%2520Receptor%25203%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14135%26doi%3D10.1038%2Fncomms14135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menhaji-Klotz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesp, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVGjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1330-1334&author=E.+Menhaji-Klotzauthor=J.+Wardauthor=J.+A.+Brownauthor=P.+M.+Loriaauthor=C.+Tanauthor=K.+D.+Hespauthor=K.+A.+Riccardiauthor=J.+Litchfieldauthor=M.+Boehm&title=Discovery+of+Diphenylacetamides+as+CXCR7+Inhibitors+with+Novel+%CE%B2-Arrestin+Antagonist+Activity&doi=10.1021%2Facsmedchemlett.0c00163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity</span></div><div class="casAuthors">Menhaji-Klotz, Elnaz; Ward, Jessica; Brown, Janice A.; Loria, Paula M.; Tan, Carina; Hesp, Kevin D.; Riccardi, Keith A.; Litchfield, John; Boehm, Markus</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1330-1334</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The atypical chemokine receptor CXCR7 has been studied in various disease settings including immunol. diseases and heart disease.  Efforts to elucidate the role of CXCR7 have been limited by the lack of suitable chem. tools with a range of pharmacol. profiles.  A high-throughput screen was conducted to discover novel chem. matter with the potential to modulate CXCR7 receptor activity.  This led to the identification of a series of diphenylacetamides confirmed in a CXCL12 competition assay indicating receptor binding.  Further evaluation of this series revealed a lack of activity in the functional assay measuring β-arrestin recruitment.  The most potent representative, compd. 10 (Ki = 597 nM), was detd. to be an antagonist in the β-arrestin assay (IC50 = 622 nM).  To our knowledge, this is the first reported small mol. β-arrestin antagonist for CXCR7, useful as an in vitro chem. tool to elucidate the effects of CXCL12 displacement with β-arrestin antagonism in models for diseases such as cardiac injury and suitable as starting point for hit optimization directed toward an in vivo tool compd. for studying CXCR7 receptor pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiX-a_AcvtQ7Vg90H21EOLACvtfcHk0ljmsmD4Hnd-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVGjsr4%253D&md5=82c8c38b8a4b4f70d316d95298b8ca9f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00163%26sid%3Dliteratum%253Aachs%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DHesp%26aufirst%3DK.%2BD.%26aulast%3DRiccardi%26aufirst%3DK.%2BA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Diphenylacetamides%2520as%2520CXCR7%2520Inhibitors%2520with%2520Novel%2520%25CE%25B2-Arrestin%2520Antagonist%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1330%26epage%3D1334%26doi%3D10.1021%2Facsmedchemlett.0c00163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fretz, H. G.</span>; <span class="NLM_string-name">Guerry, P.</span>; <span class="NLM_string-name">Kimmerlin, T.</span>; <span class="NLM_string-name">Lehembre, F.</span>; <span class="NLM_string-name">Pfeifer, T.</span>; <span class="NLM_string-name">Valdenaire, A.</span></span> <span> </span><span class="NLM_article-title">1 -[m-Carboxamido(hetero)aryl-methyl]-piperidine-4-carboxamide Derivatives as CXCR7 Modulators and their Preparation</span>. <span class="NLM_patent">US20130345199A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+G.+Fretz&author=P.+Guerry&author=T.+Kimmerlin&author=F.+Lehembre&author=T.+Pfeifer&author=A.+Valdenaire&title=1+-%5Bm-Carboxamido%28hetero%29aryl-methyl%5D-piperidine-4-carboxamide+Derivatives+as+CXCR7+Modulators+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%2BG.%26atitle%3D1%2520-%255Bm-Carboxamido%2528hetero%2529aryl-methyl%255D-piperidine-4-carboxamide%2520Derivatives%2520as%2520CXCR7%2520Modulators%2520and%2520their%2520Preparation%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+Drug+Discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0ljCfarPKGyA1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>– <span class="NLM_lpage">5880</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+Fluorinated+Motifs+in+the+Design+and+Application+of+Bioisosteres+for+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0ljCfarPKGyA1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520Fluorinated%2520Motifs%2520in%2520the%2520Design%2520and%2520Application%2520of%2520Bioisosteres%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinnerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenhan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Synthesis of a New Helix-Forming β-Amino Acid: trans-4-Aminopiperidine-3-carboxylic Acid</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1002%2Fejoc.200390112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFWntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=721-726&author=M.+Schinnerlauthor=J.+K.+Murrayauthor=J.+M.+Langenhanauthor=S.+H.+Gellman&title=Asymmetric+Synthesis+of+a+New+Helix-Forming+%CE%B2-Amino+Acid%3A+trans-4-Aminopiperidine-3-carboxylic+Acid&doi=10.1002%2Fejoc.200390112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of a new helix-forming β-amino acid: Trans-4-aminopiperidine-3-carboxylic acid</span></div><div class="casAuthors">Schinnerl, Marina; Murray, Justin K.; Langenhan, Joseph M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1434-193X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A syntheses of protected enantiomers of trans-4-aminopiperidine-3-carboxylic acid (APiC) and trans-2-aminocyclohexanecarboxylic acid (ACHC) are reported.  Purifn. of all intermediates by crystn. makes this method amenable to large-scale prepn.  The prepd. APiC and ACHC residues form the 14-helix (helical conformation defined by 14-membered C-O(i)...H-N(i-2) hydrogen bonds) in soln.  These cyclically constrained β-amino acids (APiC and ACHC) should be useful as building blocks for a construction of short β-peptides with defined conformation in aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWr7jBzSrH7Vg90H21EOLACvtfcHk0ljrf9P7WHa3Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFWntbY%253D&md5=b5272c719047cd4e3306eb22f4e146de</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200390112%26sid%3Dliteratum%253Aachs%26aulast%3DSchinnerl%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%2BK.%26aulast%3DLangenhan%26aufirst%3DJ.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520a%2520New%2520Helix-Forming%2520%25CE%25B2-Amino%2520Acid%253A%2520trans-4-Aminopiperidine-3-carboxylic%2520Acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26spage%3D721%26epage%3D726%26doi%3D10.1002%2Fejoc.200390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated Space-Group and Crystal-Structure Determination</span>. <i>Acta Crystallogr. A Found Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25537383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+Integrated+Space-Group+and+Crystal-Structure+Determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0ljrf9P7WHa3Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520Integrated%2520Space-Group%2520and%2520Crystal-Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%2520A%2520Found%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure Refinement with SHELXL</span>. <i>Acta Crystallogr. C Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25567568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+Structure+Refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lgJWWA3kUNmUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520Structure%2520Refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%2520C%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">PLATONSQUEEZE: A Tool for the Calculation of the Disordered Solvent Contribution to the Calculated Structure Factors</span>. <i>Acta Crystallogr., Sect. C</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053229614024929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25567569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=9-18&author=A.+L.+Spek&title=PLATONSQUEEZE%3A+A+Tool+for+the+Calculation+of+the+Disordered+Solvent+Contribution+to+the+Calculated+Structure+Factors&doi=10.1107%2FS2053229614024929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors</span></div><div class="casAuthors">Spek, Anthony L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The completion of a crystal structure detn. is often hampered by the presence of embedded solvent mols. or ions that are seriously disordered.  Their contribution to the calcd. structure factors in the least-squares refinement of a crystal structure has to be included in some way.  Traditionally, an atomistic solvent disorder model is attempted.  Such an approach is generally to be preferred, but it does not always lead to a satisfactory result and may even be impossible in cases where channels in the structure are filled with continuous electron d.  This paper documents the SQUEEZE method as an alternative means of addressing the solvent disorder issue.  It conveniently interfaces with the 2014 version of the least-squares refinement program SHELXL [Sheldrick (2015). Acta Cryst. C71. In the press] and other refinement programs that accept externally provided fixed contributions to the calcd. structure factors.  The PLATON SQUEEZE tool calcs. the solvent contribution to the structure factors by back-Fourier transformation of the electron d. found in the solvent-accessible region of a phase-optimized difference electron-d. map.  The actual least-squares structure refinement is delegated to, for example, SHELXL.  The current versions of PLATON SQUEEZE and SHELXL now address several of the unnecessary complications with the earlier implementation of the SQUEEZE procedure that were a necessity because least-squares refinement with the now superseded SHELXL97 program did not allow for the input of fixed externally provided contributions to the structure-factor calcn.  It is no longer necessary to subtract the solvent contribution temporarily from the obsd. intensities to be able to use SHELXL for the least-squares refinement, since that program now accepts the solvent contribution from an external file ( file) if the ABIN instruction is used.  In addn., many twinned structures contg. disordered solvents are now also treatable by SQUEEZE.  The details of a SQUEEZE calcn. are now automatically included in the CIF archive file, along with the unmerged reflection data.  The current implementation of the SQUEEZE procedure is described, and discussed and illustrated with three examples.  Two of them are based on the reflection data of published structures and one on synthetic reflection data generated for a published structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJNzAtEImLLVg90H21EOLACvtfcHk0lgJWWA3kUNmUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFejtw%253D%253D&md5=88200a7c2b687d49b1dedf1a7b7fa38d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024929%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DPLATONSQUEEZE%253A%2520A%2520Tool%2520for%2520the%2520Calculation%2520of%2520the%2520Disordered%2520Solvent%2520Contribution%2520to%2520the%2520Calculated%2520Structure%2520Factors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%26date%3D2015%26volume%3D71%26spage%3D9%26epage%3D18%26doi%3D10.1107%2FS2053229614024929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lamiaa  Ouchakour</span>, <span class="hlFld-ContribAuthor ">Melinda  Nonn</span>, <span class="hlFld-ContribAuthor ">Attila M.  Remete</span>, <span class="hlFld-ContribAuthor ">Loránd  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">An Improved Stereocontrolled Access Route to Piperidine or Azepane β‐Amino Esters and Azabicyclic β‐ and γ‐Lactams; Synthesis of Novel Functionalized Azaheterocyles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (28)
                                     , 3874-3885. <a href="https://doi.org/10.1002/ejoc.202100540" title="DOI URL">https://doi.org/10.1002/ejoc.202100540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100540%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAn%252BImproved%252BStereocontrolled%252BAccess%252BRoute%252Bto%252BPiperidine%252Bor%252BAzepane%252B%2525CE%2525B2%2525E2%252580%252590Amino%252BEsters%252Band%252BAzabicyclic%252B%2525CE%2525B2%2525E2%252580%252590%252Band%252B%2525CE%2525B3%2525E2%252580%252590Lactams%25253B%252BSynthesis%252Bof%252BNovel%252BFunctionalized%252BAzaheterocyles%26aulast%3DOuchakour%26aufirst%3DLamiaa%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D28%26spage%3D3874%26epage%3D3885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wing Yee  Lai</span>, <span class="hlFld-ContribAuthor ">Anja  Mueller</span>. </span><span class="cited-content_cbyCitation_article-title">Latest update on chemokine receptors as therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2021,</strong> <em>49 </em>
                                    (3)
                                     , 1385-1395. <a href="https://doi.org/10.1042/BST20201114" title="DOI URL">https://doi.org/10.1042/BST20201114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20201114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20201114%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DLatest%252Bupdate%252Bon%252Bchemokine%252Breceptors%252Bas%252Btherapeutic%252Btargets%26aulast%3DLai%26aufirst%3DWing%2BYee%26date%3D2021%26date%3D2021%26volume%3D49%26issue%3D3%26spage%3D1385%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn M.  Nelson</span>, <span class="hlFld-ContribAuthor ">Michael A.  Walters</span>. </span><span class="cited-content_cbyCitation_article-title">The Communication of Hit Quality Using Natural History Visualizations (NHVs). </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>36 </em>, 247255522110175. <a href="https://doi.org/10.1177/24725552211017518" title="DOI URL">https://doi.org/10.1177/24725552211017518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/24725552211017518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F24725552211017518%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DThe%252BCommunication%252Bof%252BHit%252BQuality%252BUsing%252BNatural%252BHistory%252BVisualizations%252B%252528NHVs%252529%26aulast%3DNelson%26aufirst%3DKathryn%2BM.%26date%3D2021%26date%3D2021%26volume%3D36%26spage%3D247255522110175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Huynh</span>, <span class="hlFld-ContribAuthor ">Andrea  Henrich</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Strasser</span>, <span class="hlFld-ContribAuthor ">Marie‐Laure  Boof</span>, <span class="hlFld-ContribAuthor ">Mohamed  Al‐Ibrahim</span>, <span class="hlFld-ContribAuthor ">Henriette E.  Meyer Zu Schwabedissen</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Mike  Ufer</span>. </span><span class="cited-content_cbyCitation_article-title">A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>109 </em>
                                    (6)
                                     , 1648-1659. <a href="https://doi.org/10.1002/cpt.2154" title="DOI URL">https://doi.org/10.1002/cpt.2154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.2154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.2154%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DA%252BMultipurpose%252BFirst%2525E2%252580%252590in%2525E2%252580%252590Human%252BStudy%252BWith%252Bthe%252BNovel%252BCXCR7%252BAntagonist%252BACT%2525E2%252580%2525901004%2525E2%252580%2525901239%252BUsing%252BCXCL12%252BPlasma%252BConcentrations%252Bas%252BTarget%252BEngagement%252BBiomarker%26aulast%3DHuynh%26aufirst%3DChristine%26date%3D2021%26date%3D2021%26volume%3D109%26issue%3D6%26spage%3D1648%26epage%3D1659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laetitia  Pouzol</span>, <span class="hlFld-ContribAuthor ">Nadège  Baumlin</span>, <span class="hlFld-ContribAuthor ">Anna  Sassi</span>, <span class="hlFld-ContribAuthor ">Mélanie  Tunis</span>, <span class="hlFld-ContribAuthor ">Julia  Marrie</span>, <span class="hlFld-ContribAuthor ">Enrico  Vezzali</span>, <span class="hlFld-ContribAuthor ">Hervé  Farine</span>, <span class="hlFld-ContribAuthor ">Ulrich  Mentzel</span>, <span class="hlFld-ContribAuthor ">Marianne M.  Martinic</span>. </span><span class="cited-content_cbyCitation_article-title">ACT‐1004‐1239, a first‐in‐class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2021,</strong> <em>35 </em>
                                    (3)
                                     <a href="https://doi.org/10.1096/fj.202002465R" title="DOI URL">https://doi.org/10.1096/fj.202002465R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.202002465R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.202002465R%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DACT%2525E2%252580%2525901004%2525E2%252580%2525901239%25252C%252Ba%252Bfirst%2525E2%252580%252590in%2525E2%252580%252590class%252BCXCR7%252Bantagonist%252Bwith%252Bboth%252Bimmunomodulatory%252Band%252Bpromyelinating%252Beffects%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdemyelinating%252Bdiseases%26aulast%3DPouzol%26aufirst%3DLaetitia%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the CXCR7 agonist <b>1</b> and primary screening hits <b>2–6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of (3<i>S</i>,4<i>S</i>)-1-Cyclohexyl-4-{[carboxyamino-3-carbonyl]-amino}-piperidine-3-carboxylic Acid-amide Derivatives (3<i>S</i>,4<i>S</i>)<b>-11i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-toluensulfonic acid, toluene, reflux, 18 h, quantitative; (b) NaBH<sub>4</sub>, isobutyric acid, toluene, 0 °C, 6 h; (c) NaOEt, EtOH, 50 °C, 18 h, then HCl diethylether/dioxane, 16%; (d) 10% Pd/C, HCO<sub>2</sub>NH<sub>4</sub>, MeOH, reflux, 2 h, 82%; (e) 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid, HATU, DIPEA, DMF, rt., 18 h, 51%; (f) HCl 4 N in dioxane, DCM, rt., 30 min, 99%; (g) cyclohexanone, NaBH(OAc)<sub>3</sub>, AcOH, DCM, rt., 24 h, 94%; (h) NaOH aq., THF, rt., 6 h, quantitative; and (i) dimethylamine, (40% in water), HATU, DIPEA, DMF, rt., 6 h, 36%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular structure of compound <b>28f</b> as determined by X-ray structural analysis. Anisotropic thermal ellipsoids are drawn at a 50% probability level. The cyclopropyl rest was not refined anisotropically (due to a high disorder present, for details see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>). For clarity, the disordered part and all hydrogen atoms have been omitted. The solvate molecule present (MeOH) was squeezed using software tool Platon SQUEEZE.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 1-Substituted (<i>3S</i>,<i>4S</i>)-4-{[5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic Acid (1-Pyrimidin-2-yl-cyclopropyl)-amide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-toluensulfonic acid, toluene, reflux, 18 h, quantitative; (b) NaBH<sub>4</sub>, trifluoracetic acid, THF, −18 °C, 1 h; (c) 20% Pd(OH)<sub>2</sub>/C, H<sub>2</sub>, MeOH, rt., 18 h, quantitative; (d) 5-(2,4-difluoro-phenyl)-isoxazole-3-carboxylic acid, T<sub>3</sub>P, DCM, TEA, rt., 18 h, 79%; (e) NaOEt, EtOH, EtOAc, rt., 2 h, chiral chromatography, 63%; (f) NaOH 1 N aq., THF, rt., 8 h, HCl 2 N, rt., 30 min, 98%; (g) 1-pyrimidin-2-yl-cyclopropylamine, HATU, DIPEA, DMF, rt., 18 h, 87%; (h) 4 N HCl in 1,4-dioxane, MeOH, rt., 1 h, NaHCO<sub>3</sub> aq. DCM, 98%; (i) aldehyde or ketone, NaBH(OAc)<sub>3</sub>, AcOH, DCM, rt., 24 h, 94%; and (j) alkyl bromide or iodide, base, acetone.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Determination of ACT-1004-1239 insurmountability against CXCL11 (upper panel) and CXCL12 (lower panel) in the CXCR7-agonist <b>1</b> assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Determination of the <i>K</i><sub>i</sub>, <i>K</i><sub>on</sub>, and <i>K</i><sub>off</sub> constants (specific binding) of ACT-1004-1239.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/medium/jm0c01588_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of a single oral administration (p.o.) of ascending doses of ACT-1004-1239 on CXCL12 plasma concentration (upper row) and compound plasma concentration (lower row) in naive male DBA/1 mice. CXCL12 plasma concentration was measured at 0.5 (A), 6 (B), or 24 h (C) after a single oral administration of ACT-1004-1239. Results are expressed as fold change to vehicle-treated mice. ACT-1004-1239 plasma concentration measured 0.5 (D), 6 (E), or 24 h (F) after a single oral administration. Results are expressed as mean + standard error of the mean (SEM) (<i>n</i> = 3–5/dose group). **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001 vs vehicle, using one-way analysis of variance (ANOVA) followed by the Dunnett’s multiple comparisons test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01588/20201218/images/large/jm0c01588_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMaster, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">A Novel Chemokine Receptor for SDF-1 and I-TAC Involved in Cell Survival, Cell Adhesion, and Tumor Development</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">2201</span>– <span class="NLM_lpage">2213</span>, <span class="refDoi"> DOI: 10.1084/jem.20052144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1084%2Fjem.20052144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=16940167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2201-2213&author=J.+M.+Burnsauthor=B.+C.+Summersauthor=Y.+Wangauthor=A.+Melikianauthor=R.+Berahovichauthor=Z.+Miaoauthor=M.+E.+T.+Penfoldauthor=M.+J.+Sunshineauthor=D.+R.+Littmanauthor=C.+J.+Kuoauthor=K.+Weiauthor=B.+E.+McMasterauthor=K.+Wrightauthor=M.+C.+Howardauthor=T.+J.+Schall&title=A+Novel+Chemokine+Receptor+for+SDF-1+and+I-TAC+Involved+in+Cell+Survival%2C+Cell+Adhesion%2C+and+Tumor+Development&doi=10.1084%2Fjem.20052144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development</span></div><div class="casAuthors">Burns, Jennifer M.; Summers, Bretton C.; Wang, Yu; Melikian, Anita; Berahovich, Rob; Miao, Zhenhua; Penfold, Mark E. T.; Sunshine, Mary Jean; Littman, Dan R.; Kuo, Calvin J.; Wei, Kevin; McMaster, Brian E.; Wright, Kim; Howard, Maureen C.; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2201-2213</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor (SDF-1; also known as chemokine ligand 12 [CXCL12]) regulates many essential biol. processes, including cardiac and neuronal development, stem cell motility, neovascularization, angiogenesis, apoptosis, and tumorigenesis.  It is generally believed that SDF-1 mediates these many disparate processes via a single cell surface receptor known as chemokine receptor 4 (CXCR4).  This paper characterizes an alternate receptor, CXCR7, which binds with high affinity to SDF-1 and to a second chemokine, interferon-inducible T cell α chemoattractant (I-TAC; also known as CXCL11).  Membrane-assocd. CXCR7 is expressed on many tumor cell lines, on activated endothelial cells, and on fetal liver cells, but on few other cell types.  Unlike many other chemokine receptors, ligand activation of CXCR7 does not cause Ca2+ mobilization or cell migration.  However, expression of CXCR7 provides cells with a growth and survival advantage and increased adhesion properties.  Consistent with a role for CXCR7 in cell survival and adhesion, a specific, high affinity small mol. antagonist to CXCR7 impedes in vivo tumor growth in animal models, validating this new receptor as a target for development of novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0-DTHy18ELVg90H21EOLACvtfcHk0lgjqm_ZVEmQPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlSgsL0%253D&md5=ea363d64668e8d780f94dea24c6c5d56</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1084%2Fjem.20052144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20052144%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DJ.%2BM.%26aulast%3DSummers%26aufirst%3DB.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMelikian%26aufirst%3DA.%26aulast%3DBerahovich%26aufirst%3DR.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DWei%26aufirst%3DK.%26aulast%3DMcMaster%26aufirst%3DB.%2BE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DHoward%26aufirst%3DM.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DA%2520Novel%2520Chemokine%2520Receptor%2520for%2520SDF-1%2520and%2520I-TAC%2520Involved%2520in%2520Cell%2520Survival%252C%2520Cell%2520Adhesion%252C%2520and%2520Tumor%2520Development%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2201%26epage%3D2213%26doi%3D10.1084%2Fjem.20052144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banisadr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podojil, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span> <span> </span><span class="NLM_article-title">Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions</span>. <i>J. Neuroimmune Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1007/s11481-015-9616-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1007%2Fs11481-015-9616-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25997895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BC2Mfmt1amtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=26-35&author=G.+Banisadrauthor=J.+R.+Podojilauthor=S.+D.+Millerauthor=R.+J.+Miller&title=Pattern+of+CXCR7+Gene+Expression+in+Mouse+Brain+Under+Normal+and+Inflammatory+Conditions&doi=10.1007%2Fs11481-015-9616-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions</span></div><div class="casAuthors">Banisadr Ghazal; Miller Richard J; Podojil Joseph R; Miller Stephen D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The chemokine stromal cell-derived factor-1 (SDF-1)/CXCL12 acting via its G-protein coupled receptor (GPCR) CXCR4 has been implicated in neurogenesis, neuromodulation, brain inflammation, HIV-1 encephalopathy and tumor growth.  CXCR7 was identified as an alternate receptor for SDF-1/CXCL12.  Characterization of CXCR7-deficient mice demonstrated a role for CXCR7 in fetal endothelial biology, cardiac development, and B-cell localization.  Despite its ligand binding properties, CXCR7 does not seem to signal like a conventional GPCR.  It has been suggested that CXCR7 may not function alone but in combination with CXCR4.  Here, we investigated the regional localization of CXCR7 receptors in adult mouse brain using CXCR7-EGFP transgenic mice.  We found that the receptors were expressed in various brain regions including olfactory bulb, cerebral cortex, hippocampus, subventricular zone (SVZ), hypothalamus and cerebellum.  Extensive CXCR7 expression was associated with cerebral blood vessels.  Using cell type specific markers, CXCR7 expression was found in neurons, astrocytes and oligodendrocyte progenitors.  GAD-expressing neurons exhibited CXCR7 expression in the hippocampus.  Expression of CXCR7 in the dentate gyrus included cells that expressed nestin, GFAP and cells that appeared to be immature granule cells.  In mice with Experimental Autoimmune Encephalomyelitis (EAE), CXCR7 was expressed by migrating oligodendrocyte progenitors in the SVZ.  We then compared the distribution of SDF-1/CXCL12 and CXCR7 using bitransgenic mice expressing both CXCR7-EGFP and SDF-1-mRFP.  Enhanced expression of SDF-1/CXCL12 and CXCR7 was observed in the corpus callosum, SVZ and cerebellum.  Overall, the expression of CXCR7 in normal and pathological nervous system suggests CXCR4-independent functions of SDF-1/CXCL12 mediated through its interaction with CXCR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSN5VxVyhJaE7xanA7vODO6fW6udTcc2eZoC0jL0N4lALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mfmt1amtA%253D%253D&md5=0281dcef20eaba8750ca5c616785e13a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11481-015-9616-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11481-015-9616-y%26sid%3Dliteratum%253Aachs%26aulast%3DBanisadr%26aufirst%3DG.%26aulast%3DPodojil%26aufirst%3DJ.%2BR.%26aulast%3DMiller%26aufirst%3DS.%2BD.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DPattern%2520of%2520CXCR7%2520Gene%2520Expression%2520in%2520Mouse%2520Brain%2520Under%2520Normal%2520and%2520Inflammatory%2520Conditions%26jtitle%3DJ.%2520Neuroimmune%2520Pharmacol.%26date%3D2016%26volume%3D11%26spage%3D26%26epage%3D35%26doi%3D10.1007%2Fs11481-015-9616-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balabanian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moepps, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenzana-Seisdedos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachelerie, F.</span></span> <span> </span><span class="NLM_article-title">The Chemokine SDF-1/CXCL12 Binds to and Signals Through the Orphan Receptor RDC1 in T lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">35760</span>– <span class="NLM_lpage">35766</span>, <span class="refDoi"> DOI: 10.1074/jbc.M508234200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1074%2Fjbc.M508234200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=16107333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35760-35766&author=K.+Balabanianauthor=B.+Laganeauthor=S.+Infantinoauthor=K.+Y.+C.+Chowauthor=J.+Harriagueauthor=B.+Moeppsauthor=F.+Arenzana-Seisdedosauthor=M.+Thelenauthor=F.+Bachelerie&title=The+Chemokine+SDF-1%2FCXCL12+Binds+to+and+Signals+Through+the+Orphan+Receptor+RDC1+in+T+lymphocytes&doi=10.1074%2Fjbc.M508234200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes</span></div><div class="casAuthors">Balabanian, Karl; Lagane, Bernard; Infantino, Simona; Chow, Ken Y. C.; Harriague, Julie; Moepps, Barbara; Arenzana-Seisdedos, Fernando; Thelen, Marcus; Bachelerie, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">35760-35766</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Combined phylogenetic and chromosomal location studies suggest that the orphan receptor RDC1 is related to CXC chemokine receptors.  RDC1 provides a co-receptor function for a restricted no. of human immunodeficiency virus (HIV) isolates, in particular for the CXCR4-using HIV-2 ROD strain.  Here the authors show that CXCL12, the only known natural ligand for CXCR4, binds to and signals through RDC1.  The authors demonstrate that RDC1 is expressed in T lymphocytes and that CXCL12-promoted chemotaxis is inhibited by an anti-RDC1 monoclonal antibody.  Concomitant blockade of RDC1 and CXCR4 produced additive inhibitory effects in CXCL12-induced T cell migration.  Furthermore, the authors provide evidence that interaction of CXCL12 with RDC1 is specific, saturable, and of high affinity (apparent KD ≈ 0.4 nM).  In CXCR4-neg. cells expressing RDC1, CXCL12 promotes internalization of the receptor and chemotactic signals through RDC1.  Collectively, the data indicate that RDC1, which the authors propose to rename as CXCR7, is a receptor for CXCL12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLkIE0FYknbVg90H21EOLACvtfcHk0ljXLuFTo7atig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurjO&md5=4f7e4ebfefc83383f8223e243e70a4cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508234200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508234200%26sid%3Dliteratum%253Aachs%26aulast%3DBalabanian%26aufirst%3DK.%26aulast%3DLagane%26aufirst%3DB.%26aulast%3DInfantino%26aufirst%3DS.%26aulast%3DChow%26aufirst%3DK.%2BY.%2BC.%26aulast%3DHarriague%26aufirst%3DJ.%26aulast%3DMoepps%26aufirst%3DB.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DBachelerie%26aufirst%3DF.%26atitle%3DThe%2520Chemokine%2520SDF-1%252FCXCL12%2520Binds%2520to%2520and%2520Signals%2520Through%2520the%2520Orphan%2520Receptor%2520RDC1%2520in%2520T%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D35760%26epage%3D35766%26doi%3D10.1074%2Fjbc.M508234200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruenster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahabaleshwar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Functions as a Scavenger for CXCL12 and CXCL11</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e9175</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0009175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1371%2Fjournal.pone.0009175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=20161793" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=U.+Naumannauthor=E.+Cameroniauthor=M.+Pruensterauthor=H.+Mahabaleshwarauthor=E.+Razauthor=H.+G.+Zerwesauthor=A.+Rotauthor=M.+Thelen&title=CXCR7+Functions+as+a+Scavenger+for+CXCL12+and+CXCL11&doi=10.1371%2Fjournal.pone.0009175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009175%26sid%3Dliteratum%253Aachs%26aulast%3DNaumann%26aufirst%3DU.%26aulast%3DCameroni%26aufirst%3DE.%26aulast%3DPruenster%26aufirst%3DM.%26aulast%3DMahabaleshwar%26aufirst%3DH.%26aulast%3DRaz%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DThelen%26aufirst%3DM.%26atitle%3DCXCR7%2520Functions%2520as%2520a%2520Scavenger%2520for%2520CXCL12%2520and%2520CXCL11%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0009175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Alcañiz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haege, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Bendito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, O.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Controls Neuronal Migration by Regulating Chemokine Responsiveness</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2010.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.neuron.2010.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=21220100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=77-90&author=J.+A.+S%C3%A1nchez-Alca%C3%B1izauthor=S.+Haegeauthor=W.+Muellerauthor=R.+Plaauthor=F.+Mackayauthor=S.+Schulzauthor=G.+L%C3%B3pez-Benditoauthor=R.+Stummauthor=O.+Mar%C3%ADn&title=CXCR7+Controls+Neuronal+Migration+by+Regulating+Chemokine+Responsiveness&doi=10.1016%2Fj.neuron.2010.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness</span></div><div class="casAuthors">Sanchez-Alcaniz, Juan Antonio; Haege, Sammy; Mueller, Wiebke; Pla, Ramon; MacKay, Fabienne; Schulz, Stefan; Lopez-Bendito, Guillermina; Stumm, Ralf; Marin, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-90</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The chemokine Cxcl12 binds Cxcr4 and Cxcr7 receptors to control cell migration in multiple biol. contexts, including brain development, leukocyte trafficking, and tumorigenesis.  Both receptors are expressed in the CNS, but how they cooperate during migration has not been elucidated.  Here, we used the migration of cortical interneurons as a model to study this process.  We found that Cxcr4 and Cxcr7 are coexpressed in migrating interneurons, and that Cxcr7 is essential for chemokine signaling.  Intriguingly, this process does not exclusively involve Cxcr7, but most critically the modulation of Cxcr4 function.  Thus, Cxcr7 is necessary to regulate Cxcr4 protein levels, thereby adapting chemokine responsiveness in migrating cells.  This demonstrates that a chemokine receptor modulates the function of another chemokine receptor by controlling the amt. of protein that is made available for signaling at the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQA038tiZ7gbVg90H21EOLACvtfcHk0lhkJLiwS-KoaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFSjtw%253D%253D&md5=ad8edbbf347a87b133d73596ba67f56a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Alca%25C3%25B1iz%26aufirst%3DJ.%2BA.%26aulast%3DHaege%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DPla%26aufirst%3DR.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DSchulz%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Bendito%26aufirst%3DG.%26aulast%3DStumm%26aufirst%3DR.%26aulast%3DMar%25C3%25ADn%26aufirst%3DO.%26atitle%3DCXCR7%2520Controls%2520Neuronal%2520Migration%2520by%2520Regulating%2520Chemokine%2520Responsiveness%26jtitle%3DNeuron%26date%3D2011%26volume%3D69%26spage%3D77%26epage%3D90%26doi%3D10.1016%2Fj.neuron.2010.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zohar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildbaum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsheshet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, N.</span></span> <span> </span><span class="NLM_article-title">CXCL11-Dependent Induction of FOXP3-Negative Regulatory T Cells Suppresses Autoimmune Encephalomyelitis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2009</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1172/JCI71951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1172%2FJCI71951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24713654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2009-2022&author=Y.+Zoharauthor=G.+Wildbaumauthor=R.+Novakauthor=A.+L.+Salzmanauthor=M.+Thelenauthor=R.+Alonauthor=Y.+Barsheshetauthor=C.+L.+Karpauthor=N.+Karin&title=CXCL11-Dependent+Induction+of+FOXP3-Negative+Regulatory+T+Cells+Suppresses+Autoimmune+Encephalomyelitis&doi=10.1172%2FJCI71951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis</span></div><div class="casAuthors">Zohar, Yaniv; Wildbaum, Gizi; Novak, Rostislav; Salzman, Andrew L.; Thelen, Marcus; Alon, Ronen; Barsheshet, Yiftah; Karp, Christopher L.; Karin, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2009-2022</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A single G protein-coupled receptor (GPCR) can activate multiple signaling cascades based on the binding of different ligands.  The biol. relevance of this feature in immune regulation has not been evaluated.  The chemokine-binding GPCR CXCR3 is preferentially expressed on CD4+ T cells, and canonically binds 3 structurally related chemokines: CXCL9, CXCL10, and CXCL11.  Here we have shown that CXCL10/CXCR3 interactions drive effector Th1 polarization via STAT1, STAT4, and STAT5 phosphorylation, while CXCL11/CXCR3 binding induces an immunotolerizing state that is characterized by IL-10hi (Tr1) and IL-4hi (Th2) cells, mediated via p70 kinase/mTOR in STAT3- and STAT6-dependent pathways.  CXCL11 binds CXCR3 with a higher affinity than CXCL10, suggesting that CXCL11 has the potential to restrain inflammatory autoimmunity.  We generated a CXCL11-Ig fusion mol. and evaluated its use in the EAE model of inflammatory autoimmune disease.  Administration of CXCL11-Ig during the first episode of relapsing EAE in SJL/J mice not only led to rapid remission, but also prevented subsequent relapse.  Using GFP-expressing effector CD4+ T cells, we obsd. that successful therapy was assocd. with reduced accumulation of these cells at the autoimmune site.  Finally, we showed that very low doses of CXCL11 rapidly suppress signs of EAE in C57BL/6 mice lacking functional CXCL11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4s5KlJQicp7Vg90H21EOLACvtfcHk0lhkJLiwS-KoaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVSnsLk%253D&md5=4da3ef37793be83b27f4be45a0727c03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI71951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71951%26sid%3Dliteratum%253Aachs%26aulast%3DZohar%26aufirst%3DY.%26aulast%3DWildbaum%26aufirst%3DG.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DSalzman%26aufirst%3DA.%2BL.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DAlon%26aufirst%3DR.%26aulast%3DBarsheshet%26aufirst%3DY.%26aulast%3DKarp%26aufirst%3DC.%2BL.%26aulast%3DKarin%26aufirst%3DN.%26atitle%3DCXCL11-Dependent%2520Induction%2520of%2520FOXP3-Negative%2520Regulatory%2520T%2520Cells%2520Suppresses%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2009%26epage%3D2022%26doi%3D10.1172%2FJCI71951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naseem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puccini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSkane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span> <span> </span><span class="NLM_article-title">CXCL9, CXCL10, CXCL11/CXCR3 Axis for Immune Activation - a Target for Novel Cancer Therapy</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.ctrv.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29207310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFemtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2018&pages=40-47&author=R.+Tokunagaauthor=W.+Zhangauthor=M.+Naseemauthor=A.+Pucciniauthor=M.+D.+Bergerauthor=S.+Soniauthor=M.+McSkaneauthor=H.+Babaauthor=H.+J.+Lenz&title=CXCL9%2C+CXCL10%2C+CXCL11%2FCXCR3+Axis+for+Immune+Activation+-+a+Target+for+Novel+Cancer+Therapy&doi=10.1016%2Fj.ctrv.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy</span></div><div class="casAuthors">Tokunaga, Ryuma; Zhang, Wu; Naseem, Madiha; Puccini, Alberto; Berger, Martin D.; Soni, Shivani; McSkane, Michelle; Baba, Hideo; Lenz, Heinz-Josef</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells, and cause tissue extravasation.  Given these properties, their role in anti-tumor immune response in the cancer environment is of great interest.  Although immunotherapy has shown clin. benefit for some cancer patients, other patients do not respond.  One of the mechanisms of resistance to checkpoint inhibitors may be chemokine signaling.  The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis).  However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis).  Thus, a better understanding of CXCL9, -10, -11/CXCR3 axis is necessary to develop effective cancer control.  In this article, we summarize recent evidence regarding CXCL9, CXCL10, CXCL11/CXCR3 axis in the immune system and discuss their potential role in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohPDQ1JldLTbVg90H21EOLACvtfcHk0lgrf_AKpPlL1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFemtrbO&md5=b8b5a8bab310dc632dde12ee4c86e5ad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DTokunaga%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNaseem%26aufirst%3DM.%26aulast%3DPuccini%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DM.%2BD.%26aulast%3DSoni%26aufirst%3DS.%26aulast%3DMcSkane%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DCXCL9%252C%2520CXCL10%252C%2520CXCL11%252FCXCR3%2520Axis%2520for%2520Immune%2520Activation%2520-%2520a%2520Target%2520for%2520Novel%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D63%26spage%3D40%26epage%3D47%26doi%3D10.1016%2Fj.ctrv.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torraca, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebelman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaink, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, A. H.</span></span> <span> </span><span class="NLM_article-title">The CXCR3-CXCL11 Signaling Axis Mediates Macrophage Recruitment and Dissemination of Mycobacterial Infection</span>. <i>Dis. Model Mech.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1242/dmm.017756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1242%2Fdmm.017756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25573892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BC2MvltF2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=253-269&author=V.+Torracaauthor=C.+Cuiauthor=R.+Bolandauthor=J.+P.+Bebelmanauthor=A.+M.+van+der+Sarauthor=M.+J.+Smitauthor=M.+Sideriusauthor=H.+P.+Spainkauthor=A.+H.+Meijer&title=The+CXCR3-CXCL11+Signaling+Axis+Mediates+Macrophage+Recruitment+and+Dissemination+of+Mycobacterial+Infection&doi=10.1242%2Fdmm.017756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection</span></div><div class="casAuthors">Torraca Vincenzo; Cui Chao; Boland Ralf; Spaink Herman P; Meijer Annemarie H; Bebelman Jan-Paul; Smit Martine J; Siderius Marco; van der Sar Astrid M</div><div class="citationInfo"><span class="NLM_cas:title">Disease models & mechanisms</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The recruitment of leukocytes to infectious foci depends strongly on the local release of chemoattractant mediators.  The human CXC chemokine receptor 3 (CXCR3) is an important node in the chemokine signaling network and is expressed by multiple leukocyte lineages, including T cells and macrophages.  The ligands of this receptor originate from an ancestral CXCL11 gene in early vertebrates.  Here, we used the optically accessible zebrafish embryo model to explore the function of the CXCR3-CXCL11 axis in macrophage recruitment and show that disruption of this axis increases the resistance to mycobacterial infection.  In a mutant of the zebrafish ortholog of CXCR3 (cxcr3.2), macrophage chemotaxis to bacterial infections was attenuated, although migration to infection-independent stimuli was unaffected.  Additionally, attenuation of macrophage recruitment to infection could be mimicked by treatment with NBI74330, a high-affinity antagonist of CXCR3.  We identified two infection-inducible CXCL11-like chemokines as the functional ligands of Cxcr3.2, showing that the recombinant proteins exerted a Cxcr3.2-dependent chemoattraction when locally administrated in vivo.  During infection of zebrafish embryos with Mycobacterium marinum, a well-established model for tuberculosis, we found that Cxcr3.2 deficiency limited the macrophage-mediated dissemination of mycobacteria.  Furthermore, the loss of Cxcr3.2 function attenuated the formation of granulomatous lesions, the typical histopathological features of tuberculosis, and led to a reduction in the total bacterial burden.  Prevention of mycobacterial dissemination by targeting the CXCR3 pathway, therefore, might represent a host-directed therapeutic strategy for treatment of tuberculosis.  The demonstration of a conserved CXCR3-CXCL11 signaling axis in zebrafish extends the translational applicability of this model for studying diseases involving the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ6Lw5ZIsGDFvAgqb2vdc5fW6udTcc2eZJ2ZiRBdxPTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvltF2gtg%253D%253D&md5=436a2874590a1cee94baa749b07855c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fdmm.017756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.017756%26sid%3Dliteratum%253Aachs%26aulast%3DTorraca%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DC.%26aulast%3DBoland%26aufirst%3DR.%26aulast%3DBebelman%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DSiderius%26aufirst%3DM.%26aulast%3DSpaink%26aufirst%3DH.%2BP.%26aulast%3DMeijer%26aufirst%3DA.%2BH.%26atitle%3DThe%2520CXCR3-CXCL11%2520Signaling%2520Axis%2520Mediates%2520Macrophage%2520Recruitment%2520and%2520Dissemination%2520of%2520Mycobacterial%2520Infection%26jtitle%3DDis.%2520Model%2520Mech.%26date%3D2015%26volume%3D8%26spage%3D253%26epage%3D269%26doi%3D10.1242%2Fdmm.017756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, K. M.</span></span> <span> </span><span class="NLM_article-title">Emerging Roles of Atypical Chemokine Receptor 3 (ACKR3) in Normal Development and Physiology</span>. <i>Cytokine+</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2018.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.cyto.2018.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29903572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=17-23&author=K.+E.+Quinnauthor=D.+I.+Mackieauthor=K.+M.+Caron&title=Emerging+Roles+of+Atypical+Chemokine+Receptor+3+%28ACKR3%29+in+Normal+Development+and+Physiology&doi=10.1016%2Fj.cyto.2018.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology</span></div><div class="casAuthors">Quinn, K. E.; Mackie, D. I.; Caron, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine+</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">CYTIE9</span>;
        ISSN:<span class="NLM_cas:issn">1043-4666</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The discovery that atypical chemokine receptors (ACKRs) can initiate alternative signaling pathways rather than classical G-protein coupled receptor (GPCR) signaling has changed the paradigm of chemokine receptors and their roles in modulating chemotactic responses.  The ACKR family has grown over the years, with discovery of new functions and roles in a variety of pathophysiol. conditions.  However, the extent to which these receptors regulate normal physiol. is still continuously expanding.  In particular, atypical chemokine receptor 3 (ACKR3) has proven to be an important receptor in mediating normal biol. functions, including cardiac development and migration of cortical neurons.  In this review, we illustrate the versatile and intriguing role of ACKR3 in physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Mfs54z0rSbVg90H21EOLACvtfcHk0lg8m-ih4xtXOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWlu77K&md5=6494d1fa58bbe5f991306ee513ebd7e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2018.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2018.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DK.%2BE.%26aulast%3DMackie%26aufirst%3DD.%2BI.%26aulast%3DCaron%26aufirst%3DK.%2BM.%26atitle%3DEmerging%2520Roles%2520of%2520Atypical%2520Chemokine%2520Receptor%25203%2520%2528ACKR3%2529%2520in%2520Normal%2520Development%2520and%2520Physiology%26jtitle%3DCytokine%252B%26date%3D2018%26volume%3D109%26spage%3D17%26epage%3D23%26doi%3D10.1016%2Fj.cyto.2018.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.2174/138945012799201603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.2174%2F138945012799201603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22204316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=166-172&author=Y.+Wangauthor=J.+Huangauthor=Y.+Liauthor=G.+Y.+Yang&title=Roles+of+Chemokine+CXCL12+and+its+Receptors+in+Ischemic+Stroke&doi=10.2174%2F138945012799201603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of chemokine CXCL12 and its receptors in ischemic stroke</span></div><div class="casAuthors">Wang, Yongting; Huang, Jun; Li, Yaning; Yang, Guo-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-172</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemokine CXC ligand 12 (CXCL12), originally named stromal cell-derived factor-1 (SDF-1), is a member of the CXC chemokine subfamily.  CXCL12 is found to be expressed by all cell types that are presented in the central nervous system (CNS).  It works in conjunction with the G-protein coupled receptor CXCR4, which is found at the surface of a variety of cells including neurons, astrocytes, microglia, bone marrow-derived cells, as well as other progenitor cells.  Recent studies revealed that CXCL12 could also bind and signal through receptor CXCR7.  CXCL12 and CXCR4 are constitutively expressed in the brain but are up-regulated in the ischemic penumbra regions following ischemic stroke.  CXCL12/CXCR4 play important roles in multiple processes after ischemic stroke, which include inflammatory response, focal angiogenesis, and the recruitment of bone marrow-derived cells (BMCs) and neural progenitor cell (NPC) to injury.  In addn. to its roles in stroke pathol., CXCL12 is also thought to be a key regulator in stroke repairing.  This review will focus on the function of CXCL12/CXCR4 in post-stroke inflammation and neurovascular repairing.  The potential application of CXCL12 modulation in clin. stroke treatment is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Z33EdXjs8LVg90H21EOLACvtfcHk0lg8m-ih4xtXOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSls7g%253D&md5=13aca9d2d5fa00b412bc5b864ceb28eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138945012799201603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012799201603%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DRoles%2520of%2520Chemokine%2520CXCL12%2520and%2520its%2520Receptors%2520in%2520Ischemic%2520Stroke%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D166%26epage%3D172%26doi%3D10.2174%2F138945012799201603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puchert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelkner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelov, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odoardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flügel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streit, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engele, J.</span></span> <span> </span><span class="NLM_article-title">Astrocytic Expression of the CXCL12 Receptor, CXCR7/ACKR3 is a Hallmark of the Diseased, but not Developing CNS</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2017.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.mcn.2017.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28889992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=105-118&author=M.+Puchertauthor=F.+Pelknerauthor=G.+Steinauthor=D.+N.+Angelovauthor=J.+Boltzeauthor=D.+C.+Wagnerauthor=F.+Odoardiauthor=A.+Fl%C3%BCgelauthor=W.+J.+Streitauthor=J.+Engele&title=Astrocytic+Expression+of+the+CXCL12+Receptor%2C+CXCR7%2FACKR3+is+a+Hallmark+of+the+Diseased%2C+but+not+Developing+CNS&doi=10.1016%2Fj.mcn.2017.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocytic expression of the CXCL12 receptor, CXCR7/ACKR3 is a hallmark of the diseased, but not developing CNS</span></div><div class="casAuthors">Puchert, Malte; Pelkner, Fabian; Stein, Gregor; Angelov, Doychin N.; Boltze, Johannes; Wagner, Daniel-Christoph; Odoardi, Francesca; Fluegel, Alexander; Streit, Wolfgang J.; Engele, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-118</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous demonstration of CXCR7 as the major mediator of CXCL12 signaling in cultured astrocytes, we have now compared astrocytic expression of the CXCL12 receptors, CXCR7 and CXCR4, during CNS development and disease.  In addn., we asked whether disease-assocd. conditions/factors affect expression of CXCL12 receptors in astrocytes.  In the late embryonic rat brain, CXCR7+/GFAP+ cells were restricted to the ventricular/subventricular zone while CXCR4 was widely absent from GFAP-pos. cells.  In the early postnatal and adult brain, CXCR7 and CXCR4 were almost exclusively expressed by GFAP-immunoreactive astrocytes forming the superficial glia limitans.  Contrasting the situation in the intact CNS, a striking increase in astrocytic CXCR7 expression was detectable in the cortex of rats with exptl. brain infarcts, in the spinal cord of rats with exptl. autoimmune encephalomyelitis (EAE) and after mech. compression, as well as in the in infarcted human cerebral cortex and in the hippocampus of Alzheimer's disease patients.  None of these pathologies was assocd. with substantial increases in astrocytic CXCR4 expression.  Screening of various disease-assocd. factors/conditions further revealed that CXCR7 expression of cultured cortical astrocytes increases with IFNγ as well as under hypoxic conditions whereas CXCR7 expression is attenuated following treatment with IFNβ.  Again, none of the treatments affected CXCR4 expression in cultured astrocytes.  Together, these findings support the hypothesis of a crucial role of astrocytic CXCR7 in the progression of various CNS pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNqWvYYzSp7Vg90H21EOLACvtfcHk0lizo59kApdvww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjurbE&md5=ed5df5d5c9ae85bd7492906402b32187</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2017.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DPuchert%26aufirst%3DM.%26aulast%3DPelkner%26aufirst%3DF.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DAngelov%26aufirst%3DD.%2BN.%26aulast%3DBoltze%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DD.%2BC.%26aulast%3DOdoardi%26aufirst%3DF.%26aulast%3DFl%25C3%25BCgel%26aufirst%3DA.%26aulast%3DStreit%26aufirst%3DW.%2BJ.%26aulast%3DEngele%26aufirst%3DJ.%26atitle%3DAstrocytic%2520Expression%2520of%2520the%2520CXCL12%2520Receptor%252C%2520CXCR7%252FACKR3%2520is%2520a%2520Hallmark%2520of%2520the%2520Diseased%252C%2520but%2520not%2520Developing%2520CNS%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D85%26spage%3D105%26epage%3D118%26doi%3D10.1016%2Fj.mcn.2017.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Regulates Epileptic Seizures by Controlling the Synaptic Activity of Hippocampal Granule Cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">825</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-2052-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fs41419-019-2052-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=31672961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BB3MjjslymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=825&author=T.+Xuauthor=X.+Yuauthor=J.+Dengauthor=S.+Ouauthor=X.+Liuauthor=T.+Wangauthor=Y.+Liuauthor=J.+Yangauthor=C.+Tanauthor=J.+Yuanauthor=Y.+Chen&title=CXCR7+Regulates+Epileptic+Seizures+by+Controlling+the+Synaptic+Activity+of+Hippocampal+Granule+Cells&doi=10.1038%2Fs41419-019-2052-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 regulates epileptic seizures by controlling the synaptic activity of hippocampal granule cells</span></div><div class="casAuthors">Xu Tao; Yu Xinyuan; Deng Jing; Ou Shu; Liu Xi; Wang Teng; Liu Ying; Yang Juan; Tan Changhong; Yuan Jinxian; Chen Yangmei</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">825</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">C-X-C motif chemokine receptor 7 (CXCR7), which mediates the immune response in the brain, was recently reported to regulate neurological functions.  However, the role of CXCR7 in epilepsy remains unclear.  Here, we found that CXCR7 was upregulated in the hippocampal dentate gyrus (DG) of mice subjected to kainic acid (KA)-induced epilepsy and in the brain tissues of patients with temporal lobe epilepsy.  Silencing CXCR7 in the hippocampal DG region exerted an antiepileptic effect on the KA-induced mouse model of epilepsy, whereas CXCR7 overexpression produced a seizure-aggravating effect.  Mechanistically, CXCR7 selectively regulated N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic neurotransmission in hippocampal dentate granule cells by modulating the cell membrane expression of the NMDAR subunit2A, which requires the activation of extracellular signal-regulated kinase 1/2 (ERK1/2).  Thus, CXCR7 may regulate epileptic seizures and represents a novel target for antiepileptic treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkZZ3vAQF35WgRQsDqrjW_fW6udTcc2eavE-5Jqfao7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjjslymsQ%253D%253D&md5=e148e5b25cd73b130313e7f528029bee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-2052-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-2052-9%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DOu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DCXCR7%2520Regulates%2520Epileptic%2520Seizures%2520by%2520Controlling%2520the%2520Synaptic%2520Activity%2520of%2520Hippocampal%2520Granule%2520Cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D825%26doi%3D10.1038%2Fs41419-019-2052-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trojan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ślusarczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamera, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basta-Kaim, A.</span></span> <span> </span><span class="NLM_article-title">The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">779</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.3389%2Ffphar.2017.00779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29163165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFegsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=779&author=E.+Trojanauthor=J.+%C5%9Alusarczykauthor=K.+Chameraauthor=K.+Kotarskaauthor=K.+Glombikauthor=M.+Kuberaauthor=A.+Basta-Kaim&title=The+Modulatory+Properties+of+Chronic+Antidepressant+Drugs+Treatment+on+the+Brain+Chemokine+-+Chemokine+Receptor+Network%3A+A+Molecular+Study+in+an+Animal+Model+of+Depression&doi=10.3389%2Ffphar.2017.00779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The modulatory properties of chronic antidepressant drugs treatment on the brain chemokine - chemokine receptor network: a molecular study in an animal model of depression</span></div><div class="casAuthors">Trojan, Ewa; Slusarczyk, Joanna; Chamera, Katarzyna; Kotarska, Katarzyna; Glombik, Katarzyna; Kubera, Marta; Basta-Kaim, Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">779/1-779/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">An increasing no. of studies indicate that the chemokine system may be the third major communication system of the brain.  Therefore, the role of the chemokine system in the development of brain disorders, including depression, has been recently proposed.  However, little is known about the impact of the administration of various antidepressant drugs on the brain chemokine - chemokine receptor axis.  In the present study, we used an animal model of depression based on the prenatal stress procedure.  We detd. whether chronic treatment with tianeptine, venlafaxine, or fluoxetine influenced the evoked by prenatal stress procedure changes in the mRNA and protein levels of the homeostatic chemokines, CXCL12 (SDF-1α), CX3CL1 (fractalkine) and their receptors, in the hippocampus and frontal cortex.  Moreover, the impact of mentioned antidepressants on the TGF-β, a mol. pathway related to fractalkine receptor (CX3CR1), was explored.  We found that prenatal stress caused anxiety and depressive-like disturbances in adult offspring rats, which were normalized by chronic antidepressant treatment.  Furthermore, we showed the stress-evoked CXCL12 upregulation while CXCR4 downregulation in hippocampus and frontal cortex.  CXCR7 expression was enhanced in frontal cortex but not hippocampus.  Furthermore, the levels of CX3CL1 and CX3CR1 were diminished by prenatal stress in the both examd. brain areas.  The mentioned changes were normalized with various potency by chronic administration of tested antidepressants.  All drugs in hippocampus, while tianeptine and venlafaxine in frontal cortex normalized the CXCL12 level in prenatally stressed offspring.  Moreover, in hippocampus only fluoxetine enhanced CXCR4 level, while fluoxetine and tianeptine diminished CXCR7 level in frontal cortex.  Addnl., the diminished by prenatal stress levels of CX3CL1 and CX3CR1 in the both examd. brain areas were normalized by chronic tianeptine and partially fluoxetine administration.  Tianeptine modulate also brain TGF-β signaling in the prenatal stress-induced animal model of depression.  Our results provide new evidence that not only prenatal stress-induced behavioral disturbances but also changes of CXCL12 and their receptor and at less extend in CX3CL1-CX3CR1 expression may be normalized by chronic antidepressant drug treatment.  In particular, the effect on the CXCL12 and their CXCR4 and CXCR7 receptors requires addnl. studies to elucidate the possible biol. consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXAsQ2AbIrZ7Vg90H21EOLACvtfcHk0lg4AuTcRGpVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFegsLvN&md5=436751a9f294bd9a64d9e231a265c363</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00779%26sid%3Dliteratum%253Aachs%26aulast%3DTrojan%26aufirst%3DE.%26aulast%3D%25C5%259Alusarczyk%26aufirst%3DJ.%26aulast%3DChamera%26aufirst%3DK.%26aulast%3DKotarska%26aufirst%3DK.%26aulast%3DGlombik%26aufirst%3DK.%26aulast%3DKubera%26aufirst%3DM.%26aulast%3DBasta-Kaim%26aufirst%3DA.%26atitle%3DThe%2520Modulatory%2520Properties%2520of%2520Chronic%2520Antidepressant%2520Drugs%2520Treatment%2520on%2520the%2520Brain%2520Chemokine%2520-%2520Chemokine%2520Receptor%2520Network%253A%2520A%2520Molecular%2520Study%2520in%2520an%2520Animal%2520Model%2520of%2520Depression%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D779%26doi%3D10.3389%2Ffphar.2017.00779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woerner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2008.070918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.2353%2Fajpath.2008.070918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=18276777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=799-808&author=E.+E.+McCandlessauthor=L.+Piccioauthor=B.+M.+Woernerauthor=R.+E.+Schmidtauthor=J.+B.+Rubinauthor=A.+H.+Crossauthor=R.+S.+Klein&title=Pathological+Expression+of+CXCL12+at+the+Blood-Brain+Barrier+Correlates+with+Severity+of+Multiple+Sclerosis&doi=10.2353%2Fajpath.2008.070918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span></div><div class="casAuthors">McCandless Erin E; Piccio Laura; Woerner B Mark; Schmidt Robert E; Rubin Joshua B; Cross Anne H; Klein Robyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Dysregulation of blood-brain barrier (BBB) function and transendothelial migration of leukocytes are essential components of the development and propagation of active lesions in multiple sclerosis (MS).  Animal studies indicate that polarized expression of the chemokine CXCL12 at the BBB prevents leukocyte extravasation into the central nervous system (CNS) and that disruption of CXCL12 polarity promotes entry of autoreactive leukocytes and inflammation.  In the present study, we examined expression of CXCL12 and its receptor, CXCR4, within CNS tissues from MS and non-MS patients.  Immunohistochemical analysis of CXCL12 expression at the BBB revealed basolateral localization in tissues derived from non-MS patients and at uninvolved sites in tissues from MS patients.  In contrast, within active MS lesions, CXCL12 expression was redistributed toward vessel lumena and was associated with CXCR4 activation in infiltrating leukocytes, as revealed by phospho-CXCR4-specific antibodies.  Quantitative assessment of CXCL12 expression by the CNS microvasculature established a positive correlation between CXCL12 redistribution, leukocyte infiltration, and severity of histological disease.  These results suggest that CXCL12 normally functions to localize infiltrating leukocytes to perivascular spaces, preventing CNS parenchymal infiltration.  In the patient cohort studied, altered patterns of CXCL12 expression at the BBB were specifically associated with MS, possibly facilitating trafficking of CXCR4-expressing mononuclear cells into and out of the perivascular space and leading to progression of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQozRdQ6NLRap0d-O_J5C0AfW6udTcc2ebXrYATjHU2Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D&md5=d232e834a7fc299e534176a1cbdcb24e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.070918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.070918%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPiccio%26aufirst%3DL.%26aulast%3DWoerner%26aufirst%3DB.%2BM.%26aulast%3DSchmidt%26aufirst%3DR.%2BE.%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DPathological%2520Expression%2520of%2520CXCL12%2520at%2520the%2520Blood-Brain%2520Barrier%2520Correlates%2520with%2520Severity%2520of%2520Multiple%2520Sclerosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D172%26spage%3D799%26epage%3D808%26doi%3D10.2353%2Fajpath.2008.070918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moll, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossoy, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staugaitis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucky, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietsch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span> <span> </span><span class="NLM_article-title">Imaging Correlates of Leukocyte Accumulation and CXCR4/CXCL12 in Multiple Sclerosis</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1001/archneurol.2008.512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1001%2Farchneurol.2008.512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19139298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fms12jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=44-53&author=N.+M.+Mollauthor=M.+B.+Cossoyauthor=E.+Fisherauthor=S.+M.+Staugaitisauthor=B.+H.+Tuckyauthor=A.+M.+Rietschauthor=A.+Changauthor=R.+J.+Foxauthor=B.+D.+Trappauthor=R.+M.+Ransohoff&title=Imaging+Correlates+of+Leukocyte+Accumulation+and+CXCR4%2FCXCL12+in+Multiple+Sclerosis&doi=10.1001%2Farchneurol.2008.512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis</span></div><div class="casAuthors">Moll Natalia M; Cossoy Michael B; Fisher Elizabeth; Staugaitis Susan M; Tucky Barbara H; Rietsch Anna M; Chang Ansi; Fox Robert J; Trapp Bruce D; Ransohoff Richard M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To compare leukocyte accumulation and expression of the chemokine receptor/ligand pair CXCR4/CXCL12 in magnetic resonance imaging-defined regions of interest (ROIs) in brains from patients with chronic multiple sclerosis.  We studied the following ROIs: normal-appearing white matter (NAWM); regions abnormal only on T2-weighted images (T2 only); and regions abnormal on T2- and T1-weighted images with an abnormal magnetization transfer ratio (T2/T1/MTR).  DESIGN:  Case-control study.  SETTING:  Cleveland Clinic.  PATIENTS:  Brain tissue was acquired from 5 patients with secondary progressive multiple sclerosis (MS) and 5 nonneurological controls.  INTERVENTION:  Magnetic resonance imaging pathological correlations were performed on the 5 cases.  Based on imaging characteristics, 30 ROIs were excised.  MAIN OUTCOME MEASURE:  Using immunohistochemical analysis, we evaluated myelin status, leukocyte accumulation, and CXCR4/CXCL12 expression in the MS ROIs and white matter regions from the 5 nonneurological controls.  RESULTS:  Eight of 10 T2/T1/MTR regions were chronic active or chronic inactive demyelinated lesions, whereas only 2 of 10 T2-only regions were demyelinated and characterized as active or chronic active lesions.  Equivalent numbers of CD68+ leukocytes (the predominant cell type) were present in myelinated T2-only regions as compared with NAWM.  Parenchymal T cells were significantly increased in T2/T1/MTR ROIs as compared with T2-only regions and NAWM.  Expression of CXCR4 and phospho-CXCR4 were found on reactive microglia and macrophages in T2-only and T2/T1/MTR lesions.  CXCL12 immunoreactivity was detected in astrocytes, astrocytic processes, and vascular elements in inflamed MS lesions.  CONCLUSIONS:  Inflammatory leukocyte accumulation was not increased in myelinated MS ROIs with abnormal T2 signal as compared with NAWM.  Robust expression of CXCR4/CXCL12 on inflammatory elements in MS lesions highlights a role of this chemokine/receptor pair in central nervous system inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMaDdIOGB_U5I8NvIb08rbfW6udTcc2eYed6Zv-PfLkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fms12jtg%253D%253D&md5=abea2af47af5147b60d75c27824a63a4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2008.512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2008.512%26sid%3Dliteratum%253Aachs%26aulast%3DMoll%26aufirst%3DN.%2BM.%26aulast%3DCossoy%26aufirst%3DM.%2BB.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DStaugaitis%26aufirst%3DS.%2BM.%26aulast%3DTucky%26aufirst%3DB.%2BH.%26aulast%3DRietsch%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DR.%2BJ.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DImaging%2520Correlates%2520of%2520Leukocyte%2520Accumulation%2520and%2520CXCR4%252FCXCL12%2520in%2520Multiple%2520Sclerosis%26jtitle%3DArch.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D44%26epage%3D53%26doi%3D10.1001%2Farchneurol.2008.512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Orengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Influences Leukocyte Entry into the CNS Parenchyma by Controlling Abluminal CXCL12 Abundance During Autoimmunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1084/jem.20102010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1084%2Fjem.20102010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=21300915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlCjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=327-339&author=L.+Cruz-Orengoauthor=D.+W.+Holmanauthor=D.+Dorseyauthor=L.+Zhouauthor=P.+Zhangauthor=M.+Wrightauthor=E.+E.+McCandlessauthor=J.+R.+Patelauthor=G.+D.+Lukerauthor=D.+R.+Littmanauthor=J.+H.+Russellauthor=R.+S.+Klein&title=CXCR7+Influences+Leukocyte+Entry+into+the+CNS+Parenchyma+by+Controlling+Abluminal+CXCL12+Abundance+During+Autoimmunity&doi=10.1084%2Fjem.20102010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity</span></div><div class="casAuthors">Cruz-Orengo, Lillian; Holman, David W.; Dorsey, Denise; Zhou, Liang; Zhang, Penglie; Wright, Melissa; McCandless, Erin E.; Patel, Jigisha R.; Luker, Gary D.; Littman, Dan R.; Russell, John H.; Klein, Robyn S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">208</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-339</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Loss of CXCL12, a leukocyte localizing cue, from abluminal surfaces of the blood-brain barrier occurs in multiple sclerosis (MS) lesions.  However, the mechanisms and consequences of reduced abluminal CXCL12 abundance remain unclear.  Here, we show that activation of CXCR7, which scavenges CXCL12, is essential for leukocyte entry via endothelial barriers into the central nervous system (CNS) parenchyma during exptl. autoimmune encephalomyelitis (EAE), a model for MS.  CXCR7 expression on endothelial barriers increased during EAE at sites of inflammatory infiltration.  Treatment with a CXCR7 antagonist ameliorated EAE, reduced leukocyte infiltration into the CNS parenchyma and parenchymal VCAM-1 expression, and increased abluminal levels of CXCL12.  Interleukin 17 and interleukin 1β increased, whereas interferon-γ decreased, CXCR7 expression on and CXCL12 internalization in primary brain endothelial cells in vitro.  These findings identify mol. requirements for the transvascular entry of leukocytes into the CNS and suggest that CXCR7 blockade may have therapeutic utility for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEE4dyczoX7Vg90H21EOLACvtfcHk0ljMU7lnABX96w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlCjs7Y%253D&md5=0c92141bcdd0e13efb610e2971a80a76</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1084%2Fjem.20102010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20102010%26sid%3Dliteratum%253Aachs%26aulast%3DCruz-Orengo%26aufirst%3DL.%26aulast%3DHolman%26aufirst%3DD.%2BW.%26aulast%3DDorsey%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPatel%26aufirst%3DJ.%2BR.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DCXCR7%2520Influences%2520Leukocyte%2520Entry%2520into%2520the%2520CNS%2520Parenchyma%2520by%2520Controlling%2520Abluminal%2520CXCL12%2520Abundance%2520During%2520Autoimmunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D327%26epage%3D339%26doi%3D10.1084%2Fjem.20102010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyanagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanki, T.</span></span> <span> </span><span class="NLM_article-title">Pathogenic Role of CXCR7 in Rheumatoid Arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3211</span>– <span class="NLM_lpage">3220</span>, <span class="refDoi"> DOI: 10.1002/art.27650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1002%2Fart.27650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=20617529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3211-3220&author=K.+Watanabeauthor=M.+E.+T.+Penfoldauthor=A.+Matsudaauthor=N.+Ohyanagiauthor=K.+Kanekoauthor=Y.+Miyabeauthor=K.+Matsumotoauthor=T.+J.+Schallauthor=N.+Miyasakaauthor=T.+Nanki&title=Pathogenic+Role+of+CXCR7+in+Rheumatoid+Arthritis&doi=10.1002%2Fart.27650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenic role of CXCR7 in rheumatoid arthritis</span></div><div class="casAuthors">Watanabe, Kaori; Penfold, Mark E. T.; Matsuda, Akio; Ohyanagi, Naho; Kaneko, Kayoko; Miyabe, Yoshishige; Matsumoto, Kenji; Schall, Thomas J.; Miyasaka, Nobuyuki; Nanki, Toshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3211-3220</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. The interaction between CXCL12 and its receptor, CXCR4, in the synovium of patients with rheumatoid arthritis (RA) is important for local inflammatory cell recruitment, angiogenesis, and cytokine prodn.  CXCR7 was recently identified as an alternative receptor for CXCL12.  We undertook this study to analyze the expression of CXCR7 in RA synovium and the pathogenic role of the CXCL12/CXCR7 pathway in RA.  Methods. CXCR7 expression in RA synovial tissue was analyzed using immunohistochem., while expression of CXCR4 and CXCR7 on human umbilical vein endothelial cells (HUVECs) was examd. using quant. reverse transcription-polymerase chain reaction, and CXCR7 expression was also analyzed by flow cytometry.  Tube formation and rat aortic ring angiogenesis assays were used to assess the effects of CCX733 (a CXCR7 antagonist) and AMD3100 (a CXCR4 antagonist) on CXCL12-induced angiogenesis.  The effect of anti-CXCR4 monoclonal antibody (mAb) was also analyzed using a tube formation assay.  The effects of CCX733 in a murine model of collagen-induced arthritis (CIA) were also evaluated.  Results. CXCR7 was expressed on endothelial cells in RA synovium and also on unstimulated HUVECs.  The expression of CXCR7 on HUVECs was markedly up-regulated by interleukin-1β (IL-1β) stimulation, and this overexpression was further enhanced by CXCL12 treatment.  Incubation with CXCL12 also promoted angiogenic activity, with addn. of IL-1β again augmenting the effect.  CXCL12-induced angiogenesis was inhibited by both CXCR4 and CXCR7 antagonists and by anti-CXCR4 mAb.  Furthermore, treatment with CCX773 significantly reduced the clin. arthritis scores and the nos. of vessels in the inflamed synovial tissue in mice with CIA.  Conclusion. CXCR7 and CXCR4 are both important for angiogenesis in RA synovium, making CXCR7 another potential target mol. for novel RA angiogenesis-blocking therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAwhZAzOb-bVg90H21EOLACvtfcHk0lg9npliH_-gLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrvN&md5=e68229b6aeb3086580808a77d054c627</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.27650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27650%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DOhyanagi%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DMiyabe%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DMiyasaka%26aufirst%3DN.%26aulast%3DNanki%26aufirst%3DT.%26atitle%3DPathogenic%2520Role%2520of%2520CXCR7%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D3211%26epage%3D3220%26doi%3D10.1002%2Fart.27650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meichssner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngamsri, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutershan, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SDF-1 Receptors CXCR4 and CXCR7 Attenuates Acute Pulmonary Inflammation via the Adenosine A2B-Receptor on Blood Cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2832</span> <span class="refDoi"> DOI: 10.1038/cddis.2016.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fcddis.2016.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28542132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosV2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=F.+M.+Konradauthor=N.+Meichssnerauthor=A.+Buryauthor=K.+C.+Ngamsriauthor=J.+Reutershan&title=Inhibition+of+SDF-1+Receptors+CXCR4+and+CXCR7+Attenuates+Acute+Pulmonary+Inflammation+via+the+Adenosine+A2B-Receptor+on+Blood+Cells&doi=10.1038%2Fcddis.2016.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells</span></div><div class="casAuthors">Konrad, Franziska Magdalena; Meichssner, Nadine; Bury, Annette; Ngamsri, Kristian-Christos; Reutershan, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2832</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils into the different compartments of the lung.  Recent studies showed evidence that the chemokine stromal cell-derived factor (SDF)-1 and its receptors CXCR4 and CXCR7 influence migration of immune cells and their activity was linked to adenosine concns.  We investigated the particular role of CXCR4- and CXCR7-inhibition and the potential link to the adenosine A2B-receptor, which plays an important anti-inflammatory role in the lung.  After LPS-inhalation for 45 min, administration of the CXCR4-inhibitor (AMD3100) decreased transendothelial and transepithelial migration, whereas CXCR7-antagonism influenced epithelial migration exclusively.  In A2B-/- mice, no anti-inflammatory effects were detectible through either one of the agents.  Using chimeric mice, we identified A2B on hematopoietic cells to be crucial for these anti-inflammatory effects of CXCR4/7-inhibition.  Both inhibitors decreased TNFα, IL6, CXCL1 and CXCL2/3 levels in the bronchoalveolar lavage of wild type mice, while not influencing the chemokine release in A2B-/- mice.  Inflammation augmented the expression of both receptors and their inhibition increased A2B-levels upon inflammation.  In vitro assays with human epithelium/endothelium confirmed our in vivo findings.  During inflammation, inhibition of CXCR4- and CXCR7-receptors prevented microvascular permeability in wild type but not in A2B-/- mice, highlighting the pivotal role of an active A2B-receptor in this setting.  The combination of both inhibitors had a synergistic effect in preventing capillary leakage.  In conclusion, we detd. the pivotal role of CXCR4- and CXCR7-inhibition in acute pulmonary inflammation, which depended on A2B-receptor signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrBrujqVh7LbVg90H21EOLACvtfcHk0lg9npliH_-gLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosV2qtbk%253D&md5=5ebf2bfdc0e2b242c91a02c4b7b77c2d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.482%26sid%3Dliteratum%253Aachs%26aulast%3DKonrad%26aufirst%3DF.%2BM.%26aulast%3DMeichssner%26aufirst%3DN.%26aulast%3DBury%26aufirst%3DA.%26aulast%3DNgamsri%26aufirst%3DK.%2BC.%26aulast%3DReutershan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520SDF-1%2520Receptors%2520CXCR4%2520and%2520CXCR7%2520Attenuates%2520Acute%2520Pulmonary%2520Inflammation%2520via%2520the%2520Adenosine%2520A2B-Receptor%2520on%2520Blood%2520Cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2016.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngamsri, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bösmüller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamper-Tsigaras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutershan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, F. M.</span></span> <span> </span><span class="NLM_article-title">The Pivotal Role of CXCR7 in Stabilization of the Pulmonary Epithelial Barrier in Acute Pulmonary Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">2403</span>– <span class="NLM_lpage">2413</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4049%2Fjimmunol.1601682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28188248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=2403-2413&author=K.-C.+Ngamsriauthor=A.+M%C3%BCllerauthor=H.+B%C3%B6sm%C3%BCllerauthor=J.+Gamper-Tsigarasauthor=J.+Reutershanauthor=F.+M.+Konrad&title=The+Pivotal+Role+of+CXCR7+in+Stabilization+of+the+Pulmonary+Epithelial+Barrier+in+Acute+Pulmonary+Inflammation&doi=10.4049%2Fjimmunol.1601682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Pivotal Role of CXCR7 in Stabilization of the Pulmonary Epithelial Barrier in Acute Pulmonary Inflammation</span></div><div class="casAuthors">Ngamsri, Kristian-Christos; Mueller, Anika; Boesmueller, Hans; Gamper-Tsigaras, Jutta; Reutershan, Joerg; Konrad, Franziska M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2403-2413</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Acute pulmonary inflammation is still a frightening complication in intensive care units and has a high mortality.  Specific treatment is not available, and many details of the pathomechanism remain unclear.  The recently discovered chemokine receptor CXCR7 and its ligand stromal cell-derived factor (SDF)-1 are known to be involved in inflammation.  We chose to investigate the detailed role of CXCR7 in a murine model of LPS inhalation.  Inflammation increased pulmonary expression of CXCR7, and the receptor was predominantly expressed on pulmonary epithelium and on polymorphonuclear neutrophil (PMNs) after transepithelial migration into the alveolar space.  Specific inhibition of CXCR7 reduced transepithelial PMN migration by affecting the expression of adhesion mols.  CXCR7 antagonism reduced the most potent PMN chemoattractants CXCL1 and CXCL2/3.  After inhibiting CXCR7, NF-κB phosphorylation was reduced in lungs of mice, tight junction formation increased, and protein concn. in the bronchoalveolar lavage diminished, showing the impact of CXCR7 on stabilizing microvascular permeability.  In vitro studies with human cells confirmed the pivotal role of CXCR7 in pulmonary epithelium.  Immunofluorescence of human lungs confirmed our in vivo data and showed an increase of the expression of CXCR7 in pulmonary epithelium.  Highlighting the clin. potential of CXCR7 antagonism, nebulization of the agent before and after the inflammation showed impressive anti-inflammatory effects.  Addnl. CXCR7 inhibition potentiated the effect of SDF-1 antagonism, most probably by downregulating SDF-1 and the second receptor of the chemokine (CXCR4) expression.  In conclusion, our data identified the pivotal role of the receptor CXCR7 in pulmonary inflammation with a predominant effect on the pulmonary epithelium and PMNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqGeBrOssP7Vg90H21EOLACvtfcHk0lg9npliH_-gLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOmtbw%253D&md5=ed2c4cfca6be21b3ae4d9a02690dde4d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601682%26sid%3Dliteratum%253Aachs%26aulast%3DNgamsri%26aufirst%3DK.-C.%26aulast%3DM%25C3%25BCller%26aufirst%3DA.%26aulast%3DB%25C3%25B6sm%25C3%25BCller%26aufirst%3DH.%26aulast%3DGamper-Tsigaras%26aufirst%3DJ.%26aulast%3DReutershan%26aufirst%3DJ.%26aulast%3DKonrad%26aufirst%3DF.%2BM.%26atitle%3DThe%2520Pivotal%2520Role%2520of%2520CXCR7%2520in%2520Stabilization%2520of%2520the%2520Pulmonary%2520Epithelial%2520Barrier%2520in%2520Acute%2520Pulmonary%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D2403%26epage%3D2413%26doi%3D10.4049%2Fjimmunol.1601682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syu, F.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-C.</span></span> <span> </span><span class="NLM_article-title">Critical Involvement of Atypical Chemokine Receptor CXCR7 in Allergic Airway Inflammation</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1111/imm.12881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1111%2Fimm.12881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29250768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=274-284&author=H.-C.+Changauthor=P.-H.+Huangauthor=F.-S.+Syuauthor=C.-H.+Hsiehauthor=S.+L.-Y.+Changauthor=J.+Luauthor=H.-C.+Chen&title=Critical+Involvement+of+Atypical+Chemokine+Receptor+CXCR7+in+Allergic+Airway+Inflammation&doi=10.1111%2Fimm.12881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Critical involvement of atypical chemokine receptor CXCR7 in allergic airway inflammation</span></div><div class="casAuthors">Chang, Hung-Chih; Huang, Po-Han; Syu, Fu-Sheng; Hsieh, Chia-Hung; Chang, Sunny Li-Yun; Lu, Jean; Chen, Hui-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">274-284</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Trafficking and recruitment of immune cells to the site of inflammation with spatial and temporal synchronization is crucial for the development of allergic airway inflammation.  Particularly, chemokines are known to be key players in these processes.  Previous studies revealed that the CXCL12/CXCR4 axis plays an important role in regulating allergic airway inflammation.  However, the role of CXCR7, a recently discovered second receptor for CXCL12, in regulating airway inflammation has not been explored.  Initially, CXCR7 was considered as a decoy receptor; however, numerous subsequent studies revealed that engagement of CXCR7 triggered its own signalling or modulated CXCR4-mediated signalling.  In the present study, we detected the expression of CXCR7 in airway epithelial cells.  Use of a lentiviral delivery system to knock down the expression of CXCR7 in the lung of sensitized mice abrogated the cardinal features of asthma, indicating that CXCR7 plays a role in regulating allergic airway inflammation.  The activation of mitogen-activated protein kinase and Akt signalling in response to CXCL12 in the mouse epithelial cell line MLE-12 was reduced when CXCR7 expression was knocked down.  However, either knockdown or overexpression of CXCR7 in MLE-12 did not affect CXCL12-mediated calcium influx, indicating that CXCR7 does not modulate CXCR4-mediated signalling, and that it functions as a signalling receptor rather than a decoy receptor.  Finally, we found that the expression of chemokine CCL2 is regulated by CXCR7/CXCL12-mediated signalling through β-arrestin in airway epithelial cells.  Hence, regulating the expression of CCL2 in airway epithelial cells may be one mechanism by which CXCR7 participates in regulating allergic airway inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOjlqwCxrhmbVg90H21EOLACvtfcHk0ljgNi4mSfh-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVKqsA%253D%253D&md5=5eccd848aa6aa9c760ffd2042ee02465</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fimm.12881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12881%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-C.%26aulast%3DHuang%26aufirst%3DP.-H.%26aulast%3DSyu%26aufirst%3DF.-S.%26aulast%3DHsieh%26aufirst%3DC.-H.%26aulast%3DChang%26aufirst%3DS.%2BL.-Y.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.-C.%26atitle%3DCritical%2520Involvement%2520of%2520Atypical%2520Chemokine%2520Receptor%2520CXCR7%2520in%2520Allergic%2520Airway%2520Inflammation%26jtitle%3DImmunology%26date%3D2018%26volume%3D154%26spage%3D274%26epage%3D284%26doi%3D10.1111%2Fimm.12881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Targeting and Its Major Disease Relevance</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">641</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.3389%2Ffphar.2018.00641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29977203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ahsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=641&author=C.+Wangauthor=W.+Chenauthor=J.+Shen&title=CXCR7+Targeting+and+Its+Major+Disease+Relevance&doi=10.3389%2Ffphar.2018.00641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 targeting and its major disease relevance</span></div><div class="casAuthors">Wang, Chuan; Chen, Weilin; Shen, Jianzhong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">641/1-641/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Chemokine receptors are the target of small peptide chemokines.  They play various important roles in physiol. and pathol. processes.  CXCR7, later renamed ACKR3, is a non-classical seven transmembrane-spanning receptor whose function as a signaling or non-signaling scavenger/decoy receptor is currently under debate.  Even for cell signaling mechanisms, there has been inconsistency on whether CXCR7 couples to G-proteins or β-arrestins.  Several reasons may contribute to this uncertainty or controversy.  In one hand, it has been neglected that CXCR7 has more than five natural ligands and unfortunately, most of the prior research only studied SDF-1 (CXCL12) and/or I-TAC (CXCL11); on the other hand, there are mounting evidence supporting ligand and tissue bias for receptor signaling, but limited such information is available for CXCR7.  In this review we focus on summarizing the endogenous and exogenous ligands of CXCR7, the main diseases related to CXCR7 and the biased signaling events happening on CXCR7.  These three aspects of CXCR7 pharmacol. properties may explain why the contradicting opinions of whether CXCR7 is a signaling or non-signaling receptor exist.  Further, potential new direction and perspective for the study of CXCR7 biol. and pharmacol. are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD3SaGRfdfPLVg90H21EOLACvtfcHk0lgP5ToGuXY6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ahsbo%253D&md5=ea92d28be028cc6e08f63faadc650230</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00641%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DCXCR7%2520Targeting%2520and%2520Its%2520Major%2520Disease%2520Relevance%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D641%26doi%3D10.3389%2Ffphar.2018.00641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebsworth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Omran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kioi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernikova, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulkearns-Hubert, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinyuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathia, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamchandani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, H. E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CXCR7 Extends Survival Following Irradiation of Brain Tumours in Mice and Rats</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1038/bjc.2013.830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2013.830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24423923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2014&pages=1179-1188&author=M.+J.+Waltersauthor=K.+Ebsworthauthor=R.+D.+Berahovichauthor=M.+E.+T.+Penfoldauthor=S.-C.+Liuauthor=R.+Al+Omranauthor=M.+Kioiauthor=S.+B.+Chernikovaauthor=D.+Tsengauthor=E.+E.+Mulkearns-Hubertauthor=M.+Sinyukauthor=R.+M.+Ransohoffauthor=J.+D.+Lathiaauthor=J.+Karamchandaniauthor=H.+E.+K.+Kohrtauthor=P.+Zhangauthor=J.+P.+Powersauthor=J.+C.+Jaenauthor=T.+J.+Schallauthor=M.+Merchantauthor=L.+Rechtauthor=J.+M.+Brown&title=Inhibition+of+CXCR7+Extends+Survival+Following+Irradiation+of+Brain+Tumours+in+Mice+and+Rats&doi=10.1038%2Fbjc.2013.830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats</span></div><div class="casAuthors">Walters, M. J.; Ebsworth, K.; Berahovich, R. D.; Penfold, M. E. T.; Liu, S-C.; Al Omran, R.; Kioi, M.; Chernikova, S. B.; Tseng, D.; Mulkearns-Hubert, E. E.; Sinyuk, M.; Ransohoff, R. M.; Lathia, J. D.; Karamchandani, J.; Koort, H. E. K.; Zhang, P.; Powers, J. P.; Jaen, J. C.; Schall, T. J.; Merchant, M.; Recht, L.; Brown, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: In exptl. models of glioblastoma multiforme (GBM), irradn. (IR) induces local expression of the chemokine CXCL12/SDF-1, which promotes tumor recurrence.  The role of CXCR7, the high-affinity receptor for CXCL12, in the tumor's response to IR has not been addressed.  Methods: We tested CXCR7 inhibitors for their effects on tumor growth and/or animal survival post IR in three rodent GBM models.  We used immunohistochem. to det. where CXCR7 protein is expressed in the tumors and in human GBM samples.  We used neurosphere formation assays with human GBM xenografts to det. whether CXCR7 is required for cancer stem cell (CSC) activity in vitro.  Results: CXCR7 was detected on tumor cells and/or tumor-assocd. vasculature in the rodent models and in human GBM.  In human GBM, CXCR7 expression increased with glioma grade and was spatially assocd. with CXCL12 and CXCL11/I-TAC.  In the rodent GBM models, pharmacol. inhibition of CXCR7 post IR caused tumor regression, blocked tumor recurrence, and/or substantially prolonged survival.  CXCR7 expression levels on human GBM xenograft cells correlated with neurosphere-forming activity, and a CXCR7 inhibitor blocked sphere formation by sorted CSCs.  Conclusions: These results indicate that CXCR7 inhibitors could block GBM tumor recurrence after IR, perhaps by interfering with CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3mXhvIVB3X7Vg90H21EOLACvtfcHk0lgP5ToGuXY6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyhsr0%253D&md5=e6cf80995426e58cc61998de1866aa90</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.830%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DEbsworth%26aufirst%3DK.%26aulast%3DBerahovich%26aufirst%3DR.%2BD.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DLiu%26aufirst%3DS.-C.%26aulast%3DAl%2BOmran%26aufirst%3DR.%26aulast%3DKioi%26aufirst%3DM.%26aulast%3DChernikova%26aufirst%3DS.%2BB.%26aulast%3DTseng%26aufirst%3DD.%26aulast%3DMulkearns-Hubert%26aufirst%3DE.%2BE.%26aulast%3DSinyuk%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DLathia%26aufirst%3DJ.%2BD.%26aulast%3DKaramchandani%26aufirst%3DJ.%26aulast%3DKohrt%26aufirst%3DH.%2BE.%2BK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520CXCR7%2520Extends%2520Survival%2520Following%2520Irradiation%2520of%2520Brain%2520Tumours%2520in%2520Mice%2520and%2520Rats%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D110%26spage%3D1179%26epage%3D1188%26doi%3D10.1038%2Fbjc.2013.830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimdjee-Soilihi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchetrit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goguet-Surmenian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Antomarchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Alliana, A.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Receptors Facilitate the Progression of Colon Carcinoma within Lung not within Liver</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1944</span>– <span class="NLM_lpage">1949</span>, <span class="refDoi"> DOI: 10.1038/bjc.2012.503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2012.503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=23169289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSntbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1944-1949&author=E.+Guillemotauthor=B.+Karimdjee-Soilihiauthor=E.+Pradelliauthor=M.+Benchetritauthor=E.+Goguet-Surmenianauthor=M.+A.+Milletauthor=F.+Larbretauthor=J.+F.+Michielsauthor=D.+Birnbaumauthor=P.+Alemannoauthor=H.+Schmid-Antomarchiauthor=A.+Schmid-Alliana&title=CXCR7+Receptors+Facilitate+the+Progression+of+Colon+Carcinoma+within+Lung+not+within+Liver&doi=10.1038%2Fbjc.2012.503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver</span></div><div class="casAuthors">Guillemot, E.; Karimdjee-Soilihi, B.; Pradelli, E.; Benchetrit, M.; Goguet-Surmenian, E.; Millet, M.-A.; Larbret, F.; Michiels, J.-F.; Birnbaum, D.; Alemanno, P.; Schmid-Antomarchi, H.; Schmid-Alliana, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1944-1949</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Liver and lung metastases are the predominant cause of colorectal cancer (CRC)-related mortality.  Chemokine-receptor pairs have a crit. role in detg. the metastatic progression of tumors.  Our hypothesis was that disruption of CXCR7/CXCR7 ligands axis could lead to a decrease in CRC metastases.  Methods: Primary tumors and metastatic tissues from patients with CRC were tested for the expression of CXCR7 and its ligands.  Relevance of CXCR7/CXCR7 ligands for CRC metastasis was then investigated in mice using small pharmacol. CXCR7 antagonists and CRC cell lines of human and murine origins, which - injected into mice - enable the development of lung and liver metastases.  Results: Following injection of CRC cells, mice treated daily with CXCR7 antagonists exhibited a significant redn. in lung metastases.  However, CXCR7 antagonists failed to reduce the extent of liver metastasis.  Moreover, there were subtle differences in the expression of CXCR7 and its ligands between lung and liver metastases.  Conclusion: Our study suggests that the activation of CXCR7 on tumor blood vessels by its ligands may facilitate the progression of CRC within lung but not within liver.  Moreover, we provide evidence that targeting the CXCR7 axis may be beneficial to limit metastasis from colon cancer within the lungs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1p2PoWH-YbVg90H21EOLACvtfcHk0lgP5ToGuXY6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSntbjP&md5=cee6a363511bf6d92c53f3e4552a00a3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.503%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemot%26aufirst%3DE.%26aulast%3DKarimdjee-Soilihi%26aufirst%3DB.%26aulast%3DPradelli%26aufirst%3DE.%26aulast%3DBenchetrit%26aufirst%3DM.%26aulast%3DGoguet-Surmenian%26aufirst%3DE.%26aulast%3DMillet%26aufirst%3DM.%2BA.%26aulast%3DLarbret%26aufirst%3DF.%26aulast%3DMichiels%26aufirst%3DJ.%2BF.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DAlemanno%26aufirst%3DP.%26aulast%3DSchmid-Antomarchi%26aufirst%3DH.%26aulast%3DSchmid-Alliana%26aufirst%3DA.%26atitle%3DCXCR7%2520Receptors%2520Facilitate%2520the%2520Progression%2520of%2520Colon%2520Carcinoma%2520within%2520Lung%2520not%2520within%2520Liver%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D1944%26epage%3D1949%26doi%3D10.1038%2Fbjc.2012.503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihalko, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggins, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-Positive Breast Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">4750</span>– <span class="NLM_lpage">4758</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fonc.2011.633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22266857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=4750-4758&author=K.+E.+Lukerauthor=S.+A.+Lewinauthor=L.+A.+Mihalkoauthor=B.+T.+Schmidtauthor=J.+S.+Winklerauthor=N.+L.+Cogginsauthor=D.+G.+Thomasauthor=G.+D.+Luker&title=Scavenging+of+CXCL12+by+CXCR7+Promotes+Tumor+Growth+and+Metastasis+of+CXCR4-Positive+Breast+Cancer+Cells&doi=10.1038%2Fonc.2011.633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells</span></div><div class="casAuthors">Luker, K. E.; Lewin, S. A.; Mihalko, L. A.; Schmidt, B. T.; Winkler, J. S.; Coggins, N. L.; Thomas, D. G.; Luker, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">4750-4758</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokine CXCL12 and receptor CXCR4 control multiple steps in primary tumor growth and metastasis in breast cancer and >20 other human malignancies.  Mechanisms that regulate availability of CXCL12 in tumor microenvironments will substantially impact cancer progression and ongoing efforts to target the CXCL12-CXCR4 pathway for cancer chemotherapy.  Dual luciferase imaging was used to study CXCR7-dependent scavenging of CXCL12 in breast tumors in vivo and quantify effects of CXCR7 on tumor growth and metastasis of a sep. population of CXCR4+ breast cancer cells.  In a mouse xenograft model of human breast cancer, in vivo imaging showed that malignant cells expressing CXCR7 reduced bioluminescent CXCL12 secreted in the primary tumor microenvironment.  Capitalizing on sensitive detection of bioluminescent CXCL12, also CXCR7+ cells reduced amts. of chemokine released from orthotopic tumors into the circulation.  Immunofluorescence staining of human primary breast cancers showed expression of CXCR4 and CXCR7 on malignant cells in ≈30% of cases.  In most cases, CXCR4 and CXCR7 predominantly were expressed on sep. populations of malignant cells in a tumor.  The authors modeled these cases of human breast cancer by co-implanting tumor xenografts with CXCR4+ breast cancer cells, human mammary fibroblasts secreting CXCL12, and CXCR7+ or control breast cancer cells.  Bioluminescence imaging showed that CXCR7+ breast cancer cells enhanced proliferation of CXCR4+ breast cancer cells in orthotopic tumors and spontaneous metastases.  Treatment with a small-mol. inhibitor of CXCR7 chemokine limited the growth of CXCR4+ breast cancer cells in tumors that also contained malignant CXCR7+ cells.  These studies establish a new in vivo imaging method to quantify chemokine scavenging by CXCR7 in the tumor microenvironment and identify that CXCR7+ cells promote growth and metastasis of CXCR4+ breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX_3TeuDDs17Vg90H21EOLACvtfcHk0lgMJMMOGOF0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eltrjK&md5=61ebfb979de0826cb08e73908ee9b33c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.633%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DLewin%26aufirst%3DS.%2BA.%26aulast%3DMihalko%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DB.%2BT.%26aulast%3DWinkler%26aufirst%3DJ.%2BS.%26aulast%3DCoggins%26aufirst%3DN.%2BL.%26aulast%3DThomas%26aufirst%3DD.%2BG.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DScavenging%2520of%2520CXCL12%2520by%2520CXCR7%2520Promotes%2520Tumor%2520Growth%2520and%2520Metastasis%2520of%2520CXCR4-Positive%2520Breast%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D4750%26epage%3D4758%26doi%3D10.1038%2Fonc.2011.633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goguet-Surmenian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard-Fiardo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchetrit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Brouchet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzzo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimdjee-Soilihi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Alliana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid-Antomarchi, H.</span></span> <span> </span><span class="NLM_article-title">CXCR7-Mediated Progression of Osteosarcoma in the Lungs</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1579</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1038/bjc.2013.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fbjc.2013.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24002596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=1579-1585&author=E.+Goguet-Surmenianauthor=P.+Richard-Fiardoauthor=E.+Guillemotauthor=M.+Benchetritauthor=A.+Gomez-Brouchetauthor=P.+Buzzoauthor=B.+Karimdjee-Soilihiauthor=P.+Alemannoauthor=J.+F.+Michielsauthor=A.+Schmid-Allianaauthor=H.+Schmid-Antomarchi&title=CXCR7-Mediated+Progression+of+Osteosarcoma+in+the+Lungs&doi=10.1038%2Fbjc.2013.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7-mediated progression of osteosarcoma in the lungs</span></div><div class="casAuthors">Goguet-Surmenian, E.; Richard-Fiardo, P.; Guillemot, E.; Benchetrit, M.; Gomez-Brouchet, A.; Buzzo, P.; Karimdjee-Soilihi, B.; Alemanno, P.; Michiels, J.-F.; Schmid-Alliana, A.; Schmid-Antomarchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1579-1585</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Osteosarcoma (OS) is the most frequent primary malignant bone tumor in children and adolescents with a high propensity for lung metastasis.  Chemokines and chemokine receptors have been described to have an important role in many malignancies including OS.  The aim of this study was to investigate the expression of CXCR7 receptor in OS tissues and its role in the progression of the disease in the lungs.  Methods: Immunohistochem. was used to study CXCR7 expression in primary tumors and metastatic tissues from patients with OS.  Its contribution to tumor expansion in the lungs has been also assessed using animal models and synthetic-specific CXCR7 ligands.  Results: CXCR7 was expressed on human primary bone tumors and on lung metastases.  Its expression was predominantly located on tumor-assocd. blood vessels.  Mice challenged with OS cells and systematically treated with synthetic CXCR7 ligands presented a significant redn. of lung nodules compared with untreated mice.  Conclusion: This study shows that CXCR7 has a crit. role in OS progression in the lungs, where are expressed CXCR7 ligands, esp. CXCL12.  Moreover, we highlight that synthetic CXCR7 ligands could represent a powerful therapeutic tool to impede lung OS progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg-4DcvJD0CLVg90H21EOLACvtfcHk0lgMJMMOGOF0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqu7nN&md5=66a4ba7381b179ceca86dee5e1ad72a3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.482%26sid%3Dliteratum%253Aachs%26aulast%3DGoguet-Surmenian%26aufirst%3DE.%26aulast%3DRichard-Fiardo%26aufirst%3DP.%26aulast%3DGuillemot%26aufirst%3DE.%26aulast%3DBenchetrit%26aufirst%3DM.%26aulast%3DGomez-Brouchet%26aufirst%3DA.%26aulast%3DBuzzo%26aufirst%3DP.%26aulast%3DKarimdjee-Soilihi%26aufirst%3DB.%26aulast%3DAlemanno%26aufirst%3DP.%26aulast%3DMichiels%26aufirst%3DJ.%2BF.%26aulast%3DSchmid-Alliana%26aufirst%3DA.%26aulast%3DSchmid-Antomarchi%26aufirst%3DH.%26atitle%3DCXCR7-Mediated%2520Progression%2520of%2520Osteosarcoma%2520in%2520the%2520Lungs%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D109%26spage%3D1579%26epage%3D1585%26doi%3D10.1038%2Fbjc.2013.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wani, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahirwar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, R. K.</span></span> <span> </span><span class="NLM_article-title">C-X-C Motif Chemokine 12/C-X-C Chemokine Receptor Type 7 Signaling Regulates Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">R54</span>, <span class="refDoi"> DOI: 10.1186/bcr3665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1186%2Fbcr3665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=24886617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFShtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=R54&author=N.+A.+Waniauthor=M.+W.+Nasserauthor=D.+K.+Ahirwarauthor=H.+Zhaoauthor=Z.+Miaoauthor=K.+Shiloauthor=R.+K.+Ganju&title=C-X-C+Motif+Chemokine+12%2FC-X-C+Chemokine+Receptor+Type+7+Signaling+Regulates+Breast+Cancer+Growth+and+Metastasis+by+Modulating+the+Tumor+Microenvironment&doi=10.1186%2Fbcr3665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment</span></div><div class="casAuthors">Wani, Nissar Ahmad; Nasser, Mohd W.; Ahirwar, Dinesh K.; Zhao, Helong; Miao, Zhenhua; Shilo, Konstantin; Ganju, Ramesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R54/1-R54/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Although C-X-C motif chemokine 12 (CXCL12) has been shown to bind to C-X-C chemokine receptor type 7 (CXCR7), the exact mol. mechanism regulations by CXCL12/CXCR7 axis in breast tumor growth and metastasis are not well understood.  CXCR7 expression has been shown to be upregulated during pathol. processes such as inflammation and cancer.  Breast cancer cell lines were genetically silenced or pharmacol. inhibited for CXCR7 and/or its downstream target signal transducer and activator of transcription 3 (STAT3). 4T1 or 4T1 downregulated for CXCR7 and 4T1.2 breast cancer cell lines were injected in mammary gland of BALB/c mice to form tumors and the mol. pathways regulating tumor growth and metastasis were assessed.  In this study, we obsd. that CXCL12 enhances CXCR7-mediated breast cancer migration.  Furthermore, genetic silencing or pharmacol. inhibition of CXCR7 reduced breast tumor growth and metastasis.  Further elucidation of mechanisms revealed that CXCR7 mediates tumor growth and metastasis by activating pro-inflammatory STAT3 signaling and angiogenic markers.  Furthermore, enhanced breast tumorigenicity and invasiveness were assocd. with macrophage infiltration.  CXCR7 recruits tumor promoting macrophages (M2) to the tumor site through regulation of macrophage colony-stimulating factor (MCSF)/macrophage colony-stimulating factor receptor (MCSF-R) signaling pathway.  In addn., CXCR7 regulated breast cancer metastasis by enhancing expression of metalloproteinases (MMP-9, MMP-2) and vascular cell adhesion mol.-1 (VCAM-1).  We also obsd. that CXCR7 is highly expressed in invasive ductal carcinoma (IDC) and metastatic breast tissue in human patient samples.  In addn., high CXCR7 expression in tumors correlates with worse prognosis of both overall survival and lung metastasis free survival in IDC patients.  These observations reveal that CXCR7 enhances breast cancer growth and metastasis via a novel pathway by modulating the tumor microenvironment.  These findings identify CXCR7-mediated STAT3 activation and modulation of tumor microenvironment as novel regulation of breast cancer growth and metastasis.  These studies indicate that new strategies using CXCR7 inhibitors could be developed for anti-metastatic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjiY1MKjaBbVg90H21EOLACvtfcHk0ljQiHS7vfHjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFShtbs%253D&md5=e81a1b88d2627245a6bea61830c45402</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Fbcr3665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr3665%26sid%3Dliteratum%253Aachs%26aulast%3DWani%26aufirst%3DN.%2BA.%26aulast%3DNasser%26aufirst%3DM.%2BW.%26aulast%3DAhirwar%26aufirst%3DD.%2BK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShilo%26aufirst%3DK.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DC-X-C%2520Motif%2520Chemokine%252012%252FC-X-C%2520Chemokine%2520Receptor%2520Type%25207%2520Signaling%2520Regulates%2520Breast%2520Cancer%2520Growth%2520and%2520Metastasis%2520by%2520Modulating%2520the%2520Tumor%2520Microenvironment%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2014%26volume%3D16%26spage%3DR54%26doi%3D10.1186%2Fbcr3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biben, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woehl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-A, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span> <span> </span><span class="NLM_article-title">Disrupted Cardiac Development But Normal Hematopoiesis in Mice Deficient in the Second CXCL12/SDF-1 Receptor, CXCR7</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">14759</span>– <span class="NLM_lpage">14764</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702229104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1073%2Fpnas.0702229104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=17804806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOns7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=14759-14764&author=F.+Sierroauthor=C.+Bibenauthor=L.+Martinez-Munozauthor=M.+Melladoauthor=R.+M.+Ransohoffauthor=M.+Liauthor=B.+Woehlauthor=H.+Leungauthor=J.+Groomauthor=M.+Battenauthor=R.+P.+Harveyauthor=C.+Martinez-Aauthor=C.+R.+Mackayauthor=F.+Mackay&title=Disrupted+Cardiac+Development+But+Normal+Hematopoiesis+in+Mice+Deficient+in+the+Second+CXCL12%2FSDF-1+Receptor%2C+CXCR7&doi=10.1073%2Fpnas.0702229104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7</span></div><div class="casAuthors">Sierro, Frederic; Biben, Christine; Martinez-Munoz, Laura; Mellado, Mario; Ransohoff, Richard M.; Li, Meizhang; Woehl, Blanche; Leung, Helen; Groom, Joanna; Batten, Marcel; Harvey, Richard P.; Martinez-A, Carlos; Mackay, Charles R.; Mackay, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">14759-14764</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chemotactic cytokines (chemokines) attract immune cells, although their original evolutionary role may relate more closely with embryonic development.  The authors noted differential expression of the chemokine receptor CXCR7 (RDC-1) on marginal zone B cells, a cell type assocd. with autoimmune diseases.  The authors generated Cxcr7-/- mice but found that CXCR7 deficiency had little effect on B cell compn.  However, most Cxcr7-/- mice died at birth with ventricular septal defects and semilunar heart valve malformation.  Conditional deletion of Cxcr7 in endothelium, using Tie2-Cre transgenic mice, recapitulated this phenotype.  Gene profiling of Cxcr7-/- heart valve leaflets revealed a defect in the expression of factors essential for valve formation, vessel protection, or endothelial cell growth and survival.  The authors confirmed that the principal chemokine ligand for CXCR7 was CXCL12/SDF-1, which also binds CXCR4.  CXCL12 did not induce signaling via CXCR7; however, CXCR7 formed functional heterodimers with CXCR4 and enhanced CXCL12-induced signaling.  These results reveal a specialized role for CXCR7 in endothelial biol. and valve development and highlight the distinct developmental role of evolutionary conserved chemokine receptors such as CXCR7 and CXCR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWt3RDix4v7Vg90H21EOLACvtfcHk0ljQiHS7vfHjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOns7nO&md5=8f0189651d065aec51747df0d148399d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702229104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702229104%26sid%3Dliteratum%253Aachs%26aulast%3DSierro%26aufirst%3DF.%26aulast%3DBiben%26aufirst%3DC.%26aulast%3DMartinez-Munoz%26aufirst%3DL.%26aulast%3DMellado%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWoehl%26aufirst%3DB.%26aulast%3DLeung%26aufirst%3DH.%26aulast%3DGroom%26aufirst%3DJ.%26aulast%3DBatten%26aufirst%3DM.%26aulast%3DHarvey%26aufirst%3DR.%2BP.%26aulast%3DMartinez-A%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26aulast%3DMackay%26aufirst%3DF.%26atitle%3DDisrupted%2520Cardiac%2520Development%2520But%2520Normal%2520Hematopoiesis%2520in%2520Mice%2520Deficient%2520in%2520the%2520Second%2520CXCL12%252FSDF-1%2520Receptor%252C%2520CXCR7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D14759%26epage%3D14764%26doi%3D10.1073%2Fpnas.0702229104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menhaji-Klotz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesp, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canterbury, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagley, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdziorko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerin, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3685</span>– <span class="NLM_lpage">3696</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00190</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00190" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntF2ntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3685-3696&author=E.+Menhaji-Klotzauthor=K.+D.+Hespauthor=A.+T.+Londreganauthor=A.+S.+Kalgutkarauthor=D.+W.+Piotrowskiauthor=M.+Boehmauthor=K.+Songauthor=T.+Ryderauthor=K.+Beaumontauthor=R.+M.+Jonesauthor=K.+Atkinsonauthor=J.+A.+Brownauthor=J.+Litchfieldauthor=J.+Xiaoauthor=D.+P.+Canterburyauthor=K.+Burfordauthor=B.+A.+Thumaauthor=C.+Limberakisauthor=W.+Jiaoauthor=S.+W.+Bagleyauthor=S.+Agarwalauthor=D.+Crowellauthor=S.+Pazdziorkoauthor=J.+Wardauthor=D.+A.+Priceauthor=V.+Clerin&title=Discovery+of+a+Novel+Small-Molecule+Modulator+of+C-X-C+Chemokine+Receptor+Type+7+as+a+Treatment+for+Cardiac+Fibrosis&doi=10.1021%2Facs.jmedchem.8b00190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis</span></div><div class="casAuthors">Menhaji-Klotz, Elnaz; Hesp, Kevin D.; Londregan, Allyn T.; Kalgutkar, Amit S.; Piotrowski, David W.; Boehm, Markus; Song, Kun; Ryder, Tim; Beaumont, Kevin; Jones, Rhys M.; Atkinson, Karen; Brown, Janice A.; Litchfield, John; Xiao, Jun; Canterbury, Daniel P.; Burford, Kristen; Thuma, Benjamin A.; Limberakis, Chris; Jiao, Wenhua; Bagley, Scott W.; Agarwal, Saket; Crowell, Danielle; Pazdziorko, Stephen; Ward, Jessica; Price, David A.; Clerin, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3685-3696</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-X-C chemokine receptor type 7 (CXCR7) is involved in cardiac and immune pathophysiol.  We report the discovery of a novel 1,4-diazepine CXCR7 modulator, demonstrating for the first time the role of pharmacol. CXCR7 intervention in cardiac repair.  Structure-activity-relationship (SAR) studies demonstrated that a net redn. in lipophilicity (log D) and an incorporation of satd. ring systems yielded compds. with good CXCR7 potencies and improvements in oxidative metabolic stability in human-liver microsomes (HLM).  Tethering an ethylene amide further improved the selectivity profile (e.g., for compd. 18, CXCR7 Ki = 13 nM, adrenergic α 1a Kb > 10,000 nM, and adrenergic β 2 Kb > 10,000 nM).  The s.c. administration of 18 in mice led to a statistically significant increase in circulating concns. of plasma stromal-cell-derived factor 1α (SDF-1α) of approx. 2-fold.  Chronic dosing of compd. 18 in a mouse model of isoproterenol-induced cardiac injury further resulted in a statistically significant redn. of cardiac fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2P-nnsmcbbVg90H21EOLACvtfcHk0ljQiHS7vfHjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntF2ntLw%253D&md5=edaa64c4edbe27d8fcfca0067dac1cd1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00190%26sid%3Dliteratum%253Aachs%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DHesp%26aufirst%3DK.%2BD.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DCanterbury%26aufirst%3DD.%2BP.%26aulast%3DBurford%26aufirst%3DK.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DBagley%26aufirst%3DS.%2BW.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DCrowell%26aufirst%3DD.%26aulast%3DPazdziorko%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DClerin%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Small-Molecule%2520Modulator%2520of%2520C-X-C%2520Chemokine%2520Receptor%2520Type%25207%2520as%2520a%2520Treatment%2520for%2520Cardiac%2520Fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3685%26epage%3D3696%26doi%3D10.1021%2Facs.jmedchem.8b00190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolkkonen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. S.</span></span> <span> </span><span class="NLM_article-title">Effects of CXCR7-Neutralizing Antibody on Neurogenesis in the Hippocampal Dentate Gyrus and Cognitive Function in the Chronic Phase of Cerebral Ischemia</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1079</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.270416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4103%2F1673-5374.270416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=31823888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A280%3ADC%252BB3MfovVWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1079-1085&author=B.+C.+Dongauthor=M.+X.+Liauthor=X.+Y.+Wangauthor=X.+Chengauthor=Y.+Wangauthor=T.+Xiaoauthor=J.+Jolkkonenauthor=C.+S.+Zhaoauthor=S.+S.+Zhao&title=Effects+of+CXCR7-Neutralizing+Antibody+on+Neurogenesis+in+the+Hippocampal+Dentate+Gyrus+and+Cognitive+Function+in+the+Chronic+Phase+of+Cerebral+Ischemia&doi=10.4103%2F1673-5374.270416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of CXCR7-neutralizing antibody on neurogenesis in the hippocampal dentate gyrus and cognitive function in the chronic phase of cerebral ischemia</span></div><div class="casAuthors">Dong Bing-Chao; Li Mei-Xuan; Wang Xiao-Yin; Cheng Xi; Wang Yu; Zhao Chuan-Sheng; Zhao Shan-Shan; Xiao Ting; Jolkkonen Jukka</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1079-1085</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">Stromal cell-derived factor-1 and its receptor CXCR4 are essential regulators of the neurogenesis that occurs in the adult hippocampal dentate gyrus.  However, the effects of CXCR7, a new atypical receptor of stromal cell-derived factor-1, on hippocampal neurogenesis after a stroke remain largely unknown.  Our study is the first to investigate the effect of a CXCR7-neutralizing antibody on neurogenesis in the dentate gyrus and the associated recovery of cognitive function of rats in the chronic stage of cerebral ischemia.  The rats were randomly divided into sham, sham + anti-CXCR7, ischemia and ischemia + anti-CXCR7 groups.  Endothelin-1 was injected in the ipsilateral motor cortex and striatum to induce focal cerebral ischemia.  Sham group rats were injected with saline instead of endothelin-1 via intracranial injection.  Both sham and ischemic rats were treated with intraventricular infusions of CXCR7-neutralizing antibodies for 6 days 1 week after surgery.  Immunofluorescence staining with doublecortin, a marker for neuronal precursors, was performed to assess the neurogenesis in the dentate gyrus.  We found that anti-CXCR7 antibody infusion enhanced the proliferation and dendritic development of doublecortin-labeled cells in the dentate gyrus in both ischemic and sham-operated rats.  Spatial learning and memory functions were assessed by Morris water maze tests 30-32 days after ischemia.  CXCR7-neutralizing antibody treatment significantly reduced the escape latency of the spatial navigation trial and increased the time spent in the target quadrant of spatial probe trial in animals that received ischemic insult, but not in sham operated rats.  These results suggest that CXCR7-neutralizing antibody enhances the neurogenesis in the dentate gyrus and improves the cognitive function after cerebral ischemia in rats.  All animal experimental protocols and procedures were approved by the Institutional Animal Care and Use Committee of China Medical University (CMU16089R) on December 8, 2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShcsaZQZ7B8kh5eUSa2oe_fW6udTcc2eZadZ1sQBABrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfovVWjsw%253D%253D&md5=92a955cb02a50110b2fee6c3de7acf37</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.270416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.270416%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DM.%2BX.%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DJolkkonen%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%2BS.%26aulast%3DZhao%26aufirst%3DS.%2BS.%26atitle%3DEffects%2520of%2520CXCR7-Neutralizing%2520Antibody%2520on%2520Neurogenesis%2520in%2520the%2520Hippocampal%2520Dentate%2520Gyrus%2520and%2520Cognitive%2520Function%2520in%2520the%2520Chronic%2520Phase%2520of%2520Cerebral%2520Ischemia%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2020%26volume%3D15%26spage%3D1079%26epage%3D1085%26doi%3D10.4103%2F1673-5374.270416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">CXCR7 Suppression Modulates Microglial Chemotaxis to Ameliorate Experimentally-Induced Autoimmune Encephalomyelitis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>469</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.bbrc.2015.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=26607112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2jsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2016&pages=1-7&author=J.+Baoauthor=J.+Zhuauthor=S.+Luoauthor=Y.+Chengauthor=S.+Zhou&title=CXCR7+Suppression+Modulates+Microglial+Chemotaxis+to+Ameliorate+Experimentally-Induced+Autoimmune+Encephalomyelitis&doi=10.1016%2Fj.bbrc.2015.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis</span></div><div class="casAuthors">Bao, Jianhong; Zhu, Jinying; Luo, Sheng; Cheng, Ying; Zhou, Saijun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disease of the central nervous system (CNS).  Exptl. autoimmune encephalomyelitis (EAE), widely used as an animal model of MS, classically manifests as an ascending paralysis that is characterized by extensive infiltration of the CNS by inflammatory cells.  Although several studies uncover the significant role of microglia in the development of EAE, the cellular mechanisms of microglia that govern EAE pathogenesis remain unknown.  In the current study, we report that CXCR7 expression is dynamic regulated in activated microglia during CNS autoimmunity and pos. correlates with the clin. severity of EAE.  In addn., microglial chemotaxis is mediated by CXCR7 during CNS autoimmunity, signaling through extracellular signal-regulated kinase (ERK)1/2 activation, whereas p38 mitogen-activated protein kinase (MAPK) and (c-Jun N-terminal kinase) JNK are not involved.  Most importantly, CXCR7 neutralizing treatment ameliorates the clin. severity of EAE along with ERK1/2 phosphorylation redn.  Collectively, our data demonstrate that CXCR7 suppression modulates microglial chemotaxis to ameliorate EAE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQn62BIqPJmbVg90H21EOLACvtfcHk0lihQ55_u8bRqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2jsr%252FO&md5=7723255b0253c48ff567c7003a7b476e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DS.%26atitle%3DCXCR7%2520Suppression%2520Modulates%2520Microglial%2520Chemotaxis%2520to%2520Ameliorate%2520Experimentally-Induced%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D469%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.bbrc.2015.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Blocking CXCR7-Mediated Adipose Tissue Macrophages Chemotaxis Attenuates Insulin Resistance and Inflammation in Obesity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>479</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.09.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.bbrc.2016.09.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=27693695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2016&pages=649-655&author=H.+Pengauthor=H.+Zhangauthor=H.+Zhu&title=Blocking+CXCR7-Mediated+Adipose+Tissue+Macrophages+Chemotaxis+Attenuates+Insulin+Resistance+and+Inflammation+in+Obesity&doi=10.1016%2Fj.bbrc.2016.09.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity</span></div><div class="casAuthors">Peng, Hongxia; Zhang, Hu; Zhu, Honglei</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">649-655</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipose tissue macrophages (ATMs) have been considered to have a pivotal role in the chronic inflammation development during obesity.  Although chemokine-chemokine receptor interaction has been studied in ATMs infiltration, most chemokine receptors remain incompletely understood and little is known about their mechanism of actions that lead to ATMs chemotaxis and pathogenesis of insulin resistance during obesity.  In this study, we reported that CXCR7 expression is upregulated in adipose tissue, and specifically in ATMs during obesity.  In addn., CXCL11 or CXCL12-induced ATMs chemotaxis is mediated by CXCR7 in obesity but not leanness, whereas CXCR3 and CXCR4 are not involved.  Addnl. mechanism study shows that NF-κB activation is essential in ATMs chemotaxis, and manipulates chemotaxis of ATMs via CXCR7 expression regulation in obesity.  Most importantly, CXCR7 neutralizing therapy dose dependently leads to less infiltration of macrophages into adipose tissue and thus reduces inflammation and improves insulin sensitivity in obesity.  In conclusion, these findings demonstrated that blocking CXCR7-mediated ATMs chemotaxis ameliorates insulin resistance and inflammation in obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptL6sFubXESrVg90H21EOLACvtfcHk0lg4ePISM2A9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsrfK&md5=09275ac0f68bf282a7c9edd4c7b63471</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.09.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.09.158%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DBlocking%2520CXCR7-Mediated%2520Adipose%2520Tissue%2520Macrophages%2520Chemotaxis%2520Attenuates%2520Insulin%2520Resistance%2520and%2520Inflammation%2520in%2520Obesity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D479%26spage%3D649%26epage%3D655%26doi%3D10.1016%2Fj.bbrc.2016.09.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oderup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabel, B. A.</span></span> <span> </span><span class="NLM_article-title">A Chimeric Antibody Against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1016/j.ymthe.2018.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1016%2Fj.ymthe.2018.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=29606504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1354-1365&author=N.+Salazarauthor=J.+C.+Carlsonauthor=K.+Huangauthor=Y.+Zhengauthor=C.+Oderupauthor=J.+Grossauthor=A.+D.+Jangauthor=T.+M.+Burkeauthor=S.+Lew%C3%A9nauthor=A.+Scholzauthor=S.+Huangauthor=L.+Neaseauthor=J.+Kosekauthor=M.+Mittelbronnauthor=E.+C.+Butcherauthor=H.+Tuauthor=B.+A.+Zabel&title=A+Chimeric+Antibody+Against+ACKR3%2FCXCR7+in+Combination+with+TMZ+Activates+Immune+Responses+and+Extends+Survival+in+Mouse+GBM+Models&doi=10.1016%2Fj.ymthe.2018.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models</span></div><div class="casAuthors">Salazar, Nicole; Carlson, Jeffrey C.; Huang, Kexin; Zheng, Yayue; Oderup, Cecilia; Gross, Julia; Jang, Andrew D.; Burke, Thomas M.; Lewen, Susanna; Scholz, Alexander; Huang, Serina; Nease, Leona; Kosek, Jon; Mittelbronn, Michel; Butcher, Eugene C.; Tu, Hua; Zabel, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1354-1365</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0024</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the least treatable type of brain tumor, afflicting over 15,000 people per yr in the United States.  Patients have a median survival of 16 mo, and over 95% die within 5 years.  The chemokine receptor ACKR3 is selectively expressed on both GBM cells and tumor-assocd. blood vessels.  High tumor expression of ACKR3 correlates with poor prognosis and potential treatment resistance, making it an attractive therapeutic target.  We engineered a single chain FV-human FC-IgG1 (IgG1) antibody, X7Ab, to target ACKR3 in human and mouse GBM cells.  We used hydrodynamic gene transfer to overexpress the antibody, with efficacy in vivo.  X7Ab kills GBM tumor cells and ACKR3-expressing vascular endothelial cells by engaging the cytotoxic activity of natural killer (NK) cells and complement and the phagocytic activity of macrophages.  Combining X7Ab with TMZ allows the TMZ dosage to be lowered, without compromising therapeutic efficacy.  Mice treated with X7Ab and in combination with TMZ showed significant tumor redn. by MRI and longer survival overall.  Brain-tumor-infiltrating leukocyte anal. revealed that X7Ab enhances the activation of M1 macrophages to support anti-tumor immune response in vivo.  Targeting ACKR3 with immunotherapeutic monoclonal antibodies (mAbs) in combination with std. of care therapies may prove effective in treating GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTs6mwLAJuBLVg90H21EOLACvtfcHk0lg4ePISM2A9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVagt7o%253D&md5=2d08ccbf5f3432e67a46a6c9887ccbb8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ymthe.2018.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymthe.2018.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DN.%26aulast%3DCarlson%26aufirst%3DJ.%2BC.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DOderup%26aufirst%3DC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DA.%2BD.%26aulast%3DBurke%26aufirst%3DT.%2BM.%26aulast%3DLew%25C3%25A9n%26aufirst%3DS.%26aulast%3DScholz%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DKosek%26aufirst%3DJ.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DTu%26aufirst%3DH.%26aulast%3DZabel%26aufirst%3DB.%2BA.%26atitle%3DA%2520Chimeric%2520Antibody%2520Against%2520ACKR3%252FCXCR7%2520in%2520Combination%2520with%2520TMZ%2520Activates%2520Immune%2520Responses%2520and%2520Extends%2520Survival%2520in%2520Mouse%2520GBM%2520Models%26jtitle%3DMol.%2520Ther.%26date%3D2018%26volume%3D26%26spage%3D1354%26epage%3D1365%26doi%3D10.1016%2Fj.ymthe.2018.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maussang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujić-Delić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descamps, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanlandschoot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsum, M. S.-v.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Roy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Pajuelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchiers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rompaey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span> <span> </span><span class="NLM_article-title">Llama-Derived Single Variable Domains (Nanobodies) Directed Against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">29562</span>– <span class="NLM_lpage">29572</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.498436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1074%2Fjbc.M113.498436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=23979133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Shs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=29562-29572&author=D.+Maussangauthor=A.+Muji%C4%87-Deli%C4%87author=F.+J.+Descampsauthor=C.+Stortelersauthor=P.+Vanlandschootauthor=M.+S.-v.+Walsumauthor=H.+F.+Vischerauthor=M.+van+Royauthor=M.+Vosjanauthor=M.+Gonzalez-Pajueloauthor=G.+A.+van+Dongenauthor=P.+Merchiersauthor=P.+van+Rompaeyauthor=M.+J.+Smit&title=Llama-Derived+Single+Variable+Domains+%28Nanobodies%29+Directed+Against+Chemokine+Receptor+CXCR7+Reduce+Head+and+Neck+Cancer+Cell+Growth+in+vivo&doi=10.1074%2Fjbc.M113.498436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Llama-derived single domain antibodies (Nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo</span></div><div class="casAuthors">Maussang, David; Mujic-Delic, Azra; Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; Stigter-van Walsum, Marijke; Vischer, Henry F.; van Roy, Maarten; Vosjan, Maria; Gonzalez-Pajuelo, Maria; van Dongen, Guus A. M. S.; Merchiers, Pascal; van Rompaey, Philippe; Smit, Martine J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">29562-29572</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR7, belonging to the is expressed in several tumor types.  Inhibition of CXCR7 with either small mols. or small interference (si)RNA has shown promising therapeutic benefits in several tumor models.  With the increased interest and effectiveness of biologicals inhibiting membrane-bound receptors we made use of the "Nanobody platform" to target CXCR7.  Previously we showed that Nanobodies, i.e. Ig single variable domains derived from naturally occurring heavy chain-only camelids antibodies, represent new biol. tools to efficiently tackle difficult drug targets such as G protein-coupled receptors.  In this study we developed and characterized highly selective and potent Nanobodies against CXCR7.  Interestingly, the CXCR7-targeting Nanobodies displayed antagonistic properties in contrast with previously reported CXCR7-targeting agents.  Several high affinity CXCR7-specific Nanobodies potently inhibited CXCL12-induced β-arrestin2 recruitment in vitro.  A wide variety of tumor biopsies was profiled, showing for the first time high expression of CXCR7 in head and neck cancer.  Using a patient-derived CXCR7-expressing head and neck cancer xenograft model in nude mice, tumor growth was inhibited by CXCR7-targeting Nanobody therapy.  Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.  Hence, with this novel class of CXCR7 inhibitors, we further substantiate the therapeutic relevance of targeting CXCR7 in head and neck cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGe5r9V21RZLVg90H21EOLACvtfcHk0lg4ePISM2A9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Shs7vF&md5=3b519bc099d0d326a109d7f346cbd0ea</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.498436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.498436%26sid%3Dliteratum%253Aachs%26aulast%3DMaussang%26aufirst%3DD.%26aulast%3DMuji%25C4%2587-Deli%25C4%2587%26aufirst%3DA.%26aulast%3DDescamps%26aufirst%3DF.%2BJ.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DVanlandschoot%26aufirst%3DP.%26aulast%3DWalsum%26aufirst%3DM.%2BS.-v.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dvan%2BRoy%26aufirst%3DM.%26aulast%3DVosjan%26aufirst%3DM.%26aulast%3DGonzalez-Pajuelo%26aufirst%3DM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%26aulast%3DMerchiers%26aufirst%3DP.%26aulast%3Dvan%2BRompaey%26aufirst%3DP.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26atitle%3DLlama-Derived%2520Single%2520Variable%2520Domains%2520%2528Nanobodies%2529%2520Directed%2520Against%2520Chemokine%2520Receptor%2520CXCR7%2520Reduce%2520Head%2520and%2520Neck%2520Cancer%2520Cell%2520Growth%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D29562%26epage%3D29572%26doi%3D10.1074%2Fjbc.M113.498436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zabel, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berahovich, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfold, M. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowska-Wieczorek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">3204</span>– <span class="NLM_lpage">3211</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.4049%2Fjimmunol.0900269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19641136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWrs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=3204-3211&author=B.+A.+Zabelauthor=Y.+Wangauthor=S.+Lew%C3%A9nauthor=R.+D.+Berahovichauthor=M.+E.+T.+Penfoldauthor=P.+Zhangauthor=J.+Powersauthor=B.+C.+Summersauthor=Z.+Miaoauthor=B.+Zhaoauthor=A.+Jaliliauthor=A.+Janowska-Wieczorekauthor=J.+C.+Jaenauthor=T.+J.+Schall&title=Elucidation+of+CXCR7-Mediated+Signaling+Events+and+Inhibition+of+CXCR4-Mediated+Tumor+Cell+Transendothelial+Migration+by+CXCR7+Ligands&doi=10.4049%2Fjimmunol.0900269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands</span></div><div class="casAuthors">Zabel, Brian A.; Wang, Yu; Lewen, Susanna; Berahovich, Robert D.; Penfold, Mark E. T.; Zhang, Penglie; Powers, Jay; Summers, Bretton C.; Miao, Zhenhua; Zhao, Bin; Jalili, Ali; Janowska-Wieczorek, Anna; Jaen, Juan C.; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3204-3211</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">CXCR7 binds chemokines CXCL11 (I-TAC) and CXCL12 (SDF-1) but does not act as a classical chemoattractant receptor.  Using CCX771, a novel small mol. with high affinity and selectivity for CXCR7, the authors found that, although CXCR7 is dispensable for "bare filter" in vitro chemotaxis, CXCR7 plays an essential role in the CXCL12/CXCR4-mediated transendothelial migration (TEM) of CXCR4+CXCR7+ human tumor cells.  Importantly, although CXCL11 is unable to stimulate directly the migration of these cells, it acts as a potent antagonist of their CXCL12-induced TEM.  Furthermore, even though this TEM is driven by CXCR4, the CXCR7 ligand CCX771 is substantially more potent at inhibiting it than the CXCR4 antagonist AMD3100, which is more than 100 times weaker at inhibiting TEM when compared with its ability to block bare filter chemotaxis.  Far from being a "silent" receptor, the authors show that CXCR7 displays early hallmark events assocd. with intracellular signaling.  Upon cognate chemokine binding, CXCR7 assocs. with β-arrestin2, an interaction that can be blocked by CXCR7-specific mAbs.  Remarkably, the synthetic CXCR7 ligand CCX771 also potently stimulates β-arrestin2 recruitment to CXCR7, with greater potency and efficacy than the endogenous chemokine ligands.  These results indicate that CXCR7 can regulate CXCL12-mediated migratory cues, and thus may play a crit. role in driving CXCR4+CXCR7+ tumor cell metastasis and tissue invasion.  CXCR7 ligands, such as the chemokine CXCL11 and the newly described synthetic mol. CCX771, may represent novel therapeutic opportunities for the control of such cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngb3AyBsAqrVg90H21EOLACvtfcHk0lgrdKbytCe9XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWrs7rP&md5=eb3dd5400f39f4e0245d6bc9efe68065</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900269%26sid%3Dliteratum%253Aachs%26aulast%3DZabel%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLew%25C3%25A9n%26aufirst%3DS.%26aulast%3DBerahovich%26aufirst%3DR.%2BD.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DSummers%26aufirst%3DB.%2BC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DJalili%26aufirst%3DA.%26aulast%3DJanowska-Wieczorek%26aufirst%3DA.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DElucidation%2520of%2520CXCR7-Mediated%2520Signaling%2520Events%2520and%2520Inhibition%2520of%2520CXCR4-Mediated%2520Tumor%2520Cell%2520Transendothelial%2520Migration%2520by%2520CXCR7%2520Ligands%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D3204%26epage%3D3211%26doi%3D10.4049%2Fjimmunol.0900269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luker, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, G. D.</span></span> <span> </span><span class="NLM_article-title">Imaging Chemokine Receptor Dimerization with Firefly Luciferase Complementation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1096/fj.08-116749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1096%2Ffj.08-116749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=19001056" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=823-834&author=K.+E.+Lukerauthor=M.+Guptaauthor=G.+D.+Luker&title=Imaging+Chemokine+Receptor+Dimerization+with+Firefly+Luciferase+Complementation&doi=10.1096%2Ffj.08-116749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1096%2Ffj.08-116749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.08-116749%26sid%3Dliteratum%253Aachs%26aulast%3DLuker%26aufirst%3DK.%2BE.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DLuker%26aufirst%3DG.%2BD.%26atitle%3DImaging%2520Chemokine%2520Receptor%2520Dimerization%2520with%2520Firefly%2520Luciferase%2520Complementation%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D23%26spage%3D823%26epage%3D834%26doi%3D10.1096%2Ffj.08-116749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gils, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handel, T. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Ligand Interaction with Atypical Chemokine Receptor 3</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14135</span>, <span class="refDoi"> DOI: 10.1038/ncomms14135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1038%2Fncomms14135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=28098154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14135&author=M.+Gustavssonauthor=L.+Wangauthor=N.+van+Gilsauthor=B.+S.+Stephensauthor=P.+Zhangauthor=T.+J.+Schallauthor=S.+Yangauthor=R.+Abagyanauthor=M.+R.+Chanceauthor=I.+Kufarevaauthor=T.+M.+Handel&title=Structural+Basis+of+Ligand+Interaction+with+Atypical+Chemokine+Receptor+3&doi=10.1038%2Fncomms14135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand interaction with atypical chemokine receptor 3</span></div><div class="casAuthors">Gustavsson, Martin; Wang, Liwen; van Gils, Noortje; Stephens, Bryan S.; Zhang, Penglie; Schall, Thomas J.; Yang, Sichun; Abagyan, Ruben; Chance, Mark R.; Kufareva, Irina; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14135</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokines drive cell migration through their interactions with seven-transmembrane (7TM) chemokine receptors on cell surfaces.  The atypical chemokine receptor 3 (ACKR3) binds chemokines CXCL11 and CXCL12 and signals exclusively through β-arrestin-mediated pathways, without activating canonical G-protein signalling.  This receptor is upregulated in numerous cancers making it a potential drug target.  Here we collected over 100 distinct structural probes from radiolytic footprinting, disulfide trapping, and mutagenesis to map the structures of ACKR3:CXCL12 and ACKR3:small-mol. complexes, including dynamic regions that proved unresolvable by X-ray crystallog. in homologous receptors.  The data are integrated with mol. modeling to produce complete and cohesive exptl. driven models that confirm and expand on the existing knowledge of the architecture of receptor:chemokine and receptor:small-mol. complexes.  Addnl., we detected and characterized ligand-induced conformational changes in the transmembrane and intracellular regions of ACKR3 that elucidate fundamental structural elements of agonism in this atypical receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyVMT01L6lqbVg90H21EOLACvtfcHk0lgrdKbytCe9XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7c%253D&md5=fb81a7d54258325919c1febb4be3ce16</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fncomms14135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14135%26sid%3Dliteratum%253Aachs%26aulast%3DGustavsson%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3Dvan%2BGils%26aufirst%3DN.%26aulast%3DStephens%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520Basis%2520of%2520Ligand%2520Interaction%2520with%2520Atypical%2520Chemokine%2520Receptor%25203%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14135%26doi%3D10.1038%2Fncomms14135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menhaji-Klotz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesp, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVGjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1330-1334&author=E.+Menhaji-Klotzauthor=J.+Wardauthor=J.+A.+Brownauthor=P.+M.+Loriaauthor=C.+Tanauthor=K.+D.+Hespauthor=K.+A.+Riccardiauthor=J.+Litchfieldauthor=M.+Boehm&title=Discovery+of+Diphenylacetamides+as+CXCR7+Inhibitors+with+Novel+%CE%B2-Arrestin+Antagonist+Activity&doi=10.1021%2Facsmedchemlett.0c00163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity</span></div><div class="casAuthors">Menhaji-Klotz, Elnaz; Ward, Jessica; Brown, Janice A.; Loria, Paula M.; Tan, Carina; Hesp, Kevin D.; Riccardi, Keith A.; Litchfield, John; Boehm, Markus</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1330-1334</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The atypical chemokine receptor CXCR7 has been studied in various disease settings including immunol. diseases and heart disease.  Efforts to elucidate the role of CXCR7 have been limited by the lack of suitable chem. tools with a range of pharmacol. profiles.  A high-throughput screen was conducted to discover novel chem. matter with the potential to modulate CXCR7 receptor activity.  This led to the identification of a series of diphenylacetamides confirmed in a CXCL12 competition assay indicating receptor binding.  Further evaluation of this series revealed a lack of activity in the functional assay measuring β-arrestin recruitment.  The most potent representative, compd. 10 (Ki = 597 nM), was detd. to be an antagonist in the β-arrestin assay (IC50 = 622 nM).  To our knowledge, this is the first reported small mol. β-arrestin antagonist for CXCR7, useful as an in vitro chem. tool to elucidate the effects of CXCL12 displacement with β-arrestin antagonism in models for diseases such as cardiac injury and suitable as starting point for hit optimization directed toward an in vivo tool compd. for studying CXCR7 receptor pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiX-a_AcvtQ7Vg90H21EOLACvtfcHk0lhQlDmZzEnW5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVGjsr4%253D&md5=82c8c38b8a4b4f70d316d95298b8ca9f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00163%26sid%3Dliteratum%253Aachs%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DHesp%26aufirst%3DK.%2BD.%26aulast%3DRiccardi%26aufirst%3DK.%2BA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Diphenylacetamides%2520as%2520CXCR7%2520Inhibitors%2520with%2520Novel%2520%25CE%25B2-Arrestin%2520Antagonist%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1330%26epage%3D1334%26doi%3D10.1021%2Facsmedchemlett.0c00163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fretz, H. G.</span>; <span class="NLM_string-name">Guerry, P.</span>; <span class="NLM_string-name">Kimmerlin, T.</span>; <span class="NLM_string-name">Lehembre, F.</span>; <span class="NLM_string-name">Pfeifer, T.</span>; <span class="NLM_string-name">Valdenaire, A.</span></span> <span> </span><span class="NLM_article-title">1 -[m-Carboxamido(hetero)aryl-methyl]-piperidine-4-carboxamide Derivatives as CXCR7 Modulators and their Preparation</span>. <span class="NLM_patent">US20130345199A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+G.+Fretz&author=P.+Guerry&author=T.+Kimmerlin&author=F.+Lehembre&author=T.+Pfeifer&author=A.+Valdenaire&title=1+-%5Bm-Carboxamido%28hetero%29aryl-methyl%5D-piperidine-4-carboxamide+Derivatives+as+CXCR7+Modulators+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%2BG.%26atitle%3D1%2520-%255Bm-Carboxamido%2528hetero%2529aryl-methyl%255D-piperidine-4-carboxamide%2520Derivatives%2520as%2520CXCR7%2520Modulators%2520and%2520their%2520Preparation%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+Drug+Discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lhQlDmZzEnW5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>– <span class="NLM_lpage">5880</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+Fluorinated+Motifs+in+the+Design+and+Application+of+Bioisosteres+for+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0lhQlDmZzEnW5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520Fluorinated%2520Motifs%2520in%2520the%2520Design%2520and%2520Application%2520of%2520Bioisosteres%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinnerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenhan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Synthesis of a New Helix-Forming β-Amino Acid: trans-4-Aminopiperidine-3-carboxylic Acid</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1002%2Fejoc.200390112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFWntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=721-726&author=M.+Schinnerlauthor=J.+K.+Murrayauthor=J.+M.+Langenhanauthor=S.+H.+Gellman&title=Asymmetric+Synthesis+of+a+New+Helix-Forming+%CE%B2-Amino+Acid%3A+trans-4-Aminopiperidine-3-carboxylic+Acid&doi=10.1002%2Fejoc.200390112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of a new helix-forming β-amino acid: Trans-4-aminopiperidine-3-carboxylic acid</span></div><div class="casAuthors">Schinnerl, Marina; Murray, Justin K.; Langenhan, Joseph M.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1434-193X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A syntheses of protected enantiomers of trans-4-aminopiperidine-3-carboxylic acid (APiC) and trans-2-aminocyclohexanecarboxylic acid (ACHC) are reported.  Purifn. of all intermediates by crystn. makes this method amenable to large-scale prepn.  The prepd. APiC and ACHC residues form the 14-helix (helical conformation defined by 14-membered C-O(i)...H-N(i-2) hydrogen bonds) in soln.  These cyclically constrained β-amino acids (APiC and ACHC) should be useful as building blocks for a construction of short β-peptides with defined conformation in aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWr7jBzSrH7Vg90H21EOLACvtfcHk0lgjF5Llfi8Xtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFWntbY%253D&md5=b5272c719047cd4e3306eb22f4e146de</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200390112%26sid%3Dliteratum%253Aachs%26aulast%3DSchinnerl%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%2BK.%26aulast%3DLangenhan%26aufirst%3DJ.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520a%2520New%2520Helix-Forming%2520%25CE%25B2-Amino%2520Acid%253A%2520trans-4-Aminopiperidine-3-carboxylic%2520Acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26spage%3D721%26epage%3D726%26doi%3D10.1002%2Fejoc.200390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated Space-Group and Crystal-Structure Determination</span>. <i>Acta Crystallogr. A Found Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25537383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+Integrated+Space-Group+and+Crystal-Structure+Determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lgjF5Llfi8Xtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520Integrated%2520Space-Group%2520and%2520Crystal-Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%2520A%2520Found%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure Refinement with SHELXL</span>. <i>Acta Crystallogr. C Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25567568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+Structure+Refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lgjF5Llfi8Xtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520Structure%2520Refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%2520C%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">PLATONSQUEEZE: A Tool for the Calculation of the Disordered Solvent Contribution to the Calculated Structure Factors</span>. <i>Acta Crystallogr., Sect. C</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=10.1107%2FS2053229614024929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=25567569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=9-18&author=A.+L.+Spek&title=PLATONSQUEEZE%3A+A+Tool+for+the+Calculation+of+the+Disordered+Solvent+Contribution+to+the+Calculated+Structure+Factors&doi=10.1107%2FS2053229614024929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors</span></div><div class="casAuthors">Spek, Anthony L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The completion of a crystal structure detn. is often hampered by the presence of embedded solvent mols. or ions that are seriously disordered.  Their contribution to the calcd. structure factors in the least-squares refinement of a crystal structure has to be included in some way.  Traditionally, an atomistic solvent disorder model is attempted.  Such an approach is generally to be preferred, but it does not always lead to a satisfactory result and may even be impossible in cases where channels in the structure are filled with continuous electron d.  This paper documents the SQUEEZE method as an alternative means of addressing the solvent disorder issue.  It conveniently interfaces with the 2014 version of the least-squares refinement program SHELXL [Sheldrick (2015). Acta Cryst. C71. In the press] and other refinement programs that accept externally provided fixed contributions to the calcd. structure factors.  The PLATON SQUEEZE tool calcs. the solvent contribution to the structure factors by back-Fourier transformation of the electron d. found in the solvent-accessible region of a phase-optimized difference electron-d. map.  The actual least-squares structure refinement is delegated to, for example, SHELXL.  The current versions of PLATON SQUEEZE and SHELXL now address several of the unnecessary complications with the earlier implementation of the SQUEEZE procedure that were a necessity because least-squares refinement with the now superseded SHELXL97 program did not allow for the input of fixed externally provided contributions to the structure-factor calcn.  It is no longer necessary to subtract the solvent contribution temporarily from the obsd. intensities to be able to use SHELXL for the least-squares refinement, since that program now accepts the solvent contribution from an external file ( file) if the ABIN instruction is used.  In addn., many twinned structures contg. disordered solvents are now also treatable by SQUEEZE.  The details of a SQUEEZE calcn. are now automatically included in the CIF archive file, along with the unmerged reflection data.  The current implementation of the SQUEEZE procedure is described, and discussed and illustrated with three examples.  Two of them are based on the reflection data of published structures and one on synthetic reflection data generated for a published structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJNzAtEImLLVg90H21EOLACvtfcHk0lguhGcQ9lgUZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFejtw%253D%253D&md5=88200a7c2b687d49b1dedf1a7b7fa38d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024929%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DPLATONSQUEEZE%253A%2520A%2520Tool%2520for%2520the%2520Calculation%2520of%2520the%2520Disordered%2520Solvent%2520Contribution%2520to%2520the%2520Calculated%2520Structure%2520Factors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%26date%3D2015%26volume%3D71%26spage%3D9%26epage%3D18%26doi%3D10.1107%2FS2053229614024929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01588">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02573"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01588?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01588</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed experimental procedures and analytical data of HTS hits <b>2–6</b>; synthesized compounds <b>7a–31</b> and respective precursors; X-ray crystallographic structure parameters of compound <b>28f</b>; method for the determination of the melting point by differential scanning calorimetry (DSC); method for the determination of log <i>D</i><sub>7.4</sub> and p<i>K</i><sub>a</sub> values; method describing the CXCR7-agonist <b>1</b> assay, including insurmountability determination; method describing the CXCR7-CXCL12 assay; experimental details for the biological assays to assess the potency of <b>28f</b> on CXCR7 from various species, on human CXCR4 and to determine its <i>K</i><sub>i</sub>, <i>K</i><sub>on</sub>, and <i>K</i><sub>off</sub> constants; and experimental details for the cytochrome P450 enzyme inhibition assays, for the metabolic stability studies, the detailed description of the pharmacokinetic studies in rat and dog, and the target engagement <i>in vivo</i> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf">jm0c01588_si_001.pdf (4.49 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_002.csv">jm0c01588_si_002.csv (11.97 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The corresponding data set has been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam" class="extLink">http://www.ccdc.cam</a>. c.uk/, under the following deposition number: CCDC 1993933 (compound <b>28f</b>, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01588/suppl_file/jm0c01588_si_001.pdf" class="ext-link">Supporting Information</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01588&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01588%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01588" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991ea93b053d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
